metronidazole has been researched along with vancomycin in 617 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 63 (10.21) | 18.7374 |
| 1990's | 66 (10.70) | 18.2507 |
| 2000's | 144 (23.34) | 29.6817 |
| 2010's | 282 (45.71) | 24.3611 |
| 2020's | 62 (10.05) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
| Bradbury, BJ; Buechter, DD; Cheng, J; Deshpande, M; Mushtaq, G; Podos, SD; Pucci, MJ; Thanassi, JA; Thoma, CL; Vigliotti, GA | 1 |
| Galang, MA; Gerding, DN; Hecht, DW; Johnson, S; Osmolski, JR; Sambol, SP | 1 |
| Bergeron, MG; Domingo, MC; Giroux, R; Huletsky, A; Picard, FJ | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Béliveau, C; Labbé, AC; Laverdière, M; Louie, T; Maccannell, D; Pépin, J; Poirier, L; Savoie, M | 1 |
| Amsler, KM; Bush, K; Davies, TA; Jacobs, MR; Shang, W | 1 |
| Karlowsky, JA; Laing, NM; Zhanel, GG | 1 |
| Jacobus, NV; McDermott, LA; Snydman, DR | 2 |
| Donskey, C; Goldstein, EJ; Louie, T; Miller, M; Mullane, K | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Brunner, LS; Haas, W; Lee, JC; Morris, TW; Pillar, CM; Zurenko, GE | 1 |
| Schaadt, R; Shinabarger, D; Sweeney, D; Zurenko, G | 1 |
| Bolanos, M; Finegold, SM; Molitoris, DR; Sumannen, PH | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Chong, Y; Jeong, SH; Kim, MS; Lee, K; Lee, Y; Park, Y; Yong, D | 1 |
| Bavari, S; Bowlin, TL; Butler, MM; Moir, DT; Panchal, RG; Peet, NP; Shinabarger, DL; Williams, JD | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cai, G; Cho, S; Franzblau, SG; Jaki, BU; Lee, IA; McAlpine, JB; Napolitano, JG; Pauli, GF; Suh, JW; Wang, Y; Yang, SH | 1 |
| Bremner, JB; Casadei, G; Chen, C; Doll, NK; Kelso, MJ; Lewis, K | 1 |
| Citron, D; He, Y; Herradura, P; Howland, K; Keith, D; Li, J; Mascio, CT; Mesleh, MF; Metcalf, C; Mortin, LI; Pearson, A; Silverman, J; Steenbergen, J; Thorne, GM; Van Praagh, AD; Yin, N | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brown, N; Silverman, MH; Wright, G; Xu, WC; Yu, XY | 1 |
| Chang, M; De Benedetti, S; Fisher, JF; Janardhanan, J; Lastochkin, E; Masitas, C; Mobashery, S; Oliver, AG; Qian, Y; Schroeder, VA; Speri, E; Wang, M; Wolter, WR | 1 |
| Chen, J; Ding, C; Doyle, T; Duncan, L; Ebright, RH; He, S; Lin, W; Liu, Y; Lynch, AS; Ma, Z; Molodtsov, V; Nguyen, P; Pulse, M; Robertson, GT; Wang, H; Weiss, WJ; Xu, X; Yuan, Y; Zhuang, Z | 1 |
| Del Favero, A; Menichetti, F; Morelli, A; Narducci, F; Pelli, MA | 1 |
| Waldvogel, FA | 1 |
| Burdon, DW; Keighley, M; Mogg, GA | 1 |
| Werner, H | 1 |
| Browne, RA; Ebright, JR; Fekety, R; Rifkin, GD; Silva, J | 1 |
| Finegold, SM | 1 |
| Bettin, KM; Clabots, CR; Gerding, DN; Homann, SR; Johnson, S; Peterson, LR; Quick, JN | 1 |
| Spencer, RC; Wilcox, MH | 1 |
| Bagwell, CE; Langham, MR; Mahaffey, SM; Shandling, B; Talbert, JL | 1 |
| Fruhmann, K; Krotenberg, R; Yablon, SA | 1 |
| Campbell, SF; McCormack, JG; Wynne, JM | 1 |
| Ellison, MJ | 1 |
| Chen, C | 1 |
| Dru, M | 1 |
| Dworczyński, A; Meisel-Mikołajczyk, F; Sokół, B | 1 |
| Changchien, CS; Chen, PC; Chiu, CT; Chuah, SK; Lin, HH; Wu, CS | 1 |
| Buchman, AL; Nagami, PH; Ponsillo, M | 1 |
| Bacon, AE; Fekety, R; Holloway, WJ; McGrath, S | 1 |
| Levett, PN | 1 |
| Ariano, RE; Harding, GK; Zhanel, GG | 1 |
| Aprahamian, C; Bergstein, JM; Kramer, A; Quebbeman, EJ; Wittman, DH | 1 |
| Montes de Oca, G; Oh, T; Osorno, RJ | 1 |
| Cerf, M; Levecq, H | 1 |
| Barile, C; Conforti, M; Merlo, M; Violato, F | 1 |
| Guglielmo, BJ; Jacobs, R; Oliva, SL; Pons, VG | 1 |
| Chamovitz, BN; McKenna, JP | 1 |
| Gitnick, G | 1 |
| Ciancio, SG | 1 |
| Dehne, M; el Abed, K; Hofmann, W; Kroh, U; Lennartz, H | 1 |
| Silva, J | 1 |
| Traub, WH | 1 |
| Panichi, G | 1 |
| Lindmark, A; Nord, CE; Persson, I | 1 |
| Briceland, LL; Nightingale, CH; Quintiliani, R | 1 |
| Bingley, PJ; Harding, GM | 1 |
| Carlstedt-Duke, B; Høverstad, T; Lingaas, E; Midtvedt, T; Norin, KE; Saxerholt, H; Steinbakk, M | 1 |
| Feingold, DS; Wagner, RF | 1 |
| Barclay, F; Bonnycastle, M; Borriello, SP; Piper, M; Seal, D; Welch, A | 1 |
| Goh, KL; Peh, SC; Wong, NW | 1 |
| Beart, RW; Talbot, RW; Walker, RC | 1 |
| Pankey, GA; Valainis, GT | 1 |
| Wong, HB | 1 |
| Dajani, AS; Thirumoorthi, MC | 1 |
| Höchter, W; Ottenjann, R; Wörmann, B | 1 |
| Bartlett, JG | 5 |
| McDonald, M; Young, G | 1 |
| Amin, NM | 1 |
| Adams, GL; Griebie, M | 1 |
| Hermans, PE; Wilkowske, CJ | 1 |
| Lerner, PI | 1 |
| Finegold, SM; Nastro, LJ | 1 |
| Ashley, FP; Emslie, RD | 1 |
| Gugler, R; Steudel, HC | 1 |
| Bolton, RP | 1 |
| Gebhard, RL; Gerding, DN; Lee, JT; Olson, MM; Peterson, LR; Schwartz, MJ; Teasley, DG | 1 |
| Gordon, RS | 1 |
| Everett, ED; Strausbaugh, LJ | 1 |
| Hodges, GR; Snavely, SR | 1 |
| Danziger, LH; Hau, T; Nishikawa, R | 1 |
| Arbogast, JG; Liebig, CW; Ponte, CD | 1 |
| Burdon, DW | 1 |
| Buggy, B; Deery, HG; Fekety, R; Silva, J | 1 |
| Amsel, R; Eschenbach, DA; Holmes, KK; Spiegel, CA | 1 |
| Nord, CE; Nordbring, F | 1 |
| Borriello, SP; Glazer, G; Phillips, RK | 1 |
| Brown, JR | 1 |
| Heijl, L; Lindhe, J | 1 |
| Dahlén, G; Heijl, L; Lindhe, J; Möller, A | 1 |
| Heijl, L | 1 |
| Accardo, P; Bortone, AM; D'Imperio, N; Dal Monte, PR; Formica, G; Giuliani-Piccari, G; Simoni, S | 1 |
| Keighley, MR | 1 |
| Tedesco, FJ | 2 |
| Cherry, RD; Daly, DS; Goresky, CA; Jabbari, M; Kinnear, DG; Portnoy, D | 1 |
| Eglinton, GS; Mayes, GR; Potts, DW | 1 |
| Meuwissen, SG; Mulder, CJ; Reiss, M; Rietra, PJ; Van Leeuwen, AM; Visser, J | 1 |
| Murray, D; Portnoy, D; Richards, GK; Soneji, A | 1 |
| Finegold, SM; George, WL; Rolfe, RD | 1 |
| Miller, JA; Oldenburger, D | 1 |
| Bell, B; Cooper, M; Golledge, CL; Riley, TV | 1 |
| Bohnen, JM; Burnett, RJ; Dellinger, EP; Haverstock, DC; Reinhart, HH; Rotstein, OD; Solomkin, JS; Vogel, SB | 1 |
| Delmée, M; Melin, P; Peetermans, W; Verbist, L; Verschraegen, G | 1 |
| Fraser, GM; Inbar-Yanai, I; Niv, Y | 1 |
| Gerding, DN; Lee, JT; Olson, MM; Shanholtzer, CJ | 1 |
| Althoff, PH; Fischer, M; Stern, M | 1 |
| Barton, TL; Bublin, JG | 1 |
| Demling, L; Stoll, R | 1 |
| Deveney, CW; Deveney, KE; Grasley, A; Jobe, BA; Sheppard, BC | 1 |
| Cartmill, TD; Keith, E; McCann, DC; Nice, CN; Panigrahi, H; Worsley, MA | 1 |
| Messick, CR; Reinke, CM | 1 |
| Bacon, AE; Caputo, GM; Weitekamp, MR; Whitener, C | 1 |
| Barrett, AP; Schifter, M | 1 |
| Brandt, LJ; Lu, SS; Schwartz, JM; Simon, DM | 1 |
| Berman, DS; Wenglin, BD | 1 |
| Jacobs, NF | 1 |
| Bein, G; Flocken, W; Gorenflo, M; Vogel, M; Waldschmidt, J | 1 |
| Cappell, MS; Philogene, C | 1 |
| Borucki, MJ; Clench, MH; Cozart, JC; Kalangi, SS; Pollard, RB; Soloway, RD; Taylor, DR | 1 |
| Howe, R; Wilcox, MH | 1 |
| Alexander, F; Grundfest-Broniatowski, S; Lavery, I; Milsom, J; Quader, M; Walsh, RM | 1 |
| Schweitzer, MA; Silver, DL; Stellato, TA; Sweiss, I | 1 |
| Graninger, W; Hasenhündl, M; Hirschl, AM; Parschalk, B; Wenisch, C | 1 |
| Byl, B; Jacobs, F; Struelens, MJ; Thys, JP | 1 |
| Gröschel, DH | 1 |
| Dare, A; Lapiński, TW | 1 |
| Culver, D; Danzing, L; Edwards, J; Gaynes, R; Stroud, L | 1 |
| Golden, WE; Pitts, B; Sanchez, N | 1 |
| Cartwright, K; Dooley, J; Fairclough, P; Mani, V; Oakley, C; Swarbrick, E | 1 |
| Elmer, GW; Fekety, R; Greenberg, RN; McFarland, LV; Mulligan, ME; Surawicz, CM | 1 |
| Hunter, MP; Richards, GA | 1 |
| Kusum, M; Phan-Urai, R; Wongwanich, S | 1 |
| Gerding, DN | 3 |
| Kelly, CP; LaMont, JT | 1 |
| Hazir, T; Jan, IA; Khan, MA; Khan, NA; Qazi, A | 1 |
| Kavan, P; Koutecky, J; Lochmann, O; McClain, LK; Nyc, O; Skala, PJ; Sochor, M | 1 |
| Flexner, CW; Lechtzin, N; Lucas, GM; Moore, RD; Puryear, DW; Yau, LL | 1 |
| Bailey, EM | 1 |
| Corpuz, M; Nair, S; Pitchumoni, CS; Yadav, D | 1 |
| Agrawal, M; Bhat, N; Dhawan, VK; Nachum, R; Tolbert, L | 1 |
| Elmer, GW; Fekety, R; Greenberg, RN; McFarland, LV; Rubin, M; Surawicz, CM | 1 |
| Hoshika, K | 1 |
| Luk, WK; Wong, SS; Woo, PC; Yuen, KY | 1 |
| Johnson, TE; Meldrum, ML; Suñer, IJ; Tse, DT | 1 |
| Danko, L; Elmer, GW; Greenberg, RN; McFarland, LV; Surawicz, CM | 1 |
| Barbisoni, P; Bellelli, G; Rozzini, R; Trabucchi, M | 1 |
| Adal, K; Andresen, S; Avery, R; Bolwell, B; Goldman, M; Hall, G; Kalaycio, M; Longworth, D; Mason, P; Mossad, S; Pohlman, B; Schmitt, S | 1 |
| Arrue, P; Fabie, F; Lagarrigue, J; Thorn-Kany, M; Toulemonde, A; Vally, P | 1 |
| Light, RW; Mulligan, ME; Nguyen, T; Sasse, SA; Teixeira, LR; Villarino, MA | 1 |
| McVay, CS; Rolfe, RD | 1 |
| Alcantara, CS; Guerrant, RL | 1 |
| Ballmer, PE; Bergamin, B; Hess, T; Imoberdorf, R; Jost, R | 1 |
| Dahlén, G; Molander, A; Reit, C; Samuelsson, W | 1 |
| Abe, S; Endo, T; Kawashima, T; Komatsu, M; Kubota, M; Kudou, Y; Obara, K; Okuda, R | 1 |
| Jones, RL | 1 |
| Aihara, M; Chiba, T; Hajiro, K; Nishi, A; Sakurai, T; Takakuwa, H | 1 |
| Calderwood, SB; Mylonakis, E; Ryan, ET | 1 |
| Dieleman, LA; Freitag, R; Li, F; Linde, HJ; Rath, HC; Sartor, RB; Schölmerich, J; Schultz, M | 1 |
| Kelly, CP; Kyne, L | 1 |
| Kerst, JM; Kuijper, EJ; van der Lelie, J | 1 |
| Fujikawa, T; Kobayashi, I; Matsumoto, T; Miyazaki, S; Tateda, K; Yamaguchi, K | 1 |
| Bouza, E; Muñòz, P; Palomo, J; Yáñèz, J | 1 |
| Andoh, A; Araki, Y; Bamba, T; Fujiyama, Y; Fukuda, M; Fukuoka, M; Kanauchi, O; Matsumoto, Y; Mitsuyama, K; Sata, M; Takagi, K; Toyonaga, A | 1 |
| Bender, A; Breves, G; Leonhard-Marek, S; Schröder, B; Stein, J; Winckler, C | 1 |
| Handke, R; Schmitt-Grohé, S; Steffan, J; Wiggert, E; Zielen, S | 1 |
| Baranger, B; Brinquin, L; Fangio, P; Petitjeans, F; Rouquette-Vincenti, I; Szymczyszyn, P; Villevieille, T | 1 |
| Gottlieb, T; Leroi, MJ; Siarakas, S | 1 |
| Alcalá, L; Alonso, R; Bouza, E; García-Lechuz, JM; Peláez, T; Rodríguez-Créixems, M | 1 |
| Elmer, GW; McFarland, LV; Surawicz, CM | 1 |
| Carmeli, Y; Eliopoulos, GM; Samore, MH | 1 |
| Malnick, SD; Zimhony, O | 1 |
| Lenzen-Grossimlinghaus, R; Strohmeyer, G | 1 |
| Agarwal, SK; Garg, D; Makhija, A; Pathania, A; Prakash, A; Singh, NP | 1 |
| Appt, SE; Blair, RM; Clarkson, TB; Franke, AA | 1 |
| Martirosian, G; Szczesny, A | 1 |
| Goldsmith, EA; Marino, BJ; Musher, DM; Wanahita, A | 1 |
| Glinka, D; Meisel-Mikołajczyk, F; Obuch-Woszczatyński, P; Pituch, H; Łazińska, B; Łuczak, M | 1 |
| Amato, JE; Breer, WA; Hartstein, ME; Jensen, SL | 1 |
| Bartoloni, A; Benedetti, M; Dei, R; Goldstein, BP; Mantella, A; Paradisi, F; Sbaragli, S | 1 |
| Basu, A; Fung, JJ; Keven, K; Marcos, A; Re, L; Shapiro, R; Simmons, RL; Starzl, TE; Tan, H | 1 |
| Greenberg, GR | 1 |
| Alary, ME; Chouinard, D; Forget, K; Pelletier, A; Pépin, J; Pépin, K; Valiquette, L; Villemure, P | 1 |
| Ravid, M | 1 |
| Oldfield, EC | 1 |
| Alex, P; Centola, M; Gillan, MM; Miner, J | 1 |
| McFarland, LV | 1 |
| Chek, K; Meadows, S; Ohl, ME; Stevermer, JJ; Tribuna, J | 1 |
| Parmar, MS | 1 |
| Alcalá, L; Alonso, R; Bouza, E; García-Arias, V; Marín, M; Martín-López, A; Peláez, T | 1 |
| Ackgöz, B; Altunkaya, H; Cadavi, F; Gül, S; Kalaycý, M | 1 |
| Schroeder, MS | 1 |
| Surawicz, CM | 1 |
| Brazier, J; Burmeister, S; Lewis, S | 1 |
| Aslam, S; Bhaila, I; Borchert, F; Hamill, RJ; Logan, N; Musher, DM; Nallacheru, S | 1 |
| Alary, ME; Bourassa, C; Fulop, K; Godin, D; Pepin, J; Raiche, E; Ruel, J; Valiquette, L | 1 |
| Alonso, R; Bouza, E; Muñoz, P | 1 |
| Bilsky, MH; Brown, AE; Gonen, M; Kraus, DH; Mener, D; Shah, JP | 1 |
| Aslam, S; Hamill, RJ; Musher, DM | 1 |
| Starr, J | 1 |
| Bakkeren, J; Bongaerts, G; Severijnen, R; Skladal, D; Sperl, W | 1 |
| Czupryna, A; Królczyk, G; Nowak, L; Sobocki, J; Strus, M; Szatyłowiczi, J; Thor, PJ; Zurowski, D | 1 |
| Ellis, R; McPherson, S; Panter, SJ; Rees, CJ; Soo, S | 1 |
| Akerlund, T; Aspevall, O; Burman, LG; Lundberg, A; Svenungsson, B | 1 |
| Chiang, TH; Chiu, HM; Lee, YC; Lin, JT; Liu, KL; Wang, HP | 1 |
| Cadle, RM; Darouiche, RO; Mansouri, MD | 1 |
| Høiby, N; Tvede, M | 1 |
| Beyer, I; Byl, B; Cherifi, S; Delmee, M; Mascart, G; Van Broeck, J | 1 |
| Bouza, E; Burillo, A; Muñoz, P | 1 |
| Cicogna, CE; Kuyumjian, AG; Surowiec, D; Wynd, MA | 1 |
| Heins, JR | 1 |
| Alcides, AP; Avelar, KE; Balassiano, IT; Boente, RF; Brazier, JS; de Paula, GR; Domingues, RM; Ferreira, EO; Ferreira, MC; Miranda, KR; Pinto, LJ | 1 |
| Owens, RC | 1 |
| Hornillos Calvo, M; Pareja Sierra, T | 1 |
| Blix, HS; Røed, J; Sti, MO | 1 |
| Odenholt, I; Walder, M; Wullt, M | 1 |
| Bakkanagari, SR; Davis, MB; Moorthi, KM; Zar, FA | 1 |
| Hassoun, A; Ibrahim, F | 1 |
| Nelson, R | 1 |
| Pakyz, A | 1 |
| Koh, TH; Song, KP; Tan, AL; Tan, ML; Wang, G | 1 |
| Brazeau, I; Gagnon, S; Pépin, J; Routhier, S; Valiquette, L | 1 |
| Boyle, JR; Chaudhuri, A; Gaunt, ME; Hayes, PD; Sadat, U; Varty, K | 1 |
| Read, RC | 1 |
| Shen, EP; Surawicz, CM | 1 |
| Mladenova, I; Pekova, L; Pellicano, R; Shomov, G | 1 |
| Hooker, M | 1 |
| Gerding, DN; Muto, CA; Owens, RC | 1 |
| Bishara, J; Paul, M; Wattad, M | 1 |
| Huggan, PJ; Murdoch, DR | 1 |
| Dubberke, ER; Gerding, DN; Johnson, S; Lawrence, SJ | 1 |
| Halsey, J | 1 |
| Pepin, J | 1 |
| Condron, SA; Follmar, KE; Ludwig, KA; Nathan, JD; Turner, II | 1 |
| Scheurer, D | 1 |
| Al-Nassir, WN; Donskey, CJ; Li, Y; Pultz, MJ; Riggs, MM; Sethi, AK | 1 |
| Kuipers, EJ; Surawicz, CM | 1 |
| Ackermann, G; Gerber, M; Löffler, B; Reischl, U; Tischendorf, K; Walch, C | 1 |
| Kuijper, EJ; Wilcox, MH | 1 |
| Al-Nassir, WN; Bobulsky, GS; Donskey, CJ; Jump, RL; Nerandzic, MM; Sethi, AK | 1 |
| Estes, LL; Harmsen, WS; Nyre, LM; Orenstein, R; Patel, R; Schleck, CD; Verdoorn, BP; Wendt, RF; Wilson, JW | 1 |
| Abbott, IR; Douvoyiannis, M; Goldman, DL; Litman, N | 1 |
| Barker, HC; Bilton, D; Haworth, CS; Roberts, P; Williams, D | 1 |
| Baines, SD; Freeman, J; O'Connor, R; Wilcox, MH | 1 |
| Becket, E; Bui, A; Hong, J; Kim, K; Liu, A; Miller, JH; Sitz, D; Solaimani, P; Tamae, C; Tran, KP; Yang, H | 1 |
| Cekinmez, M; Erdogan, B; Sener, L; Tufan, K | 1 |
| Calfee, DP | 1 |
| Fujimoto, Y; Ishida, Y; Konishi, H; Kowata, S; Morimoto, Y; Nomura, K; Ohshiro, M; Oyake, T; Sato, K; Taniwaki, M; Yamashita, M; Yoshikawa, T | 1 |
| Burman, LG | 1 |
| Evans, D; Scott, D; Shakur, R | 1 |
| Prassler, R | 1 |
| Clark, T; Wiselka, M | 1 |
| Abubaker, J; Khan, SG; Khursheed, M; Noman, F; Noor, SA | 1 |
| Bao, J; Guo, F; Long, J; Song, L; Sun, H; Wang, S; Zhang, W | 1 |
| Al-Nassir, WN; Donskey, CJ; Nerandzic, MM; Sethi, AK | 1 |
| Dubberke, ER; Riddle, DJ | 2 |
| Bujanda, L; Cosme, A | 1 |
| Kelly, CP | 2 |
| Garg, A; Kalra, V; Mishra, D; Seth, R; Suri, A | 1 |
| Byker, GL; Dinh, MT; Gunaratnam, NT; Malani, AN; Robinson, EA; Shehab, TM | 1 |
| Gould, FK; Hames, A; Perry, JD | 1 |
| Altman, A; Paz, Z | 1 |
| Johnson, S | 3 |
| Mittal, MK; Zimmerman, RA | 1 |
| Cober, ED; Malani, PN | 1 |
| Shen, B; Wang, Y | 1 |
| Bakken, JS | 1 |
| Bauer, MP; Kuijper, EJ; van Dissel, JT | 1 |
| Harpe, S; Oinonen, M; Pakyz, A; Polk, R; Schmiedeskamp, M | 1 |
| Scheppach, W | 1 |
| Al-Nassir, WN; Bobulsky, GS; Donskey, CJ; Nerandzic, MM; Sethi, AK | 1 |
| Guilburd, JN; Kassis, I; Shachor-Meyouhas, Y | 1 |
| Causey, MW; Spencer, MP; Steele, SR | 1 |
| Citron, DM; Goldstein, EJ; Tyrrell, KL; Warren, YA | 1 |
| Ambrosino, DM; Baxter, R; Blair, BM; Gerding, DN; Hay, CA; Leav, BA; Leney, M; Lowy, I; Molrine, DC; Nichol, G; Sloan, S; Thomas, WD | 1 |
| Gkrania-Klotsas, E; Nicholl, C; Parks, T; Wallis, S; Wilson, J | 1 |
| Barbut, F; Eckert, C | 1 |
| Nübel, U; Witte, W; Zaiss, NH | 1 |
| Chang, JH; Cho, HS; Cho, YK; Choi, MG; Chung, IS; Jung, WR; Kim, SW; Lee, YJ; Lim, CH; Nam, KW; Park, JM; Sung, HY | 1 |
| Grünewald, T; Kern, WV; Kist, M; Mutters, R; Ruf, BR | 1 |
| Carmeli, Y; Chmelnitsky, I; Goren, MG; Navon-Venezia, S; Schechner, V; Schwaber, MJ | 1 |
| Banaszkiewicz, A; Młynarczyk, G; Obuch-Woszczatyński, P; Pituch, H; Radzikowski, A; Wultańska, D | 1 |
| Banaszkiewicz, A; Brazier, JS; Młynarczyk, G; Obuch-Woszczatyński, P; Pituch, H; Radzikowski, A; van Belkum, A; Wultańska, D | 1 |
| Carroll, NV; Harpe, SE; Oinonen, M; Pakyz, AL; Polk, RE | 1 |
| Cotter, PD; Crispie, F; Dobson, A; Fouhy, F; Hill, C; Kiely, B; O'Sullivan, O; Rea, MC; Ross, RP; Shanahan, F | 1 |
| Nyc, O | 1 |
| Simor, AE | 1 |
| Jeong, JB; Jung, HC; Kim, BG; Kim, JS; Kim, JW; Lee, KL; Shin, S; Song, IS | 1 |
| Hsueh, PR; Huang, YT; Ko, WC; Lee, NY | 1 |
| Salkind, AR | 1 |
| Antoniadou, A; Armaganidis, A; Dimopoulou, I; Kopterides, P; Papadomichelakis, E; Papageorgiou, C; Tsangaris, I | 1 |
| Gerding, DN; Johnson, S | 1 |
| Barthelemy, I; Bouchet, A; Mondie, JM; Pham Dang, N | 1 |
| Ananthakrishnan, AN | 1 |
| Basiri, A; Javaherforooshzadeh, A | 1 |
| Dolgin, E | 1 |
| Hsueh, PR; Huang, YT; Ko, WC; Lee, NY; Lee, TF; Liao, CH; Lin, SY; Lin, YC; Tsai, PJ | 1 |
| Barshikar, S; Baylor, AE; Dolman, HS; Glowniak, J; Hong, K; Lavery, T; Nailor, M; Singla, R; Stassinopoulus, J; Tyburski, JG; Wilson, RF; Zimmerman, LH | 1 |
| Barman, TK; Bhatnagar, PK; Das, B; Kalia, V; Kumar, GR; Kumar, M; Mathur, T; Raj, VS; Singhal, S; Upadhyay, DJ | 1 |
| Cohen, MB; Hart, KW; Lindsell, CJ; Mann, EA; Mezoff, E | 1 |
| Alexander, J; Surawicz, CM | 1 |
| Arora, V; Baijal, SS; Lal, R; Poddar, U; Srivastava, A; Yachha, SK | 1 |
| Abraham, P; Desai, D; Deshmukh, A; Ingle, M; Joshi, A; Mankeshwar, R; Rodrigues, C | 1 |
| Antunes, LC; Croxen, MA; Ferreira, RB; Finlay, BB; Gill, N; Russell, SL; Willing, BP | 1 |
| Drekonja, DM | 1 |
| Tarchini, G | 1 |
| Baek, IH; Kim, HJ; Kim, JB; Lee, MS; Na, DK; Park, SH; Shin, SL; Shin, YC | 1 |
| Cocanour, CS | 1 |
| Dureuil, B; Gouin, P; Hariri, S; Tuech, JJ; Veber, B | 1 |
| Cheng, AC; Huysmans, M; Peel, T; Spelman, D; Spelman, T | 1 |
| Callery, S; Daneman, N; Manek, K; Williams, V | 1 |
| Amundson, WH; Decarolis, DD; Drekonja, DM; Johnson, JR; Kuskowski, MA; Lederle, FA | 1 |
| Gardner, E; Mancuso, P; Meghani, N; Thomson, A | 1 |
| Avdic, E; Carroll, KC; Cosgrove, SE; Lenhart, A; Maragakis, LL; Sydnor, ER; Trollinger, B | 1 |
| Kang, JO; Kim, J; Pai, H; Seo, MR | 1 |
| Deshpande, A; Minocha, A; Pant, C; Sferra, TJ | 1 |
| Baban, TA; El-Herte, RI; Kanj, SS | 1 |
| Jahamy, H; Johnson, LB; Khatib, R; Patel, SM; Riederer, K; Shemes, SP; Szpunar, S; Valenti, S; Venugopal, AA | 1 |
| Malkan, AD; Scholand, SJ | 1 |
| Catanzaro, M; Cirone, J | 1 |
| Citron, DM; Goldstein, EJ; Merriam, CV; Tyrrell, KL | 1 |
| Vaishnavi, C | 1 |
| Bliss, D; Butler, M; Drekonja, DM; Filice, GA; MacDonald, R; Rector, TS; Wilt, TJ | 1 |
| Allerberger, F; Kuo, HW; Laferl, H; Michl, V; Schmid, D; Tesik, P; Tucek, G; Wenisch, C; Wenisch, JM | 1 |
| Kee, VR | 1 |
| Borgundvaag, B; Croitoru, K; Gnanasuntharam, P; Le, B; Leung, W; Malhi, G; McGeer, AJ; Nguyen, GC; Silverberg, MS; Steinhart, AH; Thanabalan, R; Weizman, AV; Willey, BM | 1 |
| Falagas, ME; Patouni, K; Polyzos, KA; Rafailidis, PI; Samonis, G; Vardakas, KZ | 1 |
| Božić, M; Jovanović, M; Knežević, M; Rašić, D; Stojković, M | 1 |
| Armbruster, S; Goldkind, L | 1 |
| Johnson, ES; Kuntz, JL; Neil, N; Petrik, AF; Raebel, MA; Smith, DH; Spindel, SJ; Thorp, ML; Yang, X | 1 |
| Gerding, DN; Gorbach, SL; Johnson, S; Louie, TJ; Ruiz, NM | 1 |
| Cheema, FH; Kanwal, S; Korsten, MA; Luthra, M; Majeed, UM; Rafiullah, F; Sohail, MR | 1 |
| Bowlin, TL; Butler, MM; Citron, DM; Dvoskin, S; Feng, H; Kelly, CP; Shinabarger, DL; Tzipori, S; Wright, GE | 1 |
| Cornely, OA; Crook, DW; Gorbach, SL; Louie, TJ; Miller, MA | 1 |
| Babakhani, F; Bouillaut, L; Gomez, A; Nguyen, L; Sears, P; Sonenshein, AL | 1 |
| Johnson, S; Venugopal, AA | 1 |
| Barman, TK; Bhati, A; Bhatnagar, PK; Chakrabarti, A; Das, B; Kalia, V; Kumar, M; Mathur, T; Pandya, M; Raj, VS; Ramkumar, G; Shukla, G; Upadhyay, DJ; Vaishnavi, C | 1 |
| Carchman, EH; Nassour, I; Simmons, RL; Zuckerbraun, BS | 1 |
| Al-Banna, NA; Cerny, V; Gründling, M; Hung, O; Issekutz, TB; Johnston, B; Kelly, M; Kern, H; Lehmann, Ch; Pavlovic, D; Whynot, S; Zhou, J | 1 |
| Bossé, D; Cantin, AM; Lemire, C; Ménard, F; Ruel, J; Valiquette, L | 1 |
| Coffin, SE; Feng, R; Haynes, K; Kronman, MP; Zaoutis, TE | 1 |
| Ebinuma, H; Hibi, T; Kanai, T; Koike, Y; Mikami, Y; Nakamoto, N; Nakamura, Y; Nakano, M; Saeki, K; Yamagishi, Y | 1 |
| Farne, HA; Main, J; Martin, NK; Orchard, T; Tyrrell-Price, J | 1 |
| Anttila, VJ; Arkkila, P; Mattila, E; Mattila, PS; Tarkka, E; Tissari, P | 1 |
| Degener, JE; Feik, D; Mortensen, JE; Rams, TE; van Winkelhoff, AJ | 1 |
| Khanna, S; Pardi, DS | 1 |
| Bheemreddy, S; Biedron, C; Chalana, IK; Collins, V; Hayakawa, K; Ho, K; Judge, T; Kamatam, S; Kaye, KS; Khammam, V; Lephart, PR; Marchaim, D; Martin, ET; Nanjireddy, P; Parveen, S; Pogue, JM; Reddy, SM; Rybak, MJ; Tiwari, N; Tumma, RS; Yousuf, A | 1 |
| Guerrant, RL; Hoffman, PS; Kolling, GL; Li, Y; Moore, JH; Riggins, MS; van Opstal, EJ; Warren, CA | 1 |
| Babakhani, F; Bouillaut, L; Gomez, A; Sears, P; Sims, C; Sonenshein, AL | 1 |
| Arzese, A; Bassetti, M; Pecori, D; Villa, G; Wilcox, M | 1 |
| Chiba, J; Honda, Y; Kaku, M; Kunishima, H; Saito, M | 1 |
| Jorgensen, RA; Keach, JC; Lindor, KD; Petz, JL; Tabibian, JH; Talwalkar, JA; Weeding, E | 1 |
| Bauer, MP; Debast, SB; Kuijper, EJ; Sanders, IM; Wilcox, MH | 1 |
| Abel-Santos, E; Howerton, A; Patra, M | 1 |
| Dupont, HL | 2 |
| Dillon, JF; Paterson, JC | 1 |
| Cotter, PD; Hill, C; Mathur, H; O'Connor, PM; Ross, RP | 1 |
| Buppajarntham, S; Junpaparp, P; Madueno, FV; Varadi, G | 1 |
| Bajaj, MS; Chandra, M; Khurana, S; Pushker, N; Tejwani, LK; Velpandian, T | 1 |
| Neurath, MF; Strauss, R | 1 |
| Baji, P; Banai, J; Brodszky, V; Gulácsi, L; Kertész, A; Kopcsóné Németh, I; Ludwig, E; Péntek, M; Prinz, G; Reményi, P; Strbák, B; Zsoldiné Urbán, E | 2 |
| Bhatt, V; Parmar, SR; Schuster, M; Yang, J; Zhang, Q | 1 |
| Beyda, ND; Garey, KW; Jardin, CG; Jiang, Z; Le, F; Palmer, HR; Shah, DN | 1 |
| Clutter, DS; Dubrovskaya, Y; Merl, MY; Press, R; Safdar, A; Teperman, L | 1 |
| Jindai, K; Kunzer, B; O'Horo, JC; Safdar, N | 1 |
| Bass, SN; Bauer, SR; Lam, SW; Neuner, EA | 1 |
| Hung, YP; Ko, WC; Lee, CI; Lee, JC; Lin, HJ; Liu, HC; Tsai, PJ; Wan, L; Wu, TC; Wu, YH | 1 |
| Tart, SB | 1 |
| Kılıç, A | 1 |
| Chilton, CH; Crowther, GS; Freeman, J; Longshaw, CM; Nicholson, S; Todhunter, SL; Wilcox, MH | 1 |
| Anttila, VJ; Arkkila, P; Mattila, E | 1 |
| Abujamel, T; Cadnum, JL; Donskey, CJ; Jump, RL; Jury, LA; Kundrapu, S; Stintzi, AC; Sunkesula, VC | 1 |
| Kaufman, E; Liska, D; Nandakumar, G; Rubinshteyn, V | 1 |
| Ebigbo, A; Messmann, H | 1 |
| John, E; Lippmann, N; Lübbert, C; Mössner, J; Weis, S | 1 |
| Citron, DM; Goldstein, EJ; Tyrrell, KL | 1 |
| Keller, JM; Surawicz, CM | 1 |
| Chen, X; Enderlin, M; Fournier, E; Hubschwerlen, C; Keck, W; Kelly, CP; Klenk, A; Locher, HH; Pfaff, P; Ritz, D; Schroeder, S; Seiler, P | 1 |
| Cioara, A; Filipescu, I; Flonta, M; Lupse, M; Todor, N | 1 |
| Fortier, LC; Garneau, JR; Valiquette, L | 1 |
| Curry, SR; Marsh, JW | 1 |
| Boyd, AS; Ortleb, M | 1 |
| Kleger, A; Nitschmann, S; Seufferlein, T | 1 |
| Wilcox, MH | 2 |
| Broom, C; Chasan-Taber, S; Cornely, OA; Davidson, DM; Fitts, D; Gelone, SP; Gerding, DN; Johnson, S; Louie, TJ | 1 |
| Smith, S | 1 |
| Miigoć, H; Piekarska, M; Wandałowicz, AD | 1 |
| Chen, X; Cheng, M; Hing, TC; Ho, S; Ichikawa, Y; Kelly, CP; Koon, HW; Pothoulakis, C | 1 |
| Estes, L; Khanna, S; Pardi, D; Saffouri, G | 1 |
| Berel, D; Dezfoli, S; Dubinsky, M; Fleshner, P; Grein, J; Hirsch, J; Horton, HA; Ippoliti, A; Kaur, M; McGovern, D; Melmed, GY; Murthy, R; Shih, D; Targan, SR; Vasiliauskas, EA | 1 |
| Calvo-García, N; de Frutos-Serna, M; García-Sánchez, JE; Hernández-Egido, S; María-Blázquez, A; Siller-Ruiz, M | 1 |
| Kolho, KL; Ledder, O; Levine, A; Shaoul, R; Turner, D | 1 |
| Pulse, M; Vickers, R; Weiss, W | 1 |
| Aitken, SL; DuPont, HL; Garey, KW; Joseph, TB; Lasco, TM; Palmer, HR; Shah, DN; Xie, Y | 1 |
| Cornely, OA; Ivanescu, C; Nathwani, D; Odeyemi, IA; Odufowora-Sita, O; Retsa, P | 1 |
| Ferrara, S; Gambino, A; Martines, F; Mucia, M; Salvago, P; Sireci, F | 1 |
| Bhanot, N; Chan-Tompkins, NH; Goswami, R; McEllistrem, MC; McGraw, M; Sahud, AG | 1 |
| Froom, P | 1 |
| de Castro, CG; Ganc, AJ; Ganc, RL; Hamerschlack, N; Petrolli, MS | 1 |
| Hegarty, JP; Jayarao, BM; Lumadue, J; Stewart, DB; Varshney, JB; Venkitanarayanan, K; Very, KJ; Williams, JL | 1 |
| Alqumber, MA | 1 |
| Biltaji, E; Jensen, MK; LaFleur, J; Nelson, RE; Roberts, MS; Smith, KJ; Varier, RU | 1 |
| Belyaev, O; Chromik, AM; Deleites, C; Herzog, T; Uhl, W | 1 |
| Leeds, JA; Sachdeva, M | 1 |
| Dees, A; Jonkman, JG; van Genderen, ME; van Rijn, M | 1 |
| Johnson, S; Soriano, MM | 1 |
| Keller, JJ; Kuijper, EJ | 1 |
| Dull, RB; Hill, S; Klick, A; McCoy, RM | 1 |
| Joundi, RA; Leis, JA; Wong, BM | 1 |
| Carman, RJ; Kraus, CN; Lyerly, MW | 1 |
| Biswas, JS; Goldenberg, SD; Newsholme, W; Otter, JA; Patel, A; van Kleef, E; Wade, P | 1 |
| Chiueh, TS; Huang, ZY; Lai, MJ; Lin, JC | 1 |
| Alm, E; Burgess, J; Burns, L; Didyk, E; Edelstein, C; Giovanelli, A; Kassam, Z; Mendolia, G; Noh, A; Smith, M; Stollman, N | 1 |
| Barbut, F; Blais, L; Hirschel, B; Khanafer, N; Vanhems, P | 1 |
| Jang, BI; Kim, YG | 1 |
| Buffie, CG; Carter, RA; Gobourne, A; Leiner, I; Lewis, BB; Ling, L; Miller, LC; Pamer, EG; Toussaint, NC | 1 |
| Byrne, B; Cannon, K; Emery, J; Krulicki, W; Louie, TJ; Nguyen, D; Ward, L; Wu, K | 1 |
| Bouillaut, L; Chesnel, L; Mascio, C; McBride, S; Schmidt, DJ; Sonenshein, AL; Sorg, JA; Suarez, JM; Tzipori, S | 1 |
| Carter, GP; Elliott, B; Howden, BP; Jenkin, GA; Korman, TM; Kotsanas, D; Lyras, D; Mackin, KE; Riley, TV; Rood, JI | 1 |
| Baek, JY; Cho, SY; Chung, DR; Ha, YE; Kang, CI; Kim, SH; Ko, JH; Lee, JY; Lee, NY; Lee, WJ; Peck, KR; Song, JH | 1 |
| Beardsley, JR; Johnson, JW; Luther, VP; Ohl, CA; Rokas, KE; Williamson, JC | 1 |
| Carreiro, FT; Coelho, SC; Horta, AB; Sá, J | 1 |
| Cook, GK; Fischer, M; Rex, DK; Robb, BW; Rogers, NA; Sipe, BW; Vuppalanchi, R | 1 |
| Marra, F; Ng, K | 1 |
| Adler, A; Block, C; Bradenstein, R; Carmeli, Y; Mendelson, B; Miller-Roll, T; Paitan, Y; Parizade, M; Peled, N; Schwaber, MJ; Schwartz, D | 1 |
| Cai, P; Chen, L; Cheng, G; Dai, X; Li, Z; Wang, Z; Zhang, Z | 1 |
| Doron, S; Gorbach, S; Mizusawa, M | 1 |
| Forbes, BA; Gerding, DN; Goldstein, EJ; Jacobus, NV; Jenkins, SG; Johnson, S; McDermott, LA; Mirrett, S; Patel, R; Snydman, DR; Stone, S; Thorpe, C | 1 |
| Danielsen, TK; Holt, HM; Justesen, US | 1 |
| Greenberg, A; Matta, SK; Singh, A | 1 |
| Cojocariu, C; Girleanu, I; Miftode, E; Singeap, AM; Stanciu, C; Stoica, O; Trifan, A | 1 |
| Li, R; Lin, Y; Liu, X; Lu, L; Wang, M | 1 |
| Alby, K; Han, JH; Mills, JP; Talati, NJ | 1 |
| Carfagna, P; Falcone, M; Goldoni, P; Iraci, F; Russo, A; Venditti, M; Vullo, V | 1 |
| Jacobson, SM; Slain, D | 1 |
| Clozel, M; Enderlin-Paput, M; Locher, HH; Pfaff, P; Ritz, D; Seiler, P; Weiss, M | 1 |
| Freeman, J; Vernon, J; Vickers, R; Wilcox, MH | 1 |
| Abou Chakra, CN; Marcil-Héguy, A; Nault, V; Pépin, J; Sheitoyan-Pesant, C; Valiquette, L | 1 |
| Almendares, O; Cleveland, AA; Farley, MM; Lessa, FC; Magill, SS; Reno, J; Smith, RM; Smith, ZT; Stein, B; Vallabhaneni, S | 1 |
| Ganji, F; Pakzad, Y | 1 |
| Marimuthu, K; Ochi, H; Young, BE | 1 |
| Beardsley, JR; Gibbs, HG; Johnson, JW; Luther, VP; Ohl, CA; Rokas, KE; Williamson, JC | 1 |
| Cadnum, JL; Chan, L; Chesnel, L; Deshpande, A; Donskey, CJ; Gao, L; Hurless, K; Kundrapu, S; Polinkovsky, A | 1 |
| Alam, MJ; Bassères, E; Chesnel, L; Endres, BT; Garey, KW; Khaleduzzaman, M | 1 |
| Dubberke, ER; Gerding, DN; Kelly, CP; Mahé, C; Olsen, MA; Saeed, MJ; Stwalley, D; Young-Xu, Y | 1 |
| Alam, MJ; Bassères, E; Chang, L; Endres, BT; Garey, KW; Kakadiaris, IA; Memariani, A; Vickers, RJ | 1 |
| Baloun, B; Gilbert, J; Nelson, C; Wiedel, N | 1 |
| Beneš, J; Polívková, S | 1 |
| Belzer, C; Cranendonk, DR; de Vos, AF; de Vos, WM; Lankelma, JM; van der Poll, T; Wiersinga, WJ | 1 |
| Brodsky, D; Halevi, CN; Nitzan, O; Pastukh, N; Peretz, A; Tkhawkho, L | 1 |
| Akamine, CM; Ing, MB; Jackson, CS; Loo, LK | 1 |
| Winn, R; Zhu, KJ | 1 |
| Arakawa, T; Fujiwara, Y; Gi, M; Nagami, Y; Sawada, A; Shiba, M; Tanaka, F; Tanigawa, T; Tominaga, K; Wanibuchi, H; Watanabe, T; Yamagami, H | 1 |
| Dorsch, MP; Early, CR; Hanigan, SM; Park, JM; Pogue, KT | 1 |
| Cheng, MP; Lee, TC; Parkes, LO | 1 |
| Casey, M; Igawa, G; Koike, R; Moriya, K; Nukui, Y; Okugawa, S; Saito, R; Sawabe, E; Tohda, S | 1 |
| Dezsenyi, B; Fried, K; Gergely Szabo, B; Kadar, B; Kamotsay, K; Kunovszki, P; Nikolova, R; Prinz, G; Szidonia Lenart, K | 1 |
| Adler, A; Carmeli, Y; Cohen, D; Miller-Roll, T; Na'amnih, W | 2 |
| Cooper, P; Groß, U; Gunka, K; Janssen, I; Rupnik, M; Wetzel, D; Zimmermann, O | 1 |
| Carroll, K; Romagnoli, M; Simner, PJ; Wang, F; Workneh, M | 1 |
| Boccuzzi, E; Borali, E; Castellazzi, L; Cursi, L; De Giacomo, C; De Vita, MV; Esposito, S; Garazzino, S; Guarino, A; Lancella, L; Lo Vecchio, A; Mainetti, M; Tagliabue, C | 1 |
| Stallmach, A | 1 |
| Kriz, Z; Krutova, M; Kubicek, L; Kuijper, E; Matejkova, J; Nyc, O; Ruzicka, F; Tejkalova, R | 1 |
| Fashandi, AZ; Friel, CM; Hallowell, PT; Hays, RA; Hedrick, TL; Martin, AN; Smith, PW; Wang, PT | 1 |
| Compain, F; Guerot, E; Jarraud, S; Podglajen, I; Richaud, C; Rossi, B; Rostane, H | 1 |
| Akbari, M; Alonso, CD; Castillo, N; Kelly, CP; Leffler, DA; Patel, I; Theethira, T; Villafuerte-Galvez, J; Wungjiranirun, M | 1 |
| Hermsen, ED; Meza, JL; Njoku, JC; Olsen, KM; Qiu, F; Rupp, ME; Van Schooneveld, TC | 1 |
| Brown, KA; Croft, LD; Glassman, P; Goetz, MB; Greene, T; Jones, MM; Khader, K; Nelson, RE; Neuhauser, M; Rubin, MA; Samore, MH; Schwab-Daugherty, EM; Stevens, VW | 1 |
| Banaei, N; Deresinski, S; Gombar, S; Holubar, M; Madison, A; Schroeder, LF; Shah, N; Shepard, J; Sundararajan, G; Tekic, N; Tompkins, L; Truong, CY; Wilson, R | 1 |
| Evans, CT; Nelson, RL; Suda, KJ | 1 |
| Rasheed, J; Saleem, K; Sharif, M; Waqar, F | 1 |
| Kim, YJ; Kim, YK; Kwon, HI; Lee, HS; Lee, JC; Lee, WK; Na, SH; Nicholas, A; Selasi, GN; Shin, JH; Song, KE | 1 |
| Alcalá, L; Bouza, E; de Egea, V; González-Del Vecchio, M; Marín, M; Muñoz, P; Reigadas, E; Valerio, M | 1 |
| Alam, MJ; Bassères, E; Chang, L; Endres, B; Garey, KW; Rashid, T | 1 |
| Bachmann, O; Dersch, P; Solbach, P | 1 |
| Al Agha, RAMB; Al Salman, JM; Helmy, M | 1 |
| Leidi, F; Wu, MA | 1 |
| Cheng, JW; Kong, F; Kudinha, T; Liao, JW; Xiao, M; Xu, YC; Yang, QW; Yu, SY; Zhou, ML | 1 |
| Brodsky, D; Jackson, K; Nitzan, O; Pastukh, N; Peretz, A; Tkhawkho, L | 1 |
| Anderson, FA; Ayturk, MD; Collins, CE; Psoinos, CM; Santry, HP | 1 |
| Eckmann, L; Fuhrmann, V; Manthey, CF | 1 |
| Boyle, E; Galperine, T; Guery, B; Héquette-Ruz, R; Herbaux, C; Robin, C | 1 |
| Iguchi, M; Kuzuya, T; Mikamo, H; Morioka, H; Yagi, T | 1 |
| Burton, HE; Mitchell, SA; Watt, M | 1 |
| Boegli, L; Chesnel, L; deLancey Pulcini, E; Fisher, S; James, GA; Stewart, PS | 1 |
| Abu Sitta, E; Al Salihi, M; Kanzy, A; Kheiri, B | 1 |
| Aoyama, N; Dorr, MB; Fujimoto, G; Mikamo, H; Sawata, M; Yoshinari, T | 1 |
| Kupiec, KE; Liu, C; Miller, JL; Schmidt, SA; Skrepnek, GH; Smith, WJ; Tieu, JD | 1 |
| Andoh, A; Bamba, S; Imaeda, H; Inatomi, O; Nishida, A; Sasaki, M; Sugimoto, M | 1 |
| Chen, YB; Fang, YH; Gu, SL; Li, LJ; Lv, T; Shen, P; Tang, LL | 1 |
| Collins, JW; Crepin, VF; Elinav, E; Frankel, G; Glegola-Madejska, IT; Levy, M; Mullineaux-Sanders, C; Pevsner-Fischer, M; Ruano-Gallego, D; Sågfors, AM; Wong, JLC | 1 |
| Bishop, EJ; Botha, J; Kelley, PG; Marshall, C; Metcalfe, J; Tiruvoipati, R | 1 |
| Chahine, EB | 1 |
| Bora, SA; Cantorna, MT; Kennett, MJ; Patterson, AD; Smith, PB | 1 |
| Araj, GF; Becker, SL; Berger, FK; Bischoff, M; Dbaibo, G; Gärtner, B; Karaoui, WR; Mahfouz, R; Matar, GM; Rasheed, SS; Rimmani, HH; Sharara, AI; von Müller, L | 1 |
| Anders, S; Garcia-Diaz, J; Hand, J; Li, J; Nguyen, CT; Staffeld-Coit, C | 1 |
| Goyal, H; Perisetti, A; Rehman, MR; Singla, U | 1 |
| Dorr, MB; Dubberke, ER; Ellison, MC; Eves, K; Gerding, DN; Guris, D; Hanson, ME; Kao, D; Kelly, CP; Kumar, PN; Lee, C; Rahav, G; Yacyshyn, B | 1 |
| Arakawa, S; Fujisawa, M; Kinugawa, S; Kitagawa, K; Nakanishi, N; Osawa, K; Shigemura, K; Tokimatsu, I; Yoshida, H | 1 |
| Dow, DE; Seed, PC | 1 |
| Aldrovandi, GM; Cunningham, NJ; Kordy, K; Lee, DJ; Li, F; Romeo, AC; Saavedra, M; Tobin, N; Zabih, S | 1 |
| Drennan, K; Fabian, J; Gaylard, PC; Hepple, A; Karlsson, K; Lee, S; Lowman, W; McNamara, L; Simons, G | 1 |
| Mullish, BH; Williams, HR | 1 |
| Bernardy, J; Faldyna, M; Krejčí, J; Krutova, M; Matejkova, J; Nyc, O; Tkadlec, J; Zouharova, M | 1 |
| Bullock, K; Clish, CB; Fujisaka, S; Herzog, C; Kahn, CR; Pacheco, JA; Soto, M | 1 |
| Lv, Z; Su, J; Wang, B; Zhang, P | 1 |
| Alexandre, S; Amaratunga, KR; Choi, KB; Collet, JC; Davis, I; Du, T; Evans, GA; Frenette, C; Golding, GR; Gravel, D; Hota, S; Katz, KC; Kibsey, P; Langley, JM; Lee, BE; Lemieux, C; Longtin, Y; Mertz, D; Mieusement, LMD; Minion, J; Moore, DL; Mulvey, MR; Pelude, L; Richardson, S; Science, M; Simor, AE; Stagg, P; Suh, KN; Taljaard, M; Taylor, G; Thampi, N; Wong, A | 1 |
| Aliramezani, A; Baghani, A; Douraghi, M; Ghourchian, S; Mesdaghinia, A; Yaseri, M | 1 |
| Chaix, A; Chang, MW; Knight, R; Marotz, CA; Panda, S; Saghatelian, A; Xu, ZZ; Zarrinpar, A | 1 |
| Boulos, RA; Pagano, P; Pillar, CM; Shinabarger, DL; Wolfe, C | 1 |
| Biesiada, G; Birczyńska, M; Czepiel, J; Garlicki, A; Jędrychowski, M; Michalak, M; Pejka, K; Sobczyk-Krupiarz, I | 1 |
| Kodadek, LM; Lipsett, PA | 1 |
| Chen, Y; Huang, C; Sun, R; Tian, Z; Wang, J; Wei, H; Zheng, X; Zhou, R | 1 |
| Enoki, Y; Igarashi, Y; Kunishima, H; Matsumoto, K; Mikamo, H; Mori, N; Morinaga, Y; Nakamura, A; Ohge, H; Suzuki, H; Taguchi, K; Tashiro, S; Yamagishi, Y; Yanagihara, K; Yoshizawa, S | 1 |
| Boota, N; Bradshaw, L; Diggle, M; Jawhari, A; Major, G; Montgomery, A; Spiller, RC; Sprange, K | 1 |
| Fernández Lisón, LC; Malpartida Flores, M; Martín Rizo, L | 1 |
| Belzer, C; de Vos, WM; Haak, BW; Hugenholtz, F; Lankelma, JM; Wiersinga, WJ | 1 |
| Nielsen, SY; Nørskov-Lauritsen, N | 1 |
| Alireza Taghavi, S; Amanati, A; Bazargani, A; Heidari, H; Kalantar, K; Motamedifar, M; Nikokar, I; Sedigh Ebrahim-Saraie, H | 1 |
| Appaneal, HJ; Caffrey, AR; LaPlante, KL | 1 |
| Amirmozafari, N; Baseri, Z; Douraghi, M; Fakhre Yaseri, H; Kouhsari, E; Krutova, M; Moqarabzadeh, V; Sholeh, M; Talebi, M | 1 |
| Gross, AE; Sarna, KV | 1 |
| Berger, F; Jazmati, N; Piepenbrock, E; Stelzer, Y | 1 |
| Chen, PX; Fu, JL; Gu, XX; Jiang, HX; Yang, L; Zhang, LJ | 1 |
| Baggs, J; Guh, A; Hatfield, KM; Jernigan, JA; Kazakova, SV; McDonald, LC; Reddy, SC; Yi, SH | 1 |
| Ramesh, MS; Yee, J | 1 |
| Kimura, T; Snijder, R; Sugitani, T | 1 |
| Balen Topić, M; Bogdanić, N; Vidović, K | 1 |
| Chen, CL; Cheng, CW; Chia, CY; Chiu, CH; Deng, ST; Hsiao, HL; Lee, HY; Tsai, TC | 1 |
| Berthiller, J; Chardot, C; Duclaux-Loras, R; Ferroni, A; Goulet, O; Lacaille, F; Norsa, L | 1 |
| Alvarez, AM; Rathore, MH | 1 |
| Li, R; Lu, D; Ran, Z; Tian, M; Yang, J; Yin, J; Zhang, Y; Zhong, J; Zhou, Y | 1 |
| Echevarria, K; Jones, M; Khader, K; Nelson, RE; Rubin, MA; Samore, MH; Stevens, VW; Timbrook, TT; Zhang, Y | 1 |
| Chow, A; Lye, DC; Ng, TM; Tay, HL | 1 |
| English, M; Fukushima, A; Okumura, H; Shoji, S; Taieb, V | 1 |
| Freedberg, DE; Gomez-Simmonds, A; Li, J; Salmasian, H; Schluger, A; Wang, Y | 1 |
| Bondarenco, M; Kachlon, Y; Lazarovitch, T; Marchaim, D; Mengesha, B; Strul, N; Toledano, L; Youngster, I; Zaidenstein, R; Zilberman-Itskovich, S | 1 |
| Kimura, T; Stanhope, S; Sugitani, T | 1 |
| English, M; Okumura, H; Shoji, S; Ueyama, M | 1 |
| Boggiano, VL; Smith, KL; Sullivan, MH | 1 |
| Ebisui, A; Goto, R; Inose, R; Ishii, S; Kawabe, A; Kusama, Y; Muraki, Y; Ohmagari, N; Yagi, T | 1 |
| Banoub, M; Blackman, AL; Claeys, KC; Heil, EL; Kristie Johnson, J; Leekha, S; Vega, AD | 1 |
| Dai, W; Niu, S; Sun, J; Wang, Z; Xia, Y; Yan, L; Yang, T; Zhang, C | 1 |
| Chankhamhaengdecha, S; Harnvoravongchai, P; Janvilisri, T; Ounjai, P; Phanchana, M; Phetruen, T; Raksat, P | 1 |
| Cheng, JW; Fan, X; Hou, X; Kudinha, T; Liang, GW; Liu, C; Shao, DH; Su, JR; Wang, Y; Wei, M; Xiao, M; Xiong, ZJ; Xu, YC; Yang, CX; Yang, QW; Yu, SY | 1 |
| Athan, E; Roder, C | 1 |
| Bai, Y; Huang, GQ; Liu, J; Sun, ZQ | 1 |
| Bickett-Burkhart, K; Chalasani, N; Fischer, M; Gandhi, D; Orman, ES; Phatharacharukul, P; Purpura, RD; Xu, H | 1 |
| Katzer, K; Reuken, P; Stallmach, A | 1 |
| Abdul Wahab, Z; Amin Nordin, S; Ibrahim, R; Ishak, N | 1 |
| AbdelKhalek, A; Seleem, MN | 1 |
| Ito, H | 1 |
| Banoub, M; Blackman, A; Claeys, KC; Heil, EL; Johnson, JK; Leekha, S; Vega, A | 1 |
| Benes, J; Capek, V; Krutova, M; Polivkova, S; Sykorova, B | 1 |
| Sugimoto, H; Sugimoto, K; Yamamoto, T; Yoshihara, A | 1 |
| Campbell, DL; Gentry, CA; Williams, RJ | 1 |
| Burrello, C; Caprioli, F; Facciotti, F; Giuffrè, MR; Lattanzi, G; Pujolassos, M; Strati, F; Troisi, J | 1 |
| Bastiaanssen, TFS; Cryan, JF; Dinan, TG; Fitzgerald, P; Fulling, C; Moloney, GM; O'Connor, R; O'Riordan, KJ; Schellekens, H | 1 |
| Hopp, J; Omecene, NE; Orndahl, CM; Pakyz, AL; Stultz, JS | 1 |
| Adelman, MW; Fridkin, SK; Goodenough, D; Mackey, C; Sefton, S; Thomas, S; Woodworth, MH | 1 |
| Addison, B; Addison, RM; Anderson, DJ; Gergen-Teague, MF; Rutala, WA; Sexton, DJ; Turner, NA; Warren, BG; Weber, DJ | 1 |
| Enoki, Y; Hasegawa, N; Iketani, O; Matsumoto, K; Misawa, K; Taguchi, K; Uno, S; Uwamino, Y | 1 |
| Jane, F; Jon J, V; Mark H, W | 1 |
| Faller, WJ; Garcia, TM; Koelink, PJ; Koster, J; Meisner, S; Muncan, V; Renes, IB; Silva, J; Smit, WL; van Elburg, RM; van Roest, M; Vermeulen, JLM; Wildenberg, ME | 1 |
| Khodaparast, S; Khoramabadi, N; Mohabati Mobarez, A; Saberifiroozi, M; Vasei, M | 1 |
| Boudreau, J; Fong, A; Lee, H; Nokhbeh, R; Ross, M; Tilbe, K | 1 |
| Alangaden, GJ; Church, B; Davis, SL; Kenney, RM; Wu, T | 1 |
| Chiu, CW; Hung, YP; Ko, WC; Lee, CC; Lee, JC; Tsai, PJ | 1 |
| Abiri, R; Alvandi, A; Fathollahi, M; Kadivarian, S; Motamedi, H; Rostamian, M | 1 |
| Jeong, JS; Lee, M; Park, H | 1 |
| Collins, DA; Riley, TV | 1 |
| Stephenson, AL | 1 |
| Bazazhina, A; Najjar-Debbiny, R; Saliba, W; Schwartz, N; Shaked, P; Weber, G | 1 |
| Meng, L; Yang, H; Yang, J | 1 |
| Feng, S; Huang, C; Huo, F; Liu, H | 1 |
| Leahy, RG; Serio, AW; Tanaka, SK; Traczewski, MM; Wright, K | 1 |
| Allerberger, F; Barf, LM; Burgener, IA; Cabal, A; Ehricht, R; Feßler, AT; Finsterwalder, SK; Künzel, F; Loncaric, I; Marz, M; Monecke, S; Ruppitsch, W; Schwarz, S; Spergser, J; Szostak, MP; Tichy, A | 1 |
| Cheng, X; Guan, M; Jolkkonen, J; Lin, X; Liu, C; Liu, F; Liu, Z; Wang, Y; Xiao, T; Zhao, C; Zhao, Y; Zhong, S | 1 |
| Aouam, K; Ben Fadhel, N; Ben Fredj, N; Ben Romdhane, H; Chaabane, A; Chadli, Z; Mansour, K | 1 |
| Aftandilian, CC; Agyeman, PKA; Castagnola, E; Chirra, KM; Dupuis, LL; Groll, AH; Haeusler, GM; Lehrnbecher, T; Loves, R; Phillips, B; Schneider, C; Sung, L; van de Wetering, M | 1 |
| Gong, Y; Liu, X; Suo, X; Tang, X; Zhang, S; Zou, J | 1 |
| Dai, J; Gong, J; Guo, R | 1 |
| Adamczyk, M; Albrecht, V; Anderson, KF; Campbell, D; Elkins, CA; Gargis, AS; Guh, AY; Halpin, AL; Karlsson, M; Kent, AG; Korhonen, LC; Lutgring, JD; McAllister, G; McDonald, LC; McKay, SL; Paulick, AL; Rasheed, JK; Vlachos, N | 1 |
| Chuard, C; Meuwly, M | 1 |
| Li, J; Li, N; Liu, B; Lü, X; Wang, H; Zhang, Y | 1 |
| Bishop, EJ; Tiruvoipati, R | 1 |
| Cascio, A; Gizzi, A; Granata, G; Iaria, C; Imburgia, C; Pipitone, G; Sartelli, M | 1 |
| Li, Y; Meng, L; Yang, J | 1 |
| Enoki, Y; Matsumoto, K; Mihara, T; Okawa, R; Samura, M; Taguchi, K; Tanaka, Y; Tashiro, S; Yamagishi, Y | 1 |
| Arriaga-García, FJ; Medellín-Garibay, SE; Milán-Segovia, RDC; Pérez-González, LF; Rodríguez-Báez, AS; Romano-Moreno, S; Velarde-Salcedo, R | 1 |
| Cacace, J; Goldman, DL; Lee, P; Nemati, K; Silver, EJ | 1 |
| Álvarez-Pérez, S; Anega, B; Blanco, JL; García, ME; Hernández, M | 1 |
128 review(s) available for metronidazole and vancomycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Discovery and development of DNA polymerase IIIC inhibitors to treat Gram-positive infections.
Topics: Clostridioides difficile; Clostridium Infections; DNA Polymerase III; Drug Discovery; Humans; Microbial Sensitivity Tests; Nucleic Acid Synthesis Inhibitors; Uracil | 2019 |
[Antibiotics and pseudomembranous colitis].
Topics: Anti-Bacterial Agents; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Parenteral Nutrition, Total; Vancomycin; Water-Electrolyte Balance | 1979 |
Clostridium difficile infection: responses, relapses and re-infections.
Topics: Clinical Trials as Topic; Cross Infection; Disease Outbreaks; Enterocolitis, Pseudomembranous; Humans; Infection Control; Metronidazole; Recurrence; Vancomycin | 1992 |
Vancomycin, metronidazole, and tetracyclines.
Topics: Bacterial Infections; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Microbial; Foot Diseases; Humans; Metronidazole; Tetracyclines; Vancomycin | 1992 |
[Current status of Clostridium difficile: recent advances in diagnostic materials and treatment of colitis and diarrheas associated with antibiotic therapy].
Topics: Causality; Clinical Protocols; Colectomy; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Recurrence; Vancomycin | 1991 |
[Pseudomembranous colitis: a clinical analysis and review of literatures].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Vancomycin | 1991 |
Antibiotics and inflammatory bowel diseases.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Colitis, Ulcerative; Crohn Disease; Humans; Metronidazole; Sulfasalazine; Vancomycin | 1989 |
Update on pseudomembranous colitis.
Topics: Enterocolitis, Pseudomembranous; Humans; Metronidazole; Patient Isolation; United States; Vancomycin | 1989 |
Antibacterial therapy.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Cephalosporins; Clindamycin; Drug Combinations; Erythromycin; Humans; Methicillin; Metronidazole; Nalidixic Acid; Penicillin Resistance; Penicillins; Rifampin; Skin Diseases, Infectious; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Tetracycline; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1986 |
Treatment of bacterial infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Cephalosporins; Chloramphenicol; Drug Combinations; Humans; Infant, Newborn; Metronidazole; Penicillins; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1985 |
[Drug-induced colitis].
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bone Marrow Transplantation; Cholestyramine Resin; Cimetidine; Colitis; Contraceptives, Oral, Hormonal; Enema; Ergotamine; Flucytosine; Gold; Graft vs Host Reaction; Humans; Hydrogen Peroxide; Methyldopa; Metronidazole; Ranitidine; Suppositories; Vancomycin; Vasopressins | 1985 |
Antimicrobial agents in the treatment of obstetric and gynecologic infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antifungal Agents; Cephalosporins; Chloramphenicol; Erythromycin; Female; Genital Diseases, Female; Genitalia, Female; Humans; Idoxuridine; Infections; Lactobacillus; Metronidazole; Penicillins; Placenta; Pregnancy; Pregnancy Complications, Infectious; Puerperal Infection; Pyrimethamine; Spectinomycin; Streptococcus; Sulfonamides; Tetracycline; Vagina; Vancomycin | 1974 |
Antimicrobial agents and the central nervous system.
Topics: Abscess; Anti-Bacterial Agents; Anti-Infective Agents; Central Nervous System Diseases; Cephalosporins; Cephamycins; Chloramphenicol; Erythromycin; Humans; Infections; Lincomycin; Meningitis; Metronidazole; Penicillins; Polymyxins; Rifampin; Sulfonamides; Tetracyclines; Trimethoprim; Vancomycin | 1980 |
The neurotoxicity of antibacterial agents.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Central Nervous System Diseases; Cephalosporins; Chloramphenicol; Clindamycin; Colistin; Cranial Nerve Diseases; Dapsone; Erythromycin; Ethambutol; Humans; Lincomycin; Metronidazole; Nervous System Diseases; Neuromuscular Junction; Penicillins; Peripheral Nervous System Diseases; Polymyxin B; Sulfonamides; Tetracyclines; Vancomycin | 1984 |
Antibiotics in surgery.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Clindamycin; Erythromycin; Humans; Metronidazole; Penicillins; Preoperative Care; Surgical Wound Infection; Tetracyclines; Vancomycin | 1983 |
Pseudomembranous colitis: a case report and literature review.
Topics: Aged; Bacitracin; Enterocolitis, Pseudomembranous; Erythromycin; Female; Humans; Metronidazole; Vancomycin | 1984 |
Antibiotic-associated colitis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cholestyramine Resin; Clindamycin; Clostridium; Clostridium Infections; Colitis; Colonoscopy; Diarrhea; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Fluid Therapy; Humans; Metronidazole; Recurrence; Staphylococcal Infections; Vancomycin | 1984 |
Treatment of pseudomembranous colitis and antibiotic-associated diarrhoea.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacitracin; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Metronidazole; Middle Aged; Recurrence; Vancomycin | 1984 |
Aspects on antibacterial treatment of anaerobic infections.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Cefoxitin; Cephalosporins; Chloramphenicol; Clindamycin; Humans; Metronidazole; Penicillins; Tetracyclines; Tinidazole; Vancomycin | 1982 |
Pseudomembranous colitis.
Topics: Anion Exchange Resins; Anti-Bacterial Agents; Clindamycin; Clostridium Infections; Cytotoxins; Enterocolitis, Pseudomembranous; Feces; Humans; Intestinal Mucosa; Leukocytes; Lincomycin; Metronidazole; Vancomycin | 1982 |
Pseudomembranous colitis: pathogenesis and therapy.
Topics: Anti-Bacterial Agents; Atropine; Bacitracin; Botulinum Toxins; Cholestyramine Resin; Clostridium; Clostridium Infections; Colestipol; Diphenoxylate; Drug Combinations; Enterocolitis, Pseudomembranous; Gastrointestinal Agents; Humans; Intestinal Mucosa; Metronidazole; Vancomycin | 1982 |
Rectal use of vancomycin.
Topics: Administration, Oral; Administration, Rectal; Clostridioides difficile; Enema; Enterocolitis, Pseudomembranous; Humans; Injections, Intravenous; Metronidazole; Vancomycin | 1994 |
Update on Clostridium difficile-induced colitis, Part 2.
Topics: Administration, Oral; Anti-Bacterial Agents; Capsules; Clostridioides difficile; Drug Costs; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Vancomycin | 1994 |
Clostridium difficile infection: a common clinical problem for the general internist.
Topics: Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Enterotoxins; Family Practice; Humans; Metronidazole; Vancomycin | 1994 |
Antibiotic-induced diarrhea and pseudomembranous colitis.
Topics: Administration, Oral; Anti-Bacterial Agents; Cluster Analysis; Cross Infection; Cytotoxins; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Humans; Incidence; Infection Control; Metronidazole; Primary Prevention; Sensitivity and Specificity; Sigmoidoscopy; Vancomycin | 1994 |
Clostridium difficile colitis in the critically ill.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Colectomy; Combined Modality Therapy; Critical Illness; Enterocolitis, Pseudomembranous; Female; Hospital Mortality; Humans; Male; Metronidazole; Middle Aged; Morbidity; Retrospective Studies; Treatment Outcome; Vancomycin | 1996 |
Clostridium difficile infection.
Topics: Antitrichomonal Agents; Bacterial Proteins; Bacterial Toxins; Cells, Cultured; Clostridioides difficile; Clostridium Infections; Disease Transmission, Infectious; Enterotoxins; Feces; Glutamate Dehydrogenase; Humans; Immunoassay; Metronidazole; Polymerase Chain Reaction; Risk Factors; Vancomycin | 1996 |
Clostridium difficile infection.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Colon; Diarrhea; Drug Costs; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Exotoxins; Feces; Hospitalization; Humans; Intestinal Mucosa; Metronidazole; Recurrence; Time Factors; Vancomycin | 1998 |
[Pseudomembranous colitis (Clostridium difficile infection)].
Topics: Anti-Bacterial Agents; Antitrichomonal Agents; Clostridioides difficile; Diagnosis, Differential; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Prognosis; Vancomycin | 1999 |
[Cervical spine infection with Streptococcus anginosus. Case report].
Topics: Adult; Ampicillin; Cervical Vertebrae; Drug Therapy, Combination; Humans; Magnetic Resonance Imaging; Male; Metronidazole; Neck Pain; Spondylitis; Streptococcal Infections; Streptococcus; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1999 |
Update on Clostridium difficile infection.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Community-Acquired Infections; Disease Outbreaks; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Vancomycin | 2000 |
Treatment of Clostridium difficile-associated diarrhea and colitis.
Topics: Abdomen, Acute; Anti-Bacterial Agents; Antidiarrheals; Clinical Trials as Topic; Clostridioides difficile; Clostridium Infections; Colectomy; Colitis; Combined Modality Therapy; Contraindications; Diarrhea; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Fluid Therapy; Humans; Intestinal Perforation; Megacolon, Toxic; Metronidazole; Prospective Studies; Randomized Controlled Trials as Topic; Vancomycin | 2000 |
Clostridial enterocolitis.
Topics: Animals; Bacitracin; Clostridioides difficile; Clostridium Infections; Clostridium perfringens; Disease Outbreaks; Enterocolitis, Pseudomembranous; Horse Diseases; Horses; Metronidazole; Vancomycin | 2000 |
Clostridium difficile--Associated diarrhea: A review.
Topics: Clostridioides difficile; Colon; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Practice Guidelines as Topic; Radiography; Vancomycin | 2001 |
Recurrent Clostridium difficile diarrhoea.
Topics: Anion Exchange Resins; Anti-Bacterial Agents; Anti-Infective Agents; Enterocolitis, Pseudomembranous; Humans; Immunoglobulins, Intravenous; Metronidazole; Probiotics; Recurrence; Vancomycin | 2001 |
[Diarrhea due to Clostridium difficile toxin in hemato-oncological patients].
Topics: Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Clostridioides difficile; Dexamethasone; Diarrhea; Doxorubicin; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Middle Aged; Multiple Myeloma; Treatment Outcome; Vancomycin; Vincristine | 2001 |
Treatment of Clostridium difficile-associated diarrhea.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Drug Administration Schedule; Female; Humans; Infection Control; Metronidazole; Pregnancy; Severity of Illness Index; Vancomycin | 2002 |
[Treatment of infections associated with Clostridium difficile].
Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Drug Resistance; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Risk Factors; Species Specificity; Vancomycin | 2003 |
Antibiotics should be used as first-line therapy for Crohn's disease.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Crohn Disease; Humans; Imipenem; Metronidazole; Time Factors; Treatment Outcome; Vancomycin | 2004 |
Alternative treatments for Clostridium difficile disease: what really works?
Topics: Anti-Infective Agents; Carrier State; Clostridioides difficile; Clostridium Infections; Colitis; Complementary Therapies; Cross Infection; Humans; Metronidazole; Vancomycin | 2005 |
Clinical inquiries. What are effective therapies for Clostridium difficile-associated diarrhea?
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Humans; Metronidazole; Vancomycin | 2005 |
Clostridium difficile--associated diarrhea.
Topics: Aged; Algorithms; Anti-Infective Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fluid Therapy; Humans; Metronidazole; Vancomycin | 2005 |
Antibiotic-associated diarrhea and pseudomembranous colitis: are they less common with poorly absorbed antimicrobials?
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Clinical Trials as Topic; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Intestinal Absorption; Lactobacillus; Metronidazole; Probiotics; Vancomycin | 2005 |
Clinical manifestations, treatment and control of infections caused by Clostridium difficile.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Infection Control; Metronidazole; Vancomycin | 2005 |
Treatment of Clostridium difficile-associated disease: old therapies and new strategies.
Topics: Anti-Infective Agents; Bacterial Toxins; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Probiotics; Secondary Prevention; Vaccination; Vancomycin; Vancomycin Resistance | 2005 |
Clostridium difficile associated diarrhoea: diagnosis and treatment.
Topics: Administration, Oral; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Drug Resistance; Enterocolitis, Pseudomembranous; Feces; Humans; Metronidazole; Risk Factors; Secondary Prevention; Vancomycin | 2005 |
Antimicrobial therapy of Clostridium difficile-associated diarrhea.
Topics: Aged; Anti-Infective Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Disease Outbreaks; Feces; Humans; Infant; Megacolon, Toxic; Metronidazole; Nitro Compounds; Risk Factors; Secondary Prevention; Thiazoles; Vancomycin | 2006 |
Past, present, and future therapies for Clostridium difficile-associated disease.
Topics: Clostridioides difficile; Enterocolitis, Pseudomembranous; Forecasting; Humans; Metronidazole; Probiotics; Recurrence; Vancomycin | 2006 |
Clostridium difficile-associated disease.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Enzyme Inhibitors; Humans; Metronidazole; Probiotics; Proton Pump Inhibitors; Recurrence; Risk Factors; Saccharomyces; Vancomycin | 2006 |
Clostridium difficile-associated disease: changing epidemiology and implications for management.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Metronidazole; Risk Factors; Vancomycin | 2007 |
Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fusidic Acid; Humans; Metronidazole; Teicoplanin; Treatment Outcome; Vancomycin | 2007 |
Clostridium difficile.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Beclomethasone; Biopsy; Budesonide; Clostridioides difficile; Colonoscopy; Enterocolitis, Pseudomembranous; Feces; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infection Control; Male; Metronidazole; Middle Aged; Oncology Nursing; Primary Myelofibrosis; Risk Factors; Tacrolimus; Vancomycin | 2007 |
Treatment of Clostridium difficile infection.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Disease Management; Enterocolitis, Pseudomembranous; Humans; Metronidazole; North America; Recurrence; Therapies, Investigational; Vancomycin | 2008 |
Current and future treatment modalities for Clostridium difficile-associated disease.
Topics: Anti-Bacterial Agents; Bacterial Vaccines; Clostridioides difficile; Clostridium Infections; Cross Infection; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin | 2008 |
The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; History, 20th Century; History, 21st Century; Humans; Metronidazole; Vancomycin | 2008 |
Treatment of metronidazole-refractory Clostridium difficile enteritis with vancomycin.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Drug Resistance, Multiple; Enteritis; Female; Humans; Metronidazole; Middle Aged; Treatment Failure; Vancomycin | 2008 |
Clostridium difficile: a reemerging pathogen.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Colectomy; Communicable Diseases, Emerging; Cross Infection; Enterocolitis, Pseudomembranous; Humans; Incidence; Infection Control; Metronidazole; Risk Factors; Vancomycin | 2008 |
Clostridium difficile infection.
Topics: Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Humans; Metronidazole; Risk Factors; Treatment Failure; Vancomycin | 2008 |
Clostridium difficile infection in solid organ transplant recipients.
Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Digestive System Surgical Procedures; Enterocolitis, Pseudomembranous; Humans; Incidence; Infection Control; Metronidazole; Organ Transplantation; Risk Factors; Severity of Illness Index; Treatment Outcome; Vancomycin; Virulence | 2008 |
[Clostridium-difficile-associated diarrhea].
Topics: Aged; Anti-Bacterial Agents; Bacterial Toxins; Biological Therapy; Clostridioides difficile; Colectomy; Colonoscopy; Combined Modality Therapy; Cross Infection; Diarrhea; DNA, Bacterial; Enterocolitis, Pseudomembranous; Female; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Infant, Newborn; Male; Metronidazole; Probiotics; Recurrence; Risk Factors; Superinfection; Vancomycin | 2009 |
A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection.
Topics: Aged; Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Intestines; Male; Metronidazole; Probiotics; Recurrence; Risk Factors; Severity of Illness Index; Vancomycin | 2009 |
Recurrent Clostridium difficile infection: causality and therapeutic approaches.
Topics: Anti-Infective Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Immunotherapy; Metronidazole; Probiotics; Randomized Controlled Trials as Topic; Secondary Prevention; Vancomycin | 2009 |
Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Risk Factors; Treatment Outcome; Vancomycin | 2009 |
Clostridium difficile infection in the intensive care unit.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Incidence; Intensive Care Units; Metronidazole; Vancomycin | 2009 |
Clostridium difficile: controversies and approaches to management.
Topics: Anti-Infective Agents; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Humans; Immunization, Passive; Metronidazole; Probiotics; Vancomycin | 2009 |
[Infections with Clostridium difficile following antibiotic therapy].
Topics: Administration, Oral; Algorithms; Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Endoscopy; Enterocolitis, Pseudomembranous; Hand Disinfection; Humans; Metronidazole; Recurrence; Time Factors; Vancomycin | 2009 |
Clostridium difficile enteritis after colectomy.
Topics: Adult; Anti-Bacterial Agents; Colectomy; Enterocolitis, Pseudomembranous; Female; Humans; Ileostomy; Male; Metronidazole; Middle Aged; Vancomycin | 2009 |
[Clostridium-difficile-associated infections].
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Base Sequence; Clostridioides difficile; Combined Modality Therapy; Disease Outbreaks; Enterocolitis, Pseudomembranous; Enterotoxins; Europe; Fluid Therapy; Humans; Incidence; Metronidazole; Molecular Sequence Data; North America; Ribotyping; Vancomycin; Virulence | 2010 |
[Clostridium difficile infection].
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Clindamycin; Clostridioides difficile; Colectomy; Colonoscopy; Cross-Sectional Studies; Enterocolitis, Necrotizing; Fluoroquinolones; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Incidence; Metronidazole; Opportunistic Infections; Probiotics; Prognosis; Risk Factors; Tomography, X-Ray Computed; Vancomycin | 2010 |
Diagnosis, management, and prevention of Clostridium difficile infection in long-term care facilities: a review.
Topics: Aged; Anti-Infective Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Equipment Contamination; Humans; Infection Control; Long-Term Care; Metronidazole; Risk Factors; Severity of Illness Index; Vancomycin | 2010 |
Clostridium difficile bacteremia, Taiwan.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Child; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Taiwan; Vancomycin; Young Adult | 2010 |
Clostridium difficile: an update for the primary care clinician.
Topics: Anti-Infective Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Hand Disinfection; Humans; Metronidazole; Patient Isolation; Primary Health Care; Probiotics; Recurrence; Severity of Illness Index; Vancomycin | 2010 |
Management of Clostridium difficile infection: thinking inside and outside the box.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antibodies, Bacterial; Antibodies, Monoclonal; Antitoxins; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Vaccination; Vancomycin | 2010 |
Clostridium difficile infection: epidemiology, risk factors and management.
Topics: Clostridioides difficile; Colitis; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Prevalence; Risk Factors; Vancomycin | 2011 |
Clostridium difficile: progress and challenges.
Topics: Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Humans; Metronidazole; Polymerase Chain Reaction; Practice Guidelines as Topic; Vancomycin | 2010 |
Treatment of refractory and recurrent Clostridium difficile infection.
Topics: Clostridioides difficile; Colectomy; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Severity of Illness Index; Treatment Outcome; Vancomycin | 2011 |
Best strategies in recurrent or persistent Clostridium difficile infection.
Topics: Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Humans; Metronidazole; Probiotics; Secondary Prevention; Vancomycin | 2011 |
Clinical approach to severe Clostridium difficile infection: update for the hospital practitioner.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Hospitalists; Humans; Incidence; Internal Medicine; Metronidazole; Severity of Illness Index; Vancomycin | 2011 |
Recurrent refractory Clostridium difficile colitis treated successfully with rifaximin and tigecycline: a case report and review of the literature.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colitis; Drug Therapy, Combination; Female; Humans; Metronidazole; Minocycline; Recurrence; Rifamycins; Rifaximin; Tigecycline; Treatment Outcome; Vancomycin | 2012 |
Clostridium difficile infection: clinical spectrum and approach to management.
Topics: Aminoglycosides; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Dietary Supplements; Digestive System Surgical Procedures; Disease Management; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Routes; Fidaxomicin; Humans; Ileus; Immunoglobulins, Intravenous; Inflammatory Bowel Diseases; Metronidazole; Severity of Illness Index; Vancomycin; Withholding Treatment | 2011 |
Comparative effectiveness of Clostridium difficile treatments: a systematic review.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Comparative Effectiveness Research; Diarrhea; Drug Therapy, Combination; Fidaxomicin; Humans; Metronidazole; Recurrence; Vancomycin | 2011 |
Clostridium difficile infection in older adults: a review and update on its management.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Infection Control; Metronidazole; Risk Factors; Vancomycin | 2012 |
Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence.
Topics: Anti-Bacterial Agents; Asia; Clostridioides difficile; Clostridium Infections; Europe; Humans; Metronidazole; North America; Recurrence; Treatment Failure; Vancomycin | 2012 |
Meeting the challenge of recurrent Clostridium difficile infection.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Fluid Therapy; Humans; Hygiene; Metronidazole; Risk Factors; Secondary Prevention; Severity of Illness Index; Vancomycin | 2012 |
Current strategies for management of initial Clostridium difficile infection.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Intestines; Length of Stay; Metronidazole; Recurrence; Rehabilitation Centers; Risk Factors; Severity of Illness Index; Vancomycin | 2012 |
Acute post-surgical bilateral orbital gas-producing infection - a case report and literature review.
Topics: Acute Disease; Anti-Bacterial Agents; Drug Therapy, Combination; Emphysema; Eye Infections, Bacterial; Eyelid Diseases; Glucocorticoids; Humans; Imipenem; Male; Methylprednisolone; Metronidazole; Middle Aged; Orbital Diseases; Postoperative Complications; Staphylococcal Infections; Tomography, X-Ray Computed; Vancomycin | 2012 |
Current state of Clostridium difficile treatment options.
Topics: Anti-Bacterial Agents; Bacitracin; Clinical Trials as Topic; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Fusidic Acid; Humans; Metronidazole; Nitro Compounds; Secondary Prevention; Severity of Illness Index; Teicoplanin; Thiazoles; Treatment Outcome; Vancomycin | 2012 |
Novel management strategies in the treatment of severe Clostridium difficile infection.
Topics: Algorithms; Anti-Infective Agents; Colectomy; Enterocolitis, Pseudomembranous; Humans; Ileostomy; Immunization; Metronidazole; Prognosis; Recurrence; Risk Factors; Vancomycin | 2012 |
Impact of antibiotics on the microcirculation in local and systemic inflammation.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Autophagy; Chemotaxis, Leukocyte; Colitis; Cytokines; Humans; Immune System; Inflammation; Metronidazole; Microcirculation; Phagocytosis; Vancomycin | 2013 |
Clostridium difficile infection: new insights into management.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Clostridium Infections; Diarrhea; Humans; Infection Control; Methicillin-Resistant Staphylococcus aureus; Metronidazole; Vancomycin | 2012 |
Epidemiology, diagnosis and treatment of Clostridium difficile infection.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Risk Factors; Secondary Prevention; Severity of Illness Index; Treatment Outcome; Vancomycin | 2012 |
Diagnosis and management of Clostridium difficile infection.
Topics: Administration, Oral; Aminoglycosides; Anti-Infective Agents; Biological Therapy; Clostridioides difficile; Clostridium Infections; Colectomy; False Positive Reactions; Fidaxomicin; Humans; Immunotherapy; Metronidazole; Molecular Diagnostic Techniques; Vancomycin | 2013 |
[Antimicrobial therapy of Clostridium difficile infection. Systematic review and meta-analysis of the scientific evidence].
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Treatment Outcome; Vancomycin | 2013 |
Treatment of recurrent Clostridium difficile infection: a systematic review.
Topics: Anti-Infective Agents; Biological Therapy; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Therapy; Humans; Metronidazole; Secondary Prevention; Treatment Outcome; Vancomycin | 2014 |
[Clostridium difficile infection: epidemiology, disease burden and therapy].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Cost of Illness; Cross Infection; Diarrhea; Drug Costs; Enterocolitis, Pseudomembranous; Health Care Costs; Humans; Hungary; Metronidazole; Public Health; Recurrence; Seasons; Vancomycin | 2013 |
[Clostridium difficile infection: epidemiology, risk factors, pathogenesis, clinical features, diagnosis and therapy].
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Humans; Metronidazole; Risk Factors; Vancomycin; Virulence | 2013 |
[Fecal transfusion as treatment of Clostridium difficile infection].
Topics: Anti-Infective Agents; Enterocolitis, Pseudomembranous; Feces; Finland; Humans; Intubation, Gastrointestinal; Metronidazole; Therapeutic Irrigation; Vancomycin | 2013 |
Clostridium difficile infection in the elderly.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Disease Management; Humans; Metronidazole; Outcome Assessment, Health Care; Prevalence; Risk Factors; Severity of Illness Index; Vancomycin | 2014 |
Vancomycin-associated neutrophilic dermatitis histologically mimicking Cryptococcus.
Topics: Biopsy, Needle; Coronary Artery Disease; Cryptococcus; Dermatomycoses; Diagnosis, Differential; Drug Eruptions; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunohistochemistry; Kidney Failure, Chronic; Male; Metronidazole; Middle Aged; Pulmonary Disease, Chronic Obstructive; Renal Dialysis; Risk Assessment; Severity of Illness Index; Treatment Outcome; Triamcinolone; Vancomycin | 2014 |
[Clostridium difficile infecion--diagnostics, prevention and treatment].
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Feces; Fidaxomicin; Humans; Metronidazole; Probiotics; Secondary Prevention; Vancomycin | 2014 |
Challenges and opportunities in the management of Clostridium difficile infection.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Immunologic Factors; Metronidazole; Probiotics; Vancomycin | 2014 |
Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Clostridioides difficile; Clostridium Infections; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Treatment Outcome; Vancomycin | 2014 |
Treatment of Clostridium difficile infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Administration Schedule; Drug Therapy, Combination; Fidaxomicin; Gastrointestinal Diseases; Humans; Metronidazole; Nitro Compounds; Randomized Controlled Trials as Topic; Recurrence; Rifamycins; Rifaximin; Thiazoles; Vancomycin | 2015 |
Treatment of recurrent and severe Clostridium difficile infection.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Fidaxomicin; Humans; Metronidazole; Microbiota; Recurrence; Severity of Illness Index; Transplantation; Vancomycin | 2015 |
Luminal Toxin-Binding Agents for Clostridium difficile Infection.
Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Clostridium Infections; Humans; Metronidazole; Toxins, Biological; Vancomycin | 2016 |
Current advances related to Clostridium difficile infection.
Topics: Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Humans; Immunity, Cellular; Metronidazole; Risk Factors; Vancomycin | 2015 |
Controversies Around Epidemiology, Diagnosis and Treatment of Clostridium difficile Infection.
Topics: Aminoglycosides; Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Fidaxomicin; Humans; Incidence; Metronidazole; Molecular Diagnostic Techniques; Polymerase Chain Reaction; Probiotics; Recurrence; Risk Factors; Vancomycin | 2015 |
Clostridium difficile Diarrhea in the Elderly: Current Issues and Management Options.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Fidaxomicin; Humans; Metronidazole; Recurrence; Risk Factors; Vancomycin | 2015 |
Clostridium difficile infection in patients with liver disease: a review.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diagnostic Tests, Routine; Diarrhea; Drug Therapy, Combination; Humans; Liver Cirrhosis; Liver Transplantation; Metronidazole; Treatment Outcome; Vancomycin | 2015 |
Efficacy and Safety of Metronidazole Monotherapy versus Vancomycin Monotherapy or Combination Therapy in Patients with Clostridium difficile Infection: A Systematic Review and Meta-Analysis.
Topics: Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Clostridioides difficile; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Treatment Outcome; Vancomycin | 2015 |
Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Bacitracin; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Randomized Controlled Trials as Topic; Teicoplanin; Treatment Outcome; Vancomycin | 2017 |
[Individualized treatment strategies for Clostridium difficile infections].
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Female; Fidaxomicin; Humans; Metronidazole; Recurrence; Secondary Prevention; Vancomycin | 2017 |
Therapy for Clostridium difficile infection - any news beyond Metronidazole and Vancomycin?
Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Design; Humans; Metronidazole; Practice Guidelines as Topic; Recurrence; Severity of Illness Index; Vancomycin | 2017 |
A Systematic Literature Review of Economic Evaluations of Antibiotic Treatments for Clostridium difficile Infection.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridium Infections; Cost-Benefit Analysis; Drug Costs; Fidaxomicin; Hospitalization; Humans; Metronidazole; Recurrence; Vancomycin | 2017 |
New and emerging therapies in treatment of Clostridium difficile infection.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Fecal Microbiota Transplantation; Humans; Metronidazole; Recurrence; Severity of Illness Index; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2018 |
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Fidaxomicin; Humans; Metronidazole; Probiotics; Vancomycin | 2018 |
Prevention and Treatment of Clostridium difficile Enterocolitis.
Topics: Clostridioides difficile; Colectomy; Cross Infection; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Incidence; Male; Metronidazole; Risk Assessment; Severity of Illness Index; United States; Vancomycin | 2018 |
Oral vancomycin versus metronidazole for the treatment of Clostridioides difficile infection: Meta-analysis of randomized controlled trials.
Topics: Administration, Oral; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Metronidazole; Randomized Controlled Trials as Topic; Recurrence; Severity of Illness Index; Treatment Outcome; Vancomycin | 2018 |
Vancomycin Versus Metronidazole for Nonsevere
Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cost-Benefit Analysis; Guidelines as Topic; Humans; Metronidazole; Treatment Outcome; Vancomycin | 2019 |
Clostridioides difficile Infection in Chronic Kidney Disease/End-Stage Renal Disease.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Antimicrobial Stewardship; Broadly Neutralizing Antibodies; Clostridium Infections; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Fidaxomicin; Hand Hygiene; Health Care Costs; Humans; Infection Control; Kidney Failure, Chronic; Length of Stay; Metronidazole; Patient Isolation; Renal Insufficiency, Chronic; Secondary Prevention; Vancomycin | 2019 |
Clostridium difficile Infection in Children.
Topics: Age Factors; Anti-Infective Agents; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Community-Acquired Infections; Cross Infection; Diarrhea; Female; Humans; Incidence; Male; Metronidazole; Prognosis; Risk Assessment; Sex Factors; United States; Vancomycin | 2019 |
Fidaxomicin compared with vancomycin and metronidazole for the treatment of Clostridioides (Clostridium) difficile infection: A network meta-analysis.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Metronidazole; Recurrence; Treatment Outcome; Vancomycin | 2020 |
A worldwide systematic review and meta-analysis of bacteria related to antibiotic-associated diarrhea in hospitalized patients.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Chloramphenicol; Ciprofloxacin; Clostridioides difficile; Clostridium perfringens; Diarrhea; Humans; Klebsiella oxytoca; Metronidazole; Prevalence; Staphylococcus aureus; Vancomycin | 2021 |
Ridinilazole: a novel, narrow-spectrum antimicrobial agent targeting Clostridium (Clostridioides) difficile.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Benzimidazoles; Clostridioides; Clostridioides difficile; Clostridium; Clostridium Infections; Fidaxomicin; Humans; Metronidazole; Pyridines; Vancomycin | 2022 |
Real-world comparison of fidaxomicin versus vancomycin or metronidazole in the treatment of Clostridium difficile infection: a systematic review and meta-analysis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridium Infections; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Vancomycin | 2022 |
Management of Clostridioides difficile infection in adults and challenges in clinical practice: review and comparison of current IDSA/SHEA, ESCMID and ASID guidelines.
Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Metronidazole; Vancomycin | 2022 |
Optimal therapeutic recommendation for Clostridioides difficile infection in pediatric and adolescent populations: a systematic review and meta-analysis.
Topics: Adolescent; Anti-Bacterial Agents; Child; Clostridioides difficile; Clostridium Infections; Humans; Metronidazole; Vancomycin | 2023 |
32 trial(s) available for metronidazole and vancomycin
| Article | Year |
|---|---|
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Skin Diseases, Bacterial; Staphylococcus | 2008 |
Clinical outcomes, safety, and pharmacokinetics of OPT-80 in a phase 2 trial with patients with Clostridium difficile infection.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glycosides; Humans; Male; Middle Aged; Treatment Outcome | 2009 |
Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial.
Topics: Aged; Bacterial Typing Techniques; Carrier State; Clostridioides difficile; Clostridium Infections; Cross Infection; DNA Restriction Enzymes; Enterocolitis, Pseudomembranous; Feces; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Prohibitins; Vancomycin | 1992 |
The role of anion-exchange resins in the treatment of antibiotic-associated pseudomembranous colitis.
Topics: Adult; Anion Exchange Resins; Child; Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Ion Exchange Resins; Metronidazole; Vancomycin | 1990 |
Treatment of Clostridium difficile colitis.
Topics: Animals; Bacitracin; Clinical Trials as Topic; Clostridium; Clostridium Infections; Enterocolitis, Pseudomembranous; Fusidic Acid; Humans; Metronidazole; Random Allocation; Vancomycin | 1985 |
Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis.
Topics: Adult; Aged; Clinical Trials as Topic; Clostridium Infections; Colitis; Costs and Cost Analysis; Diarrhea; Female; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Random Allocation; Vancomycin | 1983 |
Definition of the role of enterococcus in intraabdominal infection: analysis of a prospective randomized trial.
Topics: Abscess; Adult; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Peritonitis; Prospective Studies; Sepsis; Treatment Failure; Vancomycin | 1995 |
Clostridium difficile-associated diarrhea in patients with HIV positivity and AIDS: a prospective controlled study.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; HIV Seropositivity; Humans; Male; Metronidazole; Prospective Studies; Vancomycin | 1994 |
Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fusidic Acid; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Recurrence; Teicoplanin; Vancomycin | 1996 |
Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Double-Blind Method; Feces; Female; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Recurrence; Retrospective Studies; Risk Factors; Seasons; Vancomycin | 1997 |
Recurrent Clostridium difficile disease: epidemiology and clinical characteristics.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Health Care Costs; Hospitalization; Humans; Incidence; Male; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Vancomycin | 1999 |
Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cells, Cultured; Clostridium Infections; Feces; Humans; Metronidazole; Placebos; Recurrence; Saccharomyces; Time Factors; Vancomycin | 1999 |
High prevalence of diarrhea but infrequency of documented Clostridium difficile in autologous peripheral blood progenitor cell transplant recipients.
Topics: Administration, Oral; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Hematopoietic Stem Cell Transplantation; Humans; Metronidazole; Prevalence; Transplantation, Autologous; Vancomycin | 2000 |
Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cohort Studies; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Recurrence; Remission Induction; Risk Factors; Vancomycin | 2002 |
Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Antidiarrheals; Bifidobacterium; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Length of Stay; Male; Metronidazole; Middle Aged; Oligosaccharides; Probiotics; Secondary Prevention; Treatment Outcome; Vancomycin | 2005 |
A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Clostridioides difficile; Double-Blind Method; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Severity of Illness Index; Treatment Outcome; Vancomycin | 2007 |
Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection.
Topics: Aged; Aged, 80 and over; Bacterial Typing Techniques; Clostridioides difficile; Clostridium Infections; Enterocolitis, Pseudomembranous; Environmental Microbiology; Feces; Female; Hospital Units; Humans; Male; Metronidazole; Middle Aged; Ribotyping; Skin; Spores, Bacterial; Treatment Outcome; Vancomycin | 2010 |
Treatment with monoclonal antibodies against Clostridium difficile toxins.
Topics: Adult; Aged; Aged, 80 and over; Antibodies; Antibodies, Monoclonal; Antitoxins; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Enterotoxins; Female; Humans; Male; Metronidazole; Middle Aged; Secondary Prevention; Vancomycin; Young Adult | 2010 |
Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Canada; Clostridioides difficile; Clostridium Infections; Confidence Intervals; Double-Blind Method; Europe; Feces; Female; Fidaxomicin; Humans; Kaplan-Meier Estimate; Male; Metronidazole; Middle Aged; Secondary Prevention; Time Factors; Treatment Outcome; United States; Vancomycin; Young Adult | 2012 |
Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study.
Topics: Adult; Aged; Anti-Bacterial Agents; Bilirubin; Biomarkers; Cholangitis, Sclerosing; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Metronidazole; Middle Aged; Pilot Projects; Vancomycin; Young Adult | 2013 |
Role of oral corticosteroids in orbital cellulitis.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Ceftriaxone; Child; Drug Therapy, Combination; Eye Infections, Bacterial; Eye Movements; Female; Glucocorticoids; Humans; Infusions, Intravenous; Male; Metronidazole; Middle Aged; Orbital Cellulitis; Prednisolone; Prospective Studies; Single-Blind Method; Vancomycin; Young Adult | 2013 |
[Challenges of Clostridium difficile infection].
Topics: Aminoglycosides; Biodiversity; Cause of Death; Colonoscopy; Cross Infection; Disinfection; Enterocolitis, Pseudomembranous; Feces; Fidaxomicin; Hospital Mortality; Humans; Metronidazole; Patient Readmission; Prognosis; Recurrence; Tomography, X-Ray Computed; Transplantation; Vancomycin | 2013 |
[Recurrent Clostridium difficile infection. Treatment with duodenal infusion of donor feces].
Topics: Adult; Combined Modality Therapy; Drug Resistance, Microbial; Early Termination of Clinical Trials; Enema; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Isotonic Solutions; Male; Metronidazole; Retreatment; Secondary Prevention; Vancomycin | 2014 |
Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Female; Humans; Male; Metronidazole; Middle Aged; Polymers; Recurrence; Sulfonic Acids; Vancomycin; Young Adult | 2014 |
Fecal microbiota transplant after hematopoietic SCT: report of a successful case.
Topics: Allografts; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Female; Hematopoietic Stem Cell Transplantation; Humans; Metronidazole; Microbiota; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vancomycin | 2015 |
Reduction in Clostridium difficile environmental contamination by hospitalized patients treated with fidaxomicin.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Environmental Microbiology; Female; Fidaxomicin; Hospitalization; Humans; Male; Metronidazole; Vancomycin | 2015 |
Differences of the Fecal Microflora With Clostridium difficile Therapies.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Load; Bacteroidetes; Clostridioides difficile; Clostridium Infections; Feces; Female; Gastrointestinal Microbiome; Humans; Lactobacillus; Male; Metronidazole; Middle Aged; Polymerase Chain Reaction; Polymers; Probiotics; Sulfonic Acids; Time Factors; Treatment Outcome; Vancomycin | 2015 |
Antibiotic-induced gut microbiota disruption during human endotoxemia: a randomised controlled study.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Drug Monitoring; Endotoxemia; Escherichia coli; Gastrointestinal Microbiome; Healthy Volunteers; Humans; Immunity, Innate; Klebsiella pneumoniae; Male; Metronidazole; Sepsis; Streptococcus pneumoniae; Treatment Outcome; Vancomycin | 2017 |
The effect of bezlotoxumab for prevention of recurrent Clostridium difficile infection (CDI) in Japanese patients.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Monoclonal; Antibodies, Neutralizing; Broadly Neutralizing Antibodies; Clostridioides difficile; Clostridium Infections; Double-Blind Method; Female; Humans; Japan; Male; Metronidazole; Placebos; Recurrence; Time Factors; Vancomycin | 2018 |
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Neutralizing; Broadly Neutralizing Antibodies; Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Female; Fidaxomicin; Humans; Male; Metronidazole; Middle Aged; Patient Readmission; Recurrence; Risk Factors; Secondary Prevention; Vancomycin; Young Adult | 2018 |
Follow-on RifAximin for the Prevention of recurrence following standard treatment of Infection with
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Administration Schedule; Female; Humans; Male; Metronidazole; Middle Aged; Rifaximin; Secondary Prevention; Vancomycin | 2019 |
Impact of Oral Metronidazole, Vancomycin, and Fidaxomicin on Host Shedding and Environmental Contamination With Clostridioides difficile.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Clostridioides; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Metronidazole; Prospective Studies; Vancomycin | 2022 |
457 other study(ies) available for metronidazole and vancomycin
| Article | Year |
|---|---|
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.
Topics: Animals; Anti-Infective Agents; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Quinolones; Thiazoles | 2007 |
In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Humans; Microbial Sensitivity Tests; United States | 2007 |
vanD and vanG-like gene clusters in a Ruminococcus species isolated from human bowel flora.
Topics: Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Feces; Gene Order; Genes, Bacterial; Humans; Inflammatory Bowel Diseases; Molecular Sequence Data; Multigene Family; Phylogeny; Ruminococcus; Sequence Analysis, DNA; Teicoplanin; Vancomycin | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Community-Acquired Infections; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Female; Hospitalization; Humans; Incidence; Male; Middle Aged; Prognosis; Quebec; Ribotyping; Risk Factors | 2008 |
In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Glycosides; Humans; In Vitro Techniques; Microbial Sensitivity Tests | 2008 |
In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Carbapenems; Doripenem; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
Topics: Anti-Bacterial Agents; Azepines; Bacteria, Anaerobic; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 2009 |
In vitro activity of TR-700, the active ingredient of the antibacterial prodrug TR-701, a novel oxazolidinone antibacterial agent.
Topics: Anti-Bacterial Agents; Bacteria; Enterococcus; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Oxazolidinones; Staphylococcus; Streptococcus | 2009 |
In vitro activities of telavancin and six comparator agents against anaerobic bacterial isolates.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria, Anaerobic; Clostridioides difficile; Gram-Negative Bacteria; Gram-Positive Bacteria; Lipoglycopeptides; Microbial Sensitivity Tests | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Antimicrobial susceptibility patterns for recent clinical isolates of anaerobic bacteria in South Korea.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Anaerobic; Bacteroides fragilis; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Positive Cocci; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Republic of Korea | 2010 |
Comparative in vitro activity profiles of novel bis-indole antibacterials against gram-positive and gram-negative clinical isolates.
Topics: Anti-Bacterial Agents; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Indoles; Microbial Sensitivity Tests | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Streptomyces; Vero Cells | 2013 |
Diarylacylhydrazones: Clostridium-selective antibacterials with activity against stationary-phase cells.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cell Cycle; Cell Line; Clostridioides difficile; Fidaxomicin; Humans; Hydrazones; Microbial Sensitivity Tests | 2014 |
Structure-Activity Relationship Studies of a Series of Semisynthetic Lipopeptides Leading to the Discovery of Surotomycin, a Novel Cyclic Lipopeptide Being Developed for the Treatment of Clostridium difficile-Associated Diarrhea.
Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Cricetinae; Diarrhea; Enterocolitis, Pseudomembranous; Lipopeptides; Male; Microbial Sensitivity Tests; Peptides, Cyclic; Structure-Activity Relationship | 2015 |
Structure-Activity Relationship for the Picolinamide Antibacterials that Selectively Target
Topics: | 2021 |
Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial Pathogens.
Topics: Anaerobiosis; DNA-Directed RNA Polymerases; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Rifamycins | 2022 |
[Preventive drug therapy against anaerobic bacteria].
Topics: Anti-Bacterial Agents; Bacterial Infections; Chloramphenicol; Clindamycin; Digestive System; Female; Genitalia, Female; Humans; Male; Metronidazole; Penicillin Resistance; Penicillins; Respiratory System; Surgical Wound Infection; Tetracycline; Vancomycin | 1978 |
Oral metronidazole in Clostridium difficile colitis.
Topics: Clostridium Infections; Colitis; Humans; Metronidazole; Vancomycin | 1979 |
[Antibiotic-induced pseudomembranous Clostridium difficile colitis. A new etiopathogenetically definable infectious disease].
Topics: Anaerobiosis; Animals; Anti-Bacterial Agents; Bacterial Toxins; Clindamycin; Clostridium; Enterocolitis, Pseudomembranous; Feces; Guinea Pigs; Humans; Metronidazole; Vancomycin | 1979 |
Clindamycin-induced colitis.
Topics: Animals; Bacterial Toxins; Cecum; Clindamycin; Clostridium; Clostridium Infections; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Feces; Humans; Male; Mesocricetus; Metronidazole; Vancomycin | 1979 |
Antimicrobial therapy of anaerobic infections.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Cephalosporins; Chloramphenicol; Clindamycin; Clostridium; Erythromycin; Fusobacterium; Gram-Negative Anaerobic Bacteria; Humans; Lincomycin; Metronidazole; Penicillin Resistance; Penicillins; Rifampin; Tetracycline; Thiamphenicol; Vancomycin | 1975 |
Pseudomembranous colitis following resection for Hirschsprung's disease.
Topics: Administration, Rectal; Child, Preschool; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Female; Hirschsprung Disease; Humans; Intestinal Mucosa; Male; Metronidazole; Postoperative Complications; Reoperation; Vancomycin | 1992 |
Diarrhea in hospitalized patients.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Cytotoxins; Diarrhea; Feces; Humans; Inpatients; Metronidazole; Middle Aged; Rehabilitation Centers; Vancomycin | 1992 |
Severe amoebic colitis requiring colonic resection.
Topics: Biopsy; Colectomy; Combined Modality Therapy; Dysentery, Amebic; Fluid Therapy; Humans; Ileostomy; Ioxaglic Acid; Male; Metronidazole; Middle Aged; Sigmoidoscopy; Vancomycin | 1992 |
[The diagnosis and treatment of Clostridium difficile enterocolitis].
Topics: Adult; Aged; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Vancomycin | 1991 |
Antibiotic resistance of Clostridium difficile isolates.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clindamycin; Clostridioides difficile; Diarrhea; Drug Resistance, Microbial; Glycopeptides; Humans; Infant; Infant, Newborn; Leukemia; Metronidazole; Poland; Teicoplanin; Vancomycin | 1991 |
Empyema caused by Clostridium sordellii, a rare form of pleuropulmonary disease.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridium Infections; Empyema; Female; Humans; Lactams; Metronidazole; Sputum; Vancomycin | 1991 |
In vitro synergy studies with Clostridium difficile.
Topics: Bacitracin; Clostridioides difficile; Drug Combinations; Drug Synergism; Humans; Metronidazole; Microbial Sensitivity Tests; Rifampin; Vancomycin | 1991 |
Time-dependent killing of Clostridium difficile by metronidazole and vancomycin.
Topics: Clostridioides difficile; Drug Evaluation, Preclinical; Metronidazole; Microbial Sensitivity Tests; Species Specificity; Time Factors; Vancomycin | 1991 |
Pseudomembranous colitis: how useful is endoscopy?
Topics: Colonoscopy; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Sigmoidoscopy; Vancomycin | 1990 |
Antibiotic-associated pseudomembranous colitis.
Topics: Administration, Oral; Costs and Cost Analysis; Enterocolitis, Pseudomembranous; Humans; Injections, Intravenous; Metronidazole; Vancomycin | 1990 |
[Antibiotic associated diarrhea].
Topics: Anti-Bacterial Agents; Bacitracin; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin | 1990 |
[Pseudomembranous colitis caused by antibiotic therapy during aorto-iliac surgery].
Topics: Aorta, Abdominal; Blood Vessel Prosthesis; Cholestyramine Resin; Enterocolitis, Pseudomembranous; Humans; Iliac Artery; Metronidazole; Vancomycin | 1990 |
Failure of intravenous vancomycin and intravenous metronidazole to prevent or treat antibiotic-associated pseudomembranous colitis.
Topics: Enterocolitis, Pseudomembranous; Female; Humans; Injections, Intravenous; Male; Metronidazole; Middle Aged; Vancomycin | 1989 |
Cost-effective treatment of pseudomembranous colitis.
Topics: Cost-Benefit Analysis; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Prospective Studies; Random Allocation; Vancomycin | 1989 |
Miscellaneous antibiotics of interest to dentists.
Topics: Anti-Bacterial Agents; Clindamycin; Dental Care; Humans; Metronidazole; Streptomycin; Vancomycin | 1989 |
[Dosage adjustment of drugs during continuous hemofiltration. Results and practical consequences of a prospective clinical study].
Topics: Adult; Aged; Cefotaxime; Ceftazidime; Digitoxin; Digoxin; Hemofiltration; Humans; Imipenem; Kidney Failure, Chronic; Metronidazole; Middle Aged; Netilmicin; Pharmaceutical Preparations; Phenobarbital; Phenytoin; Theophylline; Tobramycin; Vancomycin | 1989 |
Treatment of Clostridium difficile diarrhea.
Topics: Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Vancomycin | 1989 |
Clostridium perfringens type A. Comparison of in vitro and in vivo activity of twelve antimicrobial drugs.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Clostridium perfringens; Fosfomycin; Gas Gangrene; Imipenem; Metronidazole; Mice; Microbial Sensitivity Tests; Oxacillin; Penicillin G; Thienamycins; Vancomycin | 1986 |
Therapy of Clostridium difficile in pseudomembranous and antibiotic-associated colitis.
Topics: Anti-Bacterial Agents; Cholestyramine Resin; Clostridium Infections; Colitis; Glycopeptides; Humans; Metronidazole; Teicoplanin; Vancomycin | 1987 |
Susceptibility of Clostridium difficile to LY146032.
Topics: Anti-Bacterial Agents; Bacitracin; Clostridium; Daptomycin; Fusidic Acid; Humans; Metronidazole; Microbial Sensitivity Tests; Peptides; Vancomycin | 1987 |
Multidisciplinary cost-containment program promoting oral metronidazole for treatment of antibiotic-associated colitis.
Topics: Administration, Oral; Anti-Bacterial Agents; Colitis; Cost Control; Humans; Metronidazole; Pharmacists; Pharmacy and Therapeutics Committee; Pharmacy Service, Hospital; Vancomycin | 1988 |
Clostridium difficile colitis following treatment with metronidazole and vancomycin.
Topics: Adult; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Metronidazole; Opportunistic Infections; Vancomycin | 1987 |
Influence of antibiotics on intestinal mucin in healthy subjects.
Topics: Administration, Oral; Adult; Ampicillin; Anti-Bacterial Agents; Bacitracin; Clindamycin; Doxycycline; Drug Combinations; Electrophoresis, Agar Gel; Erythromycin; Feces; Germ-Free Life; Humans; Intestinal Mucosa; Intestines; Metronidazole; Mucins; Nalidixic Acid; Ofloxacin; Oxazines; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1986 |
Treatment of relapsing Clostridium difficile diarrhoea by administration of a non-toxigenic strain.
Topics: Aged; Aged, 80 and over; Clostridium; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Metronidazole; Recurrence; Vancomycin | 1987 |
Pseudomembranous colitis: local experience with 3 cases.
Topics: Aged; Enterocolitis, Pseudomembranous; Female; Humans; Intestinal Mucosa; Male; Metronidazole; Middle Aged; Sigmoidoscopy; Vancomycin | 1986 |
Changing epidemiology, diagnosis, and treatment of Clostridium difficile toxin-associated colitis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacitracin; Bacterial Toxins; Child; Child, Preschool; Clostridium; Enterocolitis, Pseudomembranous; Female; Humans; Infant; Male; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Vancomycin | 1986 |
Choosing antimicrobials. Factors to consider, available agents.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Clindamycin; Drug Interactions; Drug Therapy, Combination; Erythromycin; Humans; Kidney Failure, Chronic; Metronidazole; Penicillin Resistance; Penicillins; Rifampin; Tetracycline; Tissue Distribution; Vancomycin | 1985 |
The newer antimicrobials.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antifungal Agents; Antiviral Agents; Bacteria; Cephalosporins; Chloramphenicol; Deoxyuridine; Drug Combinations; Erythromycin; Humans; Metronidazole; Penicillins; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Viruses | 1985 |
Antibiotic-associated colitis: why do patients relapse?
Topics: Bacitracin; Colitis; Humans; Metronidazole; Recurrence; Vancomycin | 1986 |
Antibiotic-associated pseudomembranous colitis.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacitracin; Bacterial Proteins; Bacterial Toxins; Cephalosporins; Cholestyramine Resin; Clindamycin; Clostridium; Colestipol; Endoscopy; Enterocolitis, Pseudomembranous; Feces; Humans; Leukocyte Count; Metronidazole; Vancomycin | 1985 |
Clostridium difficile colitis following head and neck surgery. Report of cases.
Topics: Aged; Anti-Bacterial Agents; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Head and Neck Neoplasms; Humans; Male; Metronidazole; Middle Aged; Postoperative Complications; Premedication; Vancomycin | 1985 |
Antimicrobial considerations in anaerobic infections.
Topics: Actinomycetales Infections; Anaerobiosis; Anti-Bacterial Agents; Bacterial Infections; Bacteroides Infections; Cephalosporins; Chloramphenicol; Clindamycin; Clostridium Infections; Erythromycin; Fusobacterium; Humans; Lincomycin; Metronidazole; Microbial Sensitivity Tests; Oxygen; Penicillins; Rifampin; Streptococcal Infections; Tetracycline; Treponemal Infections; Vancomycin; Veillonella | 1974 |
Bactericidal activity of five antimicrobial agents against Bacteroides fragilis.
Topics: Anti-Bacterial Agents; Bacteroides; Clindamycin; Metronidazole; Microbial Sensitivity Tests; Rifampin; Tetracycline; Vancomycin | 1972 |
Topical treatment of acute ulcerative gingivitis: a comparison of vancomycin with penicillin and metronidazole.
Topics: Adolescent; Adult; Evaluation Studies as Topic; Gingivitis, Necrotizing Ulcerative; Humans; Metronidazole; Penicillins; Vancomycin | 1971 |
[Postpartum pseudomembranous colitis].
Topics: Adult; Cefotaxime; Colon; Colonoscopy; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Gentamicins; Humans; Hysterectomy; Methylmethacrylates; Metronidazole; Obstetric Labor Complications; Pregnancy; Puerperal Disorders; Shock; Uterine Hemorrhage; Vancomycin | 1984 |
Vancomycin dose for pseudomembranous colitis.
Topics: Costs and Cost Analysis; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin | 1980 |
Metronidazole or vancomycin for Clostridium difficile associated diarrhoea.
Topics: Clostridium Infections; Diarrhea; Humans; Metronidazole; Vancomycin | 1983 |
Treatment of antibiotic-associated colitis with vancomycin.
Topics: Adult; Anti-Bacterial Agents; Bacitracin; Bacterial Proteins; Bacterial Toxins; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Infant; Metronidazole; Vancomycin | 1984 |
Curved anaerobic bacteria in bacterial (nonspecific) vaginosis and their response to antimicrobial therapy.
Topics: Adolescent; Adult; Cefoxitin; Clindamycin; Drug Resistance, Microbial; Female; Humans; Metronidazole; Microbial Sensitivity Tests; Moxalactam; Vagina; Vaginitis; Vancomycin; Vibrio; Vibrio Infections | 1983 |
Non-Clostridium difficile pseudomembranous colitis responding to both vancomycin and metronidazole. ?
Topics: Adolescent; Clostridium; Enterocolitis, Pseudomembranous; Female; Humans; Metronidazole; Vancomycin | 1981 |
Metronidazole and antibiotic-associated colitis.
Topics: Aged; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Vancomycin | 1981 |
Effect of selective antimicrobial therapy on plaque and gingivitis in the dog.
Topics: Animals; Bacteria; Clindamycin; Dental Plaque; Dogs; Drug Evaluation, Preclinical; Female; Gingivitis; Metronidazole; Toothbrushing; Vancomycin | 1980 |
Development of plaque and gingivitis following antibiotic therapy in dogs.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Clindamycin; Dental Plaque; Dogs; Gingivitis; Metronidazole; Time Factors; Vancomycin | 1982 |
[Effect of antimicrobial therapy on plaque and gingivitis in dogs].
Topics: Animals; Anti-Bacterial Agents; Clindamycin; Dental Plaque; Dogs; Gingivitis; Metronidazole; Vancomycin | 1982 |
[Pseudomembranous colitis: observations on 13 clinical cases].
Topics: Adult; Aged; Anti-Bacterial Agents; Drug Combinations; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Loperamide; Male; Metronidazole; Middle Aged; Neomycin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1981 |
Metronidazole: an alternate therapy for antibiotic-associated colitis.
Topics: Adult; Aged; Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Vancomycin | 1982 |
Pseudomembranous colitis unresponsive to oral vancomycin therapy.
Topics: Enterocolitis, Pseudomembranous; Female; Humans; Metronidazole; Middle Aged; Vancomycin | 1982 |
Recurrence of antibiotic-associated pseudomembranous colitis after parenteral metronidazole therapy and cure by oral vancomycin: case report.
Topics: Administration, Oral; Aged; Enterocolitis, Pseudomembranous; Humans; Injections, Intravenous; Male; Metronidazole; Recurrence; Vancomycin | 1981 |
Pseudomembranous colitis: multiple relapses after treatment with metronidazole.
Topics: Aged; Cholestyramine Resin; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Metronidazole; Recurrence; Vancomycin | 1981 |
Antibiotic-associated colitis--an abating enigma.
Topics: Anti-Bacterial Agents; Bacitracin; Clindamycin; Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Lincomycin; Metronidazole; Vancomycin | 1981 |
Treatment and prevention of antimicrobial agent-induced colitis and diarrhae.
Topics: Animals; Anti-Bacterial Agents; Bacitracin; Cholestyramine Resin; Clostridium Infections; Cricetinae; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Rabbits; Vancomycin | 1980 |
Treatment of pseudomembranous colitis with oral metronidazole after relapse following vancomycin.
Topics: Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Middle Aged; Vancomycin | 1980 |
Community-acquired Clostridium difficile-associated diarrhea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Toxins; Child; Child, Preschool; Clostridioides difficile; Community-Acquired Infections; Cytotoxins; Diarrhea; Feces; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Treatment Outcome; Vancomycin | 1995 |
Treatment of Clostridium difficile colitis. Summary of a round table held in Brussels on March, 3rd, 1994.
Topics: Clostridioides difficile; Clostridium Infections; Colitis; Humans; Metronidazole; Vancomycin | 1995 |
Pseudomembranous colitis in a patient with a colostomy.
Topics: Cephalexin; Colonoscopy; Colostomy; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Middle Aged; Urinary Tract Infections; Vancomycin | 1995 |
Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991.
Topics: Administration, Oral; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Feces; Hospitals, Veterans; Humans; Metronidazole; Minnesota; Population Surveillance; Prospective Studies; Vancomycin | 1994 |
[Severe infection by methicillin-resistant staphylococci after insertion of PEG].
Topics: Aged; Aged, 80 and over; Enteral Nutrition; Female; Gastrostomy; Gentamicins; Humans; Injections, Intravenous; Methicillin Resistance; Metronidazole; Piperacillin; Shock, Septic; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1995 |
[Combatting nosocomial intestinal infections with yeasts].
Topics: Combined Modality Therapy; Cross Infection; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Saccharomyces; Vancomycin; Yeast, Dried | 1995 |
Clostridium difficile colitis: an increasing hospital-acquired illness.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Cholestyramine Resin; Cross Infection; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Fluid Therapy; Hospital Mortality; Humans; Immunosuppressive Agents; Incidence; Infant; Male; Metronidazole; Middle Aged; Premedication; Retrospective Studies; Surgical Procedures, Operative; Survival Rate; Vancomycin | 1995 |
Management and control of a large outbreak of diarrhoea due to Clostridium difficile.
Topics: Aged; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Disease Outbreaks; England; Enterotoxins; Hospitals, General; Humans; Infection Control; Metronidazole; Middle Aged; Recurrence; Vancomycin | 1994 |
Antibiotic strategy in orofacial/head and neck infections in severe neutropenia.
Topics: Adolescent; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Clinical Protocols; Drug Therapy, Combination; Edema; Face; Female; Humans; Infusions, Intravenous; Lactams; Leukemia; Lymphoma; Male; Metronidazole; Middle Aged; Mouth Diseases; Neck; Neutropenia; Periapical Diseases; Periodontal Diseases; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Vancomycin | 1994 |
Clostridium difficile colitis.
Topics: Aged; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin | 1994 |
Arterioportal fistula in infancy.
Topics: Angiography; Arteriovenous Fistula; Cefotaxime; Diagnosis, Differential; Female; Hepatic Artery; Humans; Infant, Newborn; Liver; Metronidazole; Portal Vein; Vancomycin | 1993 |
Clostridium difficile infection is a treatable cause of diarrhea in patients with advanced human immunodeficiency virus infection: a study of seven consecutive patients admitted from 1986 to 1992 to a university teaching hospital.
Topics: Adult; AIDS-Related Opportunistic Infections; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fluid Therapy; Humans; Male; Metronidazole; Vancomycin | 1993 |
Clostridium difficile diarrhea in patients with AIDS versus non-AIDS controls. Methods of treatment and clinical response to treatment.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Bacterial Toxins; Case-Control Studies; Chi-Square Distribution; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Leukocyte Count; Male; Metronidazole; Vancomycin | 1993 |
Diarrhoea caused by Clostridium difficile: response time for treatment with metronidazole and vancomycin.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antidiarrheals; Clostridioides difficile; Clostridium Infections; Diarrhea; Female; Humans; Loperamide; Macrolides; Male; Metronidazole; Middle Aged; Retrospective Studies; Time Factors; Vancomycin | 1995 |
The clinical spectrum of Clostridium difficile colitis in immunocompromised patients.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Immunocompromised Host; Male; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome; Vancomycin | 1996 |
Extraintestinal Clostridium difficile infections.
Topics: Adolescent; Aged; Anti-Bacterial Agents; Antitrichomonal Agents; Bacteremia; Ceftazidime; Cephalosporins; Clostridioides difficile; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Liver Transplantation; Male; Metronidazole; Middle Aged; Vancomycin; Wounds and Injuries | 1996 |
[Occurrence and clinical picture of Clostridium difficile infections after antibiotic therapy].
Topics: Adult; Anti-Bacterial Agents; Cholestyramine Resin; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Vancomycin | 1995 |
Risk factors for mortality associated with enterococcal bloodstream infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cohort Studies; Cross Infection; Drug Resistance, Microbial; Enterococcus; Female; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies; Risk Factors; Streptococcal Infections; United States; Vancomycin | 1996 |
Pseudomembranous colitis.
Topics: Administration, Oral; Anti-Infective Agents; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin | 1996 |
Antibiotic prophylaxis in gastrointestinal endoscopy: a report by a Working Party for the British Society of Gastroenterology Endoscopy Committee.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteremia; Cephalosporins; Cholangiopancreatography, Endoscopic Retrograde; Cholestasis; Ciprofloxacin; Drug Hypersensitivity; Endocarditis, Bacterial; Endoscopy, Gastrointestinal; Gentamicins; Humans; Immunocompromised Host; Metronidazole; Neutropenia; Pancreatic Pseudocyst; Penicillins; Risk Factors; Teicoplanin; Vancomycin | 1997 |
Diarrhoea in the intensive care unit.
Topics: Anti-Bacterial Agents; Antitrichomonal Agents; Cross Infection; Diarrhea; Humans; Intensive Care Units; Metronidazole; Vancomycin | 1997 |
Antibacterial activity of teicoplanin against Clostridium difficile.
Topics: Anti-Bacterial Agents; Antitrichomonal Agents; Clindamycin; Clostridioides difficile; Dose-Response Relationship, Drug; In Vitro Techniques; Metronidazole; Microbial Sensitivity Tests; Teicoplanin; Vancomycin | 1996 |
Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection?
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Enterocolitis, Pseudomembranous; Gram-Positive Bacterial Infections; Humans; Metronidazole; Vancomycin | 1997 |
Fulminant pseudomembranous colitis leading to total colonic stricture.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Child; Colectomy; Colonic Diseases; Constriction, Pathologic; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Humans; Ileostomy; Metronidazole; Proctocolectomy, Restorative; Rectal Diseases; Vancomycin | 1997 |
Pseudomembraneous clostridium after autologous bone marrow transplantation.
Topics: Adolescent; Anti-Bacterial Agents; Antitrichomonal Agents; Bone Marrow Transplantation; Clostridioides difficile; Enterocolitis, Pseudomembranous; Hematopoiesis; Hodgkin Disease; Humans; Male; Metronidazole; Transplantation, Autologous; Vancomycin | 1998 |
Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Cross Infection; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Metronidazole; Middle Aged; Multivariate Analysis; Risk Factors; Vancomycin | 1998 |
Managing C. difficile-associated diarrhea.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Resistance, Microbial; Humans; Metronidazole; United States; Vancomycin | 1998 |
ASHP therapeutic position statement on the preferential use of metronidazole for the treatment of Clostridium difficile-associated disease.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Resistance, Microbial; Humans; Metronidazole; Vancomycin | 1998 |
Clostridium difficile colitis: factors influencing treatment failure and relapse--a prospective evaluation.
Topics: Aged; Anti-Bacterial Agents; Case-Control Studies; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Humans; Linear Models; Male; Metronidazole; Prospective Studies; Recurrence; Risk Factors; Serum Albumin; Time Factors; Treatment Failure; Vancomycin | 1998 |
Vancomycin-resistant enterococcal colonization in nonhospitalized HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Amoxicillin; Anti-Bacterial Agents; Bisexuality; Black People; Cephalexin; Cephalosporins; Clarithromycin; Dicloxacillin; Doxycycline; Drug Resistance, Microbial; Enterococcus; Feces; Female; Gram-Positive Bacterial Infections; Homosexuality, Male; Humans; Male; Metronidazole; Middle Aged; Ofloxacin; Penicillins; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; White People | 1998 |
Susceptibility testing of Clostridium difficile against metronidazole and vancomycin by disk diffusion and Etest.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Microbial Sensitivity Tests; Prospective Studies; Vancomycin | 1999 |
Necrotizing fasciitis after cosmetic blepharoplasty.
Topics: Aged; Blepharoplasty; Debridement; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Eyelids; Facial Paralysis; Fasciitis, Necrotizing; Female; Fever; Humans; Hyperbaric Oxygenation; Metronidazole; Skin Diseases; Streptococcus pyogenes; Vancomycin | 1999 |
A rare case of successful antibiotic therapy in an elderly man with a retarded aorto-bifemoral graft infection.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Aortic Aneurysm, Abdominal; Aortic Dissection; Humans; Male; Metronidazole; Prosthesis-Related Infections; Streptococcal Infections; Sulbactam; Vancomycin | 1999 |
Antibiotic levels in empyemic pleural fluid.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Ceftriaxone; Clindamycin; Disease Models, Animal; Empyema, Pleural; Gentamicins; Humans; Infusions, Intravenous; Metronidazole; Pasteurella Infections; Pasteurella multocida; Penicillins; Rabbits; Vancomycin | 2000 |
In vitro and in vivo activities of nitazoxanide against Clostridium difficile.
Topics: Animals; Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Metronidazole; Microbial Sensitivity Tests; Nitro Compounds; Thiazoles; Vancomycin | 2000 |
[Recurrent Clostridium difficile enterocolitis].
Topics: Aged; Aged, 80 and over; Clostridioides difficile; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Immunoglobulins, Intravenous; Metronidazole; Recurrence; Saccharomyces; Vancomycin | 2000 |
Identification and antimicrobial susceptibility of enterococci isolated from the root canal.
Topics: Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Calcium Hydroxide; Clindamycin; Dental Pulp Cavity; Dental Pulp Diseases; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Erythromycin; Gram-Positive Bacterial Infections; Humans; Metronidazole; Penicillin G; Penicillin Resistance; Penicillins; Root Canal Filling Materials; Tetracycline; Tetracycline Resistance; Treatment Failure; Vancomycin | 2000 |
Addition of antibacterial agents to MMA-TBB dentin bonding systems--influence on tensile bond strength and antibacterial effect.
Topics: Acrylic Resins; Actinomyces; Actinomyces viscosus; Analysis of Variance; Animals; Anti-Bacterial Agents; Bacteria; Boron Compounds; Cattle; Composite Resins; Dental Bonding; Dental Stress Analysis; Dentin; Dentin-Bonding Agents; Methacrylates; Methylmethacrylate; Methylmethacrylates; Metronidazole; Polymethyl Methacrylate; Resin Cements; Streptococcus; Streptococcus mutans; Streptococcus sanguis; Tensile Strength; Vancomycin | 2000 |
Liver abscess caused by Clostridium difficile.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drainage; Female; Humans; Liver Abscess; Metronidazole; Recurrence; Treatment Failure; Vancomycin | 2001 |
Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice.
Topics: Animals; Bacteroides; Ciprofloxacin; Colitis; Enterobacteriaceae; Female; HLA-B27 Antigen; Imipenem; Interleukin-1; Metronidazole; Mice; Mice, Inbred BALB C; Rats; Rats, Inbred F344; Vancomycin | 2001 |
Development of systemic bacteraemia after oral inoculation of vancomycin-resistant enterococci in mice.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bacterial Translocation; Cyclophosphamide; Drug Therapy, Combination; Enterococcus; Escherichia coli; Gram-Positive Bacterial Infections; Immunosuppressive Agents; Intestines; Kanamycin; Metronidazole; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred ICR; Mice, Nude; Mice, SCID; Neutropenia; Vancomycin; Vancomycin Resistance; Virulence | 2001 |
Clinical microbiological case: a heart transplant recipient with diarrhea and abdominal pain. Recurring C. difficile infection.
Topics: Abdominal Pain; Adult; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Graft Rejection; Heart Transplantation; Humans; Immunocompromised Host; Male; Metronidazole; Vancomycin | 2001 |
Prebiotic treatment of experimental colitis with germinated barley foodstuff: a comparison with probiotic or antibiotic treatment.
Topics: Animal Feed; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Body Weight; Colitis; Diet; Disease Models, Animal; Hordeum; Male; Metronidazole; Phytotherapy; Plant Preparations; Probiotics; Rats; Rats, Sprague-Dawley; Vancomycin | 2002 |
Colonic fermentation as affected by antibiotics and acidic pH: Application of an in vitro model.
Topics: Acid-Base Equilibrium; Animals; Anti-Bacterial Agents; Bacteria; Colon; Dose-Response Relationship, Drug; Fatty Acids, Volatile; Fermentation; Homeostasis; In Vitro Techniques; Male; Metronidazole; Swine; Vancomycin | 2001 |
Severe antibiotic-associated colitis in a patient with cystic fibrosis and colonic wall thickening.
Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Colon; Cystic Fibrosis; Diagnosis, Differential; Enterocolitis, Pseudomembranous; Feces; Humans; Male; Metronidazole; Recurrence; Tomography, X-Ray Computed; Ultrasonography; Vancomycin | 2002 |
[Obesity, diabetes mellitus, and gas gangrene: a major therapeutic challenge].
Topics: Abscess; Amikacin; Anus Diseases; Buttocks; Candidiasis; Ceftazidime; Colostomy; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 1; Disease Susceptibility; Drug Therapy, Combination; Fasciitis; Female; Gas Gangrene; Humans; Hyperbaric Oxygenation; Hypertension; Metronidazole; Middle Aged; Obesity, Morbid; Postoperative Complications; Shock, Septic; Vancomycin | 2001 |
E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid.
Topics: Acetamides; Anti-Infective Agents; Aza Compounds; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Fluoroquinolones; Fusidic Acid; Gatifloxacin; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Oxazolidinones; Quinolines; Sensitivity and Specificity; Vancomycin | 2002 |
Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin.
Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; HIV Infections; Humans; Metronidazole; Microbial Sensitivity Tests; Time Factors; Vancomycin | 2002 |
Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Case-Control Studies; Cephalosporins; Enterococcus; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Metronidazole; Middle Aged; Risk Factors; Vancomycin; Vancomycin Resistance | 2002 |
[Antibiotic-associated diarrhea].
Topics: Anti-Bacterial Agents; Diarrhea; Enterocolitis, Pseudomembranous; Fluid Therapy; Humans; Metronidazole; Recurrence; Vancomycin | 2003 |
Staphylococcal pericarditis in a chronic renal failure patient.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Echocardiography; Female; Humans; Kidney Failure, Chronic; Metronidazole; Pericarditis; Renal Dialysis; Staphylococcal Infections; Staphylococcus aureus; Tomography, X-Ray Computed; Vancomycin | 2003 |
Treatment with antibiotics reduces plasma equol concentration in cynomolgus monkeys (Macaca fascicularis).
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Chromans; Doxycycline; Equol; Feces; Female; Isoflavones; Kanamycin; Macaca fascicularis; Metronidazole; Vancomycin | 2003 |
Clostridium difficile infection in patients with unexplained leukocytosis.
Topics: Anti-Infective Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Leukocytosis; Male; Metronidazole; Middle Aged; Prospective Studies; Vancomycin | 2003 |
[Assessment of susceptibility to metronidazole and vancomycin of Clostridium difficile strains isolated between 1998-2002].
Topics: Anti-Bacterial Agents; Clostridioides difficile; Drug Resistance, Multiple, Bacterial; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Microbial Sensitivity Tests; Vancomycin | 2003 |
Bilateral periorbital necrotizing fasciitis.
Topics: Aged; Anti-Bacterial Agents; Arthritis, Rheumatoid; Bacteremia; Bronchopneumonia; Ceftriaxone; Debridement; Dermatitis, Perioral; Diagnosis, Differential; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Emphysema; Fasciitis, Necrotizing; Fatal Outcome; Female; Heart Failure; Humans; Metronidazole; Respiration, Artificial; Streptococcus agalactiae; Vancomycin | 2004 |
In-vitro activity of nisin against clinical isolates of Clostridium difficile.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Microbial Sensitivity Tests; Nisin; Vancomycin | 2004 |
Clostridium difficile colitis in patients after kidney and pancreas-kidney transplantation.
Topics: Adult; Aged; Anti-Infective Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Kidney Transplantation; Male; Metronidazole; Middle Aged; Pancreas Transplantation; Risk Factors; Vancomycin | 2004 |
Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Chi-Square Distribution; Child; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Disease Progression; Female; Humans; Incidence; Logistic Models; Male; Metronidazole; Middle Aged; Quebec; Retrospective Studies; Severity of Illness Index; Vancomycin | 2004 |
Pseudomembranous colitis.
Topics: Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin | 2004 |
Clostridium difficile-associated diarrhea: risk factors, diagnostic methods, and treatment.
Topics: Anti-Bacterial Agents; Diarrhea; Endoscopy, Gastrointestinal; Enterocolitis, Pseudomembranous; Feces; Humans; Immunoenzyme Techniques; Metronidazole; Recurrence; Risk Factors; Vancomycin | 2004 |
Steroid-refractory ulcerative colitis treated with corticosteroids, metronidazole and vancomycin: a case report.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Clostridioides difficile; Clostridium Infections; Colitis, Ulcerative; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Humans; Male; Metronidazole; Prednisone; Steroids; Vancomycin | 2005 |
Treating C. difficile.
Topics: Anion Exchange Resins; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Interactions; Drug Therapy, Combination; Metronidazole; Vancomycin | 2005 |
In vitro activity of ramoplanin against Clostridium difficile, including strains with reduced susceptibility to vancomycin or with resistance to metronidazole.
Topics: Clostridioides difficile; Depsipeptides; Drug Resistance, Bacterial; Metronidazole; Microbial Sensitivity Tests; Vancomycin | 2005 |
Subdural empyema due to spinal anesthesia.
Topics: Adult; Anesthesia, Spinal; Anti-Bacterial Agents; Anti-Infective Agents; Brain; Ceftriaxone; Cesarean Section; Craniotomy; Empyema, Subdural; Female; Fever; Headache; Humans; Metronidazole; Postoperative Complications; Tomography, X-Ray Computed; Vancomycin | 2005 |
Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole.
Topics: Anti-Bacterial Agents; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Follow-Up Studies; Humans; Metronidazole; Prospective Studies; Treatment Failure; Vancomycin | 2005 |
Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Enterocolitis, Pseudomembranous; Humans; Infant; Metronidazole; Middle Aged; Quebec; Recurrence; Risk Factors; Treatment Failure; Vancomycin | 2005 |
Metronidazole for Clostridium difficile-associated disease: is it okay for Mom?
Topics: Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Vancomycin | 2005 |
A standardized regimen of antibiotics prevents infectious complications in skull base surgery.
Topics: Adult; Aged; Analysis of Variance; Antibiotic Prophylaxis; Case-Control Studies; Ceftazidime; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Neoplasm Staging; Neurosurgical Procedures; Preoperative Care; Probability; Prognosis; Prospective Studies; Reference Values; Risk Assessment; Skull Base Neoplasms; Surgical Wound Infection; Survival Rate; Treatment Outcome; Vancomycin | 2005 |
Yeast mediates lactic acidosis suppression after antibiotic cocktail treatment in short small bowel?
Topics: Acidosis, Lactic; Adolescent; Anti-Bacterial Agents; Child; Colistin; Drug Therapy, Combination; Feces; Female; Gentamicins; Humans; Lactobacillus; Metronidazole; Short Bowel Syndrome; Vancomycin; Yeasts | 2005 |
Effect of bowel decontamination with metronidazole and vancomycin on gastroduodenal myoelectric activity.
Topics: Animals; Anti-Infective Agents; Duodenum; Female; Gastrointestinal Motility; Metronidazole; Rats; Rats, Wistar; Stomach; Vancomycin | 2004 |
Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; C-Reactive Protein; Clostridioides difficile; Colitis; Diarrhea; Humans; Hypoalbuminemia; Immunoglobulins, Intravenous; Leukocyte Count; Metronidazole; Middle Aged; Proteins; Retrospective Studies; Secondary Prevention; Time Factors; Treatment Outcome; Vancomycin | 2006 |
Antimicrobial susceptibility pattern of Clostridium difficile and its relation to PCR ribotypes in a Swedish university hospital.
Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Drug Resistance, Bacterial; Fusidic Acid; Hospitals, University; Humans; Metronidazole; Microbial Sensitivity Tests; Ribotyping; Serotyping; Sweden; Vancomycin | 2006 |
Sonographic diagnosis of a toothpick traversing the duodenum and penetrating into the liver.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Cefoxitin; Duodenum; Follow-Up Studies; Foreign-Body Migration; Humans; Intestinal Perforation; Liver; Liver Abscess; Male; Methicillin Resistance; Metronidazole; Middle Aged; Staphylococcal Infections; Tomography, X-Ray Computed; Ultrasonography; Vancomycin | 2006 |
Vancomycin-induced elevation of liver enzyme levels.
Topics: Alanine Transaminase; Anti-Bacterial Agents; Aspartate Aminotransferases; Clostridioides difficile; Diarrhea; Drug Resistance; Enterocolitis, Pseudomembranous; Humans; Liver; Liver Function Tests; Male; Metronidazole; Middle Aged; Vancomycin | 2006 |
[Occurrence and treatment of Clostridium difficile-associated diarrhea].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin | 2006 |
Management of an outbreak of Clostridium difficile-associated disease among geriatric patients.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Clostridioides difficile; Cross Infection; Disease Outbreaks; Enterocolitis, Pseudomembranous; Feces; Female; Geriatrics; HeLa Cells; Hospital Units; Humans; Incidence; Infection Control; Male; Metronidazole; Saccharomyces; Treatment Outcome; Vancomycin | 2006 |
Treatment of Clostridium difficile-associated disease (CDAD).
Topics: Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin | 2006 |
New PCR ribotypes of Clostridium difficile detected in children in Brazil: prevalent types of Clostridium difficile in Brazil.
Topics: Brazil; Child; Child, Preschool; Clindamycin; Clostridioides difficile; Electrophoresis, Polyacrylamide Gel; Enterocolitis, Pseudomembranous; Humans; Infant; Metronidazole; Microbial Sensitivity Tests; Polymerase Chain Reaction; Ribotyping; Vancomycin | 2007 |
[Clostridium difficile associated diarrhea in the elderly patient].
Topics: Age Factors; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Vancomycin | 2007 |
Large variation in antibacterial use among Norwegian nursing homes.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Drug Therapy; Humans; Methenamine; Metronidazole; Norway; Nursing Homes; Pharmacoepidemiology; Retrospective Studies; Vancomycin | 2007 |
Pharmacodynamic studies of vancomycin, metronidazole and fusidic acid against Clostridium difficile.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Dose-Response Relationship, Drug; Fusidic Acid; Metronidazole; Microbial Sensitivity Tests; Vancomycin | 2007 |
Use of intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis.
Topics: Aged; Anti-Bacterial Agents; Carcinoma, Merkel Cell; Clostridioides difficile; Cytotoxins; Diarrhea; Ear Neoplasms; Enterocolitis, Pseudomembranous; Esomeprazole; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Levofloxacin; Male; Metronidazole; Ofloxacin; Skin Neoplasms; Thyroxine; Vancomycin | 2007 |
A case of recurrent Clostridium difficile diarrhea.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Lactobacillus; Metronidazole; Probiotics; Recurrence; Treatment Failure; Vancomycin | 2007 |
Epidemiology of Clostridium difficile infection in a large teaching hospital in Singapore.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Female; Hospitals, Teaching; Humans; Incidence; Male; Metronidazole; Middle Aged; Ribotyping; RNA, Bacterial; Singapore; Vancomycin | 2007 |
Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.
Topics: Aged; Anti-Bacterial Agents; Chi-Square Distribution; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Logistic Models; Male; Metronidazole; Quebec; Recurrence; Retrospective Studies; Risk Factors; Severity of Illness Index; Treatment Outcome; Vancomycin | 2007 |
Five day antibiotic prophylaxis for major lower limb amputation reduces wound infection rates and the length of in-hospital stay.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; England; Female; Floxacillin; Gentamicins; Humans; Length of Stay; Lower Extremity; Male; Medical Audit; Metronidazole; Middle Aged; Prospective Studies; Reoperation; Retrospective Studies; Surgical Wound Infection; Treatment Outcome; Vancomycin | 2008 |
Editorial commentary: Vancomycin for your mother, metronidazole for your mother-in-law.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Drug Resistance, Multiple, Bacterial; Female; Humans; Metronidazole; Microbial Sensitivity Tests; Mothers; Vancomycin | 2007 |
The changing face of Clostridium difficile: what treatment options remain?
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Quebec; Recurrence; Risk Factors; Severity of Illness Index; Treatment Outcome; Vancomycin | 2007 |
Clostridium difficile-associated disease with lethal outcome in a 77-year-old woman. A case report.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Cholecystitis; Clostridioides difficile; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Famotidine; Female; Humans; Metronidazole; Postoperative Complications; Vancomycin | 2007 |
Vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Double-Blind Method; Humans; Metronidazole; Prospective Studies; Randomized Controlled Trials as Topic; Vancomycin | 2007 |
Vancomycin therapy for severe Clostridium difficile-associated diarrhea.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Double-Blind Method; Humans; Metronidazole; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome; Vancomycin | 2007 |
Clostridium difficile-associated disease treatment response depends on definition of cure.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Double-Blind Method; Humans; Metronidazole; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome; Vancomycin | 2007 |
Vancomycin for the treatment of Clostridium difficile Infection: for whom is this expensive bullet really magic?
Topics: Administration, Oral; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Europe; Humans; Metronidazole; North America; Vancomycin | 2008 |
Diagnostic and treatment delays in recurrent Clostridium difficile-associated disease.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Cross Infection; Female; Hospitalists; Humans; Male; Metronidazole; Practice Patterns, Physicians'; Retrospective Studies; Secondary Prevention; Vancomycin | 2008 |
Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease.
Topics: Administration, Oral; Aged; Aged, 80 and over; Clostridioides difficile; Cross Infection; Enterococcus; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Vancomycin; Vancomycin Resistance | 2008 |
Clostridium difficile infection.
Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Infant, Newborn; Metronidazole; Risk Factors; Vancomycin | 2008 |
Effect of sub-MIC concentrations of metronidazole, vancomycin, clindamycin and linezolid on toxin gene transcription and production in Clostridium difficile.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clindamycin; Clostridioides difficile; Enterotoxins; Gene Expression Regulation, Bacterial; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Oxazolidinones; Polymerase Chain Reaction; Time Factors; Transcription, Genetic; Vancomycin | 2008 |
Decreased effectiveness of metronidazole for the treatment of Clostridium difficile infection?
Topics: Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Treatment Outcome; Vancomycin | 2008 |
Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Clostridioides difficile; Colony Count, Microbial; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Humans; Kaplan-Meier Estimate; Metronidazole; Middle Aged; Proportional Hazards Models; Prospective Studies; Time Factors; Treatment Outcome; Vancomycin | 2008 |
Effect of telephoned notification of positive Clostridium difficile test results on the time to the ordering of antimicrobial therapy.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Disease Notification; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Humans; Length of Stay; Medical Records Systems, Computerized; Metronidazole; Practice Patterns, Physicians'; Telephone; Time Factors; Vancomycin | 2008 |
Posterior fossa dermoid cyst with sinus tract and meningitis in a toddler.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Cranial Sinuses; Dermoid Cyst; Humans; Infant; Infratentorial Neoplasms; Magnetic Resonance Imaging; Male; Meningitis; Metronidazole; Neurosurgical Procedures; Vancomycin | 2008 |
Clostridium difficile pancolitis in adults with cystic fibrosis.
Topics: Adult; Clostridioides difficile; Cystic Fibrosis; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Steroids; Vancomycin | 2008 |
In vitro susceptibility of genotypically distinct and clonal Clostridium difficile strains to oritavancin.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Culture Media; DNA Fingerprinting; Enterocolitis, Pseudomembranous; Genotype; Glycopeptides; Humans; Lipoglycopeptides; Metronidazole; Microbial Sensitivity Tests; Ribotyping; Vancomycin | 2008 |
Determination of antibiotic hypersensitivity among 4,000 single-gene-knockout mutants of Escherichia coli.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Escherichia coli; Genes, Bacterial; Gentamicins; Metronidazole; Microbial Sensitivity Tests; Mutation; Rifampin; Sulfamethoxazole; Vancomycin | 2008 |
Infected lumbar dermoid cyst presenting with tetraparesis secondary to holocord central lesion.
Topics: Abscess; Cefotaxime; Child; Dermoid Cyst; Drug Therapy, Combination; Follow-Up Studies; Gram-Negative Bacterial Infections; Humans; Laminectomy; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Metronidazole; Neurologic Examination; Postoperative Care; Postoperative Complications; Quadriplegia; Sacrum; Spina Bifida Occulta; Spinal Cord; Spinal Cord Neoplasms; Vancomycin | 2008 |
Absence of pseudomembranes in Clostridium difficile-associated diarrhea in patients using immunosuppression agents.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Toxins; Clostridioides difficile; Colitis, Ulcerative; Colonoscopy; Diarrhea; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Metronidazole; Middle Aged; Retrospective Studies; Treatment Outcome; Vancomycin | 2009 |
Metronidazole and vancomycin: equivalence of initial efficacy in CDAD.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Treatment Outcome; Vancomycin | 2008 |
Antibiotic prescribing.
Topics: Anti-Bacterial Agents; Cellulitis; Clindamycin; Clostridioides difficile; Diarrhea; Humans; Medical Staff, Hospital; Metronidazole; Penicillins; Pneumonia; Professional Practice; Urinary Tract Infections; Vancomycin | 2008 |
[Percutaneous endoscopic colostomy for treatment of an antibiotic-induced pseudomembranous colitis].
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Colonoscopy; Colostomy; Enterocolitis, Pseudomembranous; Feces; Humans; Male; Metronidazole; Middle Aged; Pulmonary Disease, Chronic Obstructive; Vancomycin | 2008 |
"Moraxella lacunata" endocarditis treated with penicillin.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Endocarditis, Bacterial; Gentamicins; Humans; Male; Meropenem; Metronidazole; Moraxellaceae Infections; Penicillins; Protein Synthesis Inhibitors; Thienamycins; Vancomycin | 2008 |
Clinical features and outcome analysis of 90 cases with brain abscess in central China.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Brain; Brain Abscess; Cephalosporins; Child; Child, Preschool; China; Drug Therapy, Combination; Female; Humans; Infant; Injections, Intravenous; Injections, Spinal; Male; Metronidazole; Middle Aged; Retrospective Studies; Treatment Outcome; Vancomycin; Young Adult | 2008 |
Skin and environmental contamination with vancomycin-resistant Enterococci in patients receiving oral metronidazole or oral vancomycin treatment for Clostridium difficile-associated disease.
Topics: Administration, Oral; Aged; Anti-Infective Agents; Clostridioides difficile; Enterococcus; Enterocolitis, Pseudomembranous; Environmental Microbiology; Equipment Contamination; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Skin; Vancomycin; Vancomycin Resistance | 2009 |
Intraventricular neurocysticercosis.
Topics: Anti-Bacterial Agents; Antifungal Agents; Ceftriaxone; Cerebral Ventricles; Child; Female; Humans; Magnetic Resonance Imaging; Meningitis; Metronidazole; Neurocysticercosis; Vancomycin | 2009 |
Management of Clostridium difficile infection: survey of practices and compliance with national guidelines among primary care physicians.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Guideline Adherence; Health Care Surveys; Metronidazole; Physicians, Family; Practice Guidelines as Topic; Practice Patterns, Physicians'; Vancomycin | 2009 |
In vitro effect of metronidazole and vancomycin in combination on Clostridium difficile.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Drug Synergism; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Microbial Sensitivity Tests; Vancomycin | 2009 |
[The approach to recurrent infections with Clostridium difficile].
Topics: Anti-Bacterial Agents; Brachytherapy; Clostridioides difficile; Combined Modality Therapy; Complementary Therapies; Enterocolitis, Pseudomembranous; Humans; Immunoglobulins, Intravenous; Metronidazole; Probiotics; Recurrence; Vancomycin | 2008 |
Meningitis and epidural abscess related to pansinusitis.
Topics: Bacteroidaceae Infections; Cefotaxime; Ceftriaxone; Child; Combined Modality Therapy; Consciousness Disorders; Diagnostic Imaging; Drug Therapy, Combination; Eikenella; Emergencies; Endoscopy; Epidural Abscess; Female; Fusobacterium Infections; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Meningitis, Bacterial; Metronidazole; Otorhinolaryngologic Surgical Procedures; Peptostreptococcus; Prevotella intermedia; Sinusitis; Staphylococcal Infections; Vancomycin | 2009 |
Clostridium difficile infection in the "oldest" old: clinical outcomes in patients aged 80 and older.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Female; Humans; Logistic Models; Male; Metronidazole; Michigan; Retrospective Studies; Risk Factors; Treatment Failure; Treatment Outcome; Vancomycin | 2009 |
Clostridium difficile-associated diarrhea in Crohn's disease patients with ostomy.
Topics: Adult; Clostridioides difficile; Colectomy; Crohn Disease; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Ostomy; Postoperative Complications; Prognosis; Vancomycin | 2010 |
Resolution of recurrent Clostridium difficile-associated diarrhea using staggered antibiotic withdrawal and kefir.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Cultured Milk Products; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Probiotics; Secondary Prevention; Vancomycin | 2009 |
Clostridium difficile infection: historic review.
Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cricetinae; Enterocolitis, Pseudomembranous; Female; Guinea Pigs; History, 20th Century; Humans; Metronidazole; Vancomycin; Young Adult | 2009 |
Use of International Classification of Diseases, Ninth Revision, Clinical Modification codes and medication use data to identify nosocomial Clostridium difficile infection.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Cross-Sectional Studies; Female; Humans; International Classification of Diseases; Male; Medical Records Systems, Computerized; Metronidazole; Middle Aged; Predictive Value of Tests; Sensitivity and Specificity; United States; United States Dept. of Health and Human Services; Vancomycin | 2009 |
Brain abscess complicating foreign body aspiration.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Brain Abscess; Bronchi; Ceftriaxone; Child, Preschool; Contrast Media; Drug Therapy, Combination; Follow-Up Studies; Foreign Bodies; Fusobacterium; Humans; Male; Metronidazole; Parietal Lobe; Radiography, Thoracic; Streptococcus; Temporal Lobe; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vancomycin | 2009 |
Bactericidal activity of telavancin, vancomycin and metronidazole against Clostridium difficile.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Humans; Lipoglycopeptides; Metronidazole; Microbial Sensitivity Tests; Prohibitins; Time Factors; Vancomycin | 2010 |
Continuing diarrhoea after ten days of oral metronidazole or oral vancomycin for presumed, hospital-acquired Clostridium difficile colitis in elderly hospital patients.
Topics: Aged, 80 and over; Albumins; Anti-Bacterial Agents; C-Reactive Protein; Clostridioides difficile; Clostridium Infections; Creatinine; Cross Infection; Diarrhea; Female; Hospitals; Humans; Leukocyte Count; Male; Metronidazole; Time Factors; United Kingdom; Vancomycin | 2010 |
Fluoroquinolone resistance and Clostridium difficile, Germany.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fluoroquinolones; Germany; Humans; Metronidazole; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prevalence; Ribotyping; Vancomycin | 2010 |
[Change of Clostridium difficile colitis during recent 10 years in Korea].
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Republic of Korea; Retrospective Studies; Vancomycin | 2010 |
Transfer of carbapenem-resistant plasmid from Klebsiella pneumoniae ST258 to Escherichia coli in patient.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Colistin; Conjugation, Genetic; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Escherichia coli; Escherichia coli Infections; Gastrointestinal Tract; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Male; Metronidazole; Plasmids; Vancomycin | 2010 |
[Prevalence of Clostridium difficile in the gastrointestinal tract of hospitalized children under two years of age].
Topics: Aza Compounds; Ciprofloxacin; Clindamycin; Clostridioides difficile; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Female; Fluoroquinolones; Gastrointestinal Tract; Gatifloxacin; Genotype; Humans; Infant; Infant, Newborn; Male; Metronidazole; Moxifloxacin; Phenotype; Quinolines; Species Specificity; Vancomycin | 2010 |
Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease.
Topics: Adolescent; Ambulatory Care; Anti-Bacterial Agents; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; DNA, Bacterial; Feces; Female; Humans; Inflammatory Bowel Diseases; Male; Metronidazole; Microbial Sensitivity Tests; Prevalence; Recurrence; Ribotyping; Rifampin; Severity of Illness Index; Vancomycin | 2010 |
Increase in use of vancomycin for Clostridium difficile infection in US hospitals.
Topics: Academic Medical Centers; Adult; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Humans; Metronidazole; United States; Vancomycin; Young Adult | 2010 |
Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon.
Topics: Anti-Bacterial Agents; Bacteriocins; Base Sequence; Clostridioides difficile; Colon; Feces; Humans; Metagenome; Metronidazole; Models, Biological; Molecular Sequence Data; Sequence Analysis, DNA; Vancomycin | 2011 |
[Approach to the treatment of intestinal infectious diseases caused by Clostridium difficile].
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Metronidazole; Vancomycin | 2010 |
Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Inpatients; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Recurrence; Retrospective Studies; Risk Factors; Vancomycin | 2010 |
Failure of tigecycline to treat severe Clostridium difficile infection.
Topics: Aged; Anti-Bacterial Agents; Critical Care; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Immunoglobulins, Intravenous; Male; Metronidazole; Minocycline; Severity of Illness Index; Tigecycline; Treatment Failure; Vancomycin | 2010 |
[Frontal sinusitis, mucocele and subperiosteal superolateral orbit abscess].
Topics: Abscess; Anti-Bacterial Agents; Cefotaxime; Child; Drainage; Drug Combinations; Exophthalmos; Frontal Sinusitis; Humans; Magnetic Resonance Imaging; Male; Metronidazole; Mucocele; Orbital Cellulitis; Radiography; Vancomycin | 2011 |
Percutaneous drainage for treatment of prostate abscess.
Topics: Abscess; Aged; Ceftazidime; Cystostomy; Drainage; Escherichia coli; Escherichia coli Infections; Humans; Male; Metronidazole; Prostatic Diseases; Vancomycin | 2010 |
'Game changer' antibiotic and others in works for superbug.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Secondary Prevention; Streptococcal Infections; United States; United States Food and Drug Administration; Vancomycin | 2011 |
Antimicrobial susceptibilities and molecular epidemiology of clinical isolates of Clostridium difficile in taiwan.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacterial Proteins; Clostridioides difficile; Fluoroquinolones; Genotype; Metronidazole; Microbial Sensitivity Tests; Molecular Epidemiology; Moxifloxacin; Polymerase Chain Reaction; Quinolines; Ribotyping; Taiwan; Vancomycin | 2011 |
Impact of evaluating antibiotic concentrations in abdominal abscesses percutaneously drained.
Topics: Abdominal Abscess; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; Exudates and Transudates; Female; Fluconazole; Humans; Male; Metronidazole; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Suction; Treatment Outcome; Vancomycin | 2011 |
Treatment of clostridium difficile infection.
Topics: Anti-Infective Agents; Bacterial Infections; Clostridioides difficile; Diarrhea; Drugs, Investigational; Humans; Metronidazole; Risk Factors; Secondary Prevention; Vancomycin | 2011 |
Activity of RBx 11760, a novel biaryl oxazolidinone, against Clostridium difficile.
Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Cricetinae; Disease Models, Animal; Humans; Mesocricetus; Metronidazole; Oxazolidinones; Spores, Bacterial; Vancomycin | 2011 |
Clostridium difficile infection and treatment in the pediatric inflammatory bowel disease population.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Child; Clostridioides difficile; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Female; Hospitals, Pediatric; Humans; Incidence; Inflammatory Bowel Diseases; Male; Metronidazole; Ohio; Retrospective Studies; Secondary Prevention; Vancomycin | 2011 |
Identification of high-risk group and therapeutic options in children with liver abscess.
Topics: Adolescent; Anti-Infective Agents; Cefotaxime; Child; Child, Preschool; Cloxacillin; Drainage; Drug Therapy, Combination; Female; Humans; Leukocytosis; Liver Abscess; Male; Metronidazole; Neutrophils; Retrospective Studies; Risk Assessment; Treatment Outcome; Vancomycin | 2012 |
Prevalence and clinical course of Clostridium difficile infection in a tertiary-care hospital: a retrospective analysis.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Toxins; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Diarrhea; Enzyme-Linked Immunosorbent Assay; Feces; Female; Hospitals, General; Humans; India; Male; Metronidazole; Middle Aged; Prevalence; Retrospective Studies; Vancomycin | 2011 |
The intestinal microbiota plays a role in Salmonella-induced colitis independent of pathogen colonization.
Topics: Animals; Anti-Infective Agents; Bacteria; Cation Transport Proteins; Ecosystem; Enterocolitis; Feces; Host-Pathogen Interactions; In Situ Hybridization, Fluorescence; Intestines; Metagenome; Metronidazole; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Salmonella Infections, Animal; Salmonella typhimurium; Species Specificity; Streptomycin; Vancomycin | 2011 |
Vancomycin "telephone".
Topics: Administration, Oral; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Humans; Metronidazole; Treatment Outcome; Vancomycin | 2011 |
Clostridium difficile disease and vancomycin--questionable clinical superiority.
Topics: Administration, Oral; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Humans; Metronidazole; Treatment Outcome; Vancomycin | 2011 |
[Left-sided ulcerative colitis reactivated and aggravated during clostridium difficile infection].
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; C-Reactive Protein; Clostridioides difficile; Clostridium Infections; Colitis, Ulcerative; Colonoscopy; Drug Therapy, Combination; Feces; Female; Humans; Metronidazole; Middle Aged; Sulfasalazine; Vancomycin | 2011 |
Clostridium difficile infection causing multiple organ failure and small-bowel enteritis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Drug Therapy, Combination; Enteritis; Esophageal Neoplasms; Esophagectomy; Humans; Intestine, Small; Length of Stay; Male; Metronidazole; Middle Aged; Multiple Organ Failure; Time Factors; Treatment Outcome; Vancomycin | 2011 |
Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia.
Topics: Adult; Age Factors; Aged; Bacteremia; Bone Marrow Transplantation; Case-Control Studies; Catheterization, Central Venous; Enterococcus; Female; Gastrointestinal Diseases; Hospitals; Humans; Hypoalbuminemia; Male; Meropenem; Metronidazole; Middle Aged; Multivariate Analysis; Neutropenia; Odds Ratio; Phenotype; Risk Factors; Thienamycins; Transplantation, Homologous; Vancomycin; Vancomycin Resistance | 2012 |
Reducing the risk of severe complications among patients with Clostridium difficile infection.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antiprotozoal Agents; Comorbidity; Confusion; Enterocolitis, Pseudomembranous; Female; Humans; Hypotension; Leukocytosis; Male; Metronidazole; Multivariate Analysis; Retrospective Studies; Severity of Illness Index; Vancomycin | 2011 |
Antimicrobial use and risk for recurrent Clostridium difficile infection.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Hospitals, Veterans; Humans; Male; Metronidazole; Middle Aged; Minnesota; Recurrence; Retrospective Studies; Risk Factors; Vancomycin | 2011 |
Recognizing metronidazole resistant C. difficile.
Topics: Anti-Infective Agents; Clostridioides difficile; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Metronidazole; Middle Aged; Opportunistic Infections; Probiotics; Recurrence; Vancomycin | 2011 |
Antimicrobial prescribing practices in response to different Clostridium difficile diagnostic methodologies.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Decision Making; Drug Prescriptions; Enterotoxins; Feces; Female; Glutamate Dehydrogenase; Humans; Immunoenzyme Techniques; Male; Metronidazole; Middle Aged; Neutralization Tests; Polymerase Chain Reaction; Practice Patterns, Physicians'; Retrospective Studies; Vancomycin; Young Adult | 2011 |
Epidemiology and clinical characteristics of Clostridium difficile infection in a Korean tertiary hospital.
Topics: Aged; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Female; Hospitals; Humans; Incidence; Male; Metronidazole; Middle Aged; Prospective Studies; Recurrence; Republic of Korea; Treatment Outcome; Vancomycin | 2011 |
Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Recurrence; Treatment Outcome; Vancomycin | 2012 |
Preventing downstream Clostridium difficile infections with upstream antibiotic management.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Humans; Metronidazole; Risk Factors; Secondary Prevention; Vancomycin | 2012 |
Real-time polymerase chain reaction testing for Clostridium difficile reduces isolation time and improves patient management in a small community hospital.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Utilization; Female; Hospitals, Community; Humans; Male; Metronidazole; Molecular Diagnostic Techniques; Patient Isolation; Real-Time Polymerase Chain Reaction; Retrospective Studies; Time Factors; Treatment Outcome; Vancomycin | 2012 |
In vitro activities of CB-183,315, vancomycin, and metronidazole against 556 strains of Clostridium difficile, 445 other intestinal anaerobes, and 56 Enterobacteriaceae species.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Clostridioides difficile; Enterobacteriaceae; Enterobacteriaceae Infections; Enterocolitis, Pseudomembranous; Humans; Intestines; Lipopeptides; Metronidazole; Microbial Sensitivity Tests; Peptides, Cyclic; Vancomycin | 2012 |
Prospective observational study comparing three different treatment regimes in patients with Clostridium difficile infection.
Topics: Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cohort Studies; Data Interpretation, Statistical; Drug Therapy, Combination; Endpoint Determination; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Injections, Intravenous; Male; Metronidazole; Middle Aged; Poisson Distribution; Prospective Studies; Risk; Sex Factors; Treatment Outcome; Vancomycin; Young Adult | 2012 |
Activity of a novel cyclic lipopeptide, CB-183,315, against resistant Clostridium difficile and other Gram-positive aerobic and anaerobic intestinal pathogens.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Drug Resistance, Multiple, Bacterial; Enterococcus; Intestines; Lipopeptides; Methicillin-Resistant Staphylococcus aureus; Metronidazole; Microbial Sensitivity Tests; Peptostreptococcus; Vancomycin | 2012 |
Prevalence and predictors of MRSA, ESBL, and VRE colonization in the ambulatory IBD population.
Topics: Adult; Aged; Ambulatory Care; Anti-Bacterial Agents; beta-Lactamases; Carrier State; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Enterococcus; Female; Histamine H2 Antagonists; Hospitalization; Humans; Inflammatory Bowel Diseases; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Metronidazole; Middle Aged; Nose; Prevalence; Proton Pump Inhibitors; Rectum; Risk Factors; Staphylococcal Infections; Vancomycin; Vancomycin Resistance; Young Adult | 2012 |
A 5-year retrospective review of experience with Clostridium difficile-associated diarrhea.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Hospitals, Military; Humans; Incidence; Inpatients; Male; Medical Records Systems, Computerized; Metronidazole; Middle Aged; Military Medicine; Outpatients; Recurrence; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; United States; Vancomycin; Veterans | 2012 |
Clostridium difficile infection, Colorado and the northwestern United States, 2007.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colorado; Female; Humans; Incidence; Male; Metronidazole; Middle Aged; Northwestern United States; Vancomycin; Young Adult | 2012 |
Sustained clinical response as an endpoint in treatment trials of Clostridium difficile-associated diarrhea.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Clostridioides difficile; Diarrhea; Endpoint Determination; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Polymers; Sulfonic Acids; Treatment Outcome; Vancomycin | 2012 |
Successful use of nitazoxanide in the treatment of recurrent Clostridium difficile infection.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Male; Metronidazole; Nitro Compounds; Recurrence; Thiazoles; Vancomycin | 2011 |
MBX-500, a hybrid antibiotic with in vitro and in vivo efficacy against toxigenic Clostridium difficile.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Clostridioides difficile; Cricetinae; DNA Gyrase; DNA Topoisomerases, Type I; DNA-Directed DNA Polymerase; Enterocolitis, Pseudomembranous; Enzyme Inhibitors; Metronidazole; Mice; Nucleic Acid Synthesis Inhibitors; Species Specificity; Survival Rate; Topoisomerase II Inhibitors; Vancomycin; Weight Gain | 2012 |
Fidaxomicin inhibits spore production in Clostridium difficile.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Load; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Gene Expression Regulation, Bacterial; Genes, Bacterial; Metronidazole; Microbial Sensitivity Tests; Rifamycins; Rifaximin; Spores, Bacterial; Vancomycin | 2012 |
In vitro and in vivo activities of the novel Ketolide RBx 14255 against Clostridium difficile.
Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Cricetinae; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Humans; Ketolides; Metronidazole; Microbial Sensitivity Tests; Survival Rate; Vancomycin | 2012 |
Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection.
Topics: Administration, Oral; Adult; Anaphylaxis; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cystic Fibrosis; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Minocycline; Severity of Illness Index; Tigecycline; Vancomycin | 2013 |
Antibiotic exposure and IBD development among children: a population-based cohort study.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Carbapenems; Cefoxitin; Child; Child, Preschool; Clindamycin; Cohort Studies; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Incidence; Inflammatory Bowel Diseases; Logistic Models; Male; Metronidazole; Penicillins; Proportional Hazards Models; Retrospective Studies; Risk; Tetracycline; United Kingdom; Vancomycin | 2012 |
MyD88-dependent interleukin-10 production from regulatory CD11b⁺Gr-1(high) cells suppresses development of acute cerulein pancreatitis in mice.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; CD11b Antigen; CD4-Positive T-Lymphocytes; Ceruletide; Flow Cytometry; Interleukin-10; Macrophage Activation; Macrophages; Metronidazole; Mice; Mice, Inbred C57BL; Mice, Knockout; Myeloid Differentiation Factor 88; Neomycin; Pancreas; Pancreatitis; Receptors, Cell Surface; Signal Transduction; Toll-Like Receptors; Vancomycin | 2012 |
C-reactive protein is a useful predictor of metronidazole treatment failure in mild-to-moderate Clostridium difficile infection.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Biomarkers; C-Reactive Protein; Clostridioides difficile; Clostridium Infections; Creatinine; Drug Substitution; Female; Humans; Leukocyte Count; Logistic Models; Male; Metronidazole; Middle Aged; Odds Ratio; Predictive Value of Tests; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Failure; Vancomycin | 2013 |
Rifaximin in the treatment of recurrent Clostridium difficile infection.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Rifamycins; Rifaximin; Treatment Outcome; Vancomycin; Young Adult | 2013 |
Antibiotic susceptibility of periodontal Enterococcus faecalis.
Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriological Techniques; Chronic Periodontitis; Ciprofloxacin; Clindamycin; Dental Plaque; Drug Resistance, Bacterial; Enterococcus faecalis; Erythromycin; Female; Gingiva; Gram-Positive Bacterial Infections; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Periodontal Pocket; Periodontitis; Teicoplanin; Tetracycline Resistance; Vancomycin | 2013 |
Epidemiology of vancomycin-resistant enterococci with reduced susceptibility to daptomycin.
Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Cephalosporins; Comorbidity; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Immunosuppression Therapy; Male; Metronidazole; Middle Aged; Proportional Hazards Models; Retrospective Studies; Risk Factors; Statistics, Nonparametric; Vancomycin; Vancomycin Resistance | 2012 |
Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteroides; Cecum; Clostridioides difficile; Clostridium Infections; DNA, Bacterial; Enterocolitis, Pseudomembranous; Feces; Fidaxomicin; Intestines; Male; Metronidazole; Mice; Mice, Inbred C57BL; Nitro Compounds; Recurrence; Thiazoles; Treatment Outcome; Vancomycin | 2013 |
Fidaxomicin inhibits toxin production in Clostridium difficile.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Culture Media; Enterotoxins; Enzyme-Linked Immunosorbent Assay; Fidaxomicin; Gene Expression; Gene Expression Profiling; Humans; Metronidazole; Vancomycin | 2013 |
Antimicrobial susceptibilities of Clostridium difficile isolated in Japan.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Humans; Japan; Metronidazole; Microbial Sensitivity Tests; Vancomycin | 2013 |
Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Enterocolitis, Pseudomembranous; Europe; Fidaxomicin; Humans; Metronidazole; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymerase Chain Reaction; Ribotyping; Thiazoles; Treatment Outcome; Vancomycin | 2013 |
A new strategy for the prevention of Clostridium difficile infection.
Topics: Animals; Anti-Bacterial Agents; Bile Acids and Salts; Clostridioides difficile; Clostridium Infections; Colistin; Diarrhea; Dose-Response Relationship, Drug; Feces; Female; Gentamicins; Kanamycin; Metagenome; Metronidazole; Mice; Mice, Inbred C57BL; Spores, Bacterial; Vancomycin | 2013 |
Commentary: vancomycin or metronidazole in patients with primary sclerosing cholangitis?
Topics: Anti-Bacterial Agents; Cholangitis, Sclerosing; Female; Humans; Male; Metronidazole; Vancomycin | 2013 |
Analysis of anti-Clostridium difficile activity of thuricin CD, vancomycin, metronidazole, ramoplanin, and actagardine, both singly and in paired combinations.
Topics: Anti-Bacterial Agents; Bacteriocins; Clostridioides difficile; Depsipeptides; Drug Synergism; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Microbial Sensitivity Tests; Peptides; Vancomycin | 2013 |
Concomitant typhlitis and Clostridium difficile colitis developed after first R-CHOP chemotherapy in a non-Hodgkin lymphoma patient.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cefepime; Cephalosporins; Clostridioides difficile; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Lymphoma, Non-Hodgkin; Male; Metronidazole; Middle Aged; Polymerase Chain Reaction; Prednisone; Radiography; Rituximab; Typhlitis; Vancomycin; Vincristine | 2013 |
[Clostridium difficile infections - still a major challenge].
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Colectomy; Combined Modality Therapy; Cross Infection; Disease Notification; Enterocolitis, Pseudomembranous; Fidaxomicin; Metronidazole; Probiotics; Vancomycin; Virulence | 2013 |
A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Endpoint Determination; Enterocolitis, Pseudomembranous; Female; Hematologic Neoplasms; Humans; Incidence; Male; Metronidazole; Middle Aged; Retrospective Studies; Treatment Outcome; Vancomycin | 2014 |
Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Female; Humans; Male; Metronidazole; Middle Aged; Organizational Policy; Severity of Illness Index; Treatment Outcome; Vancomycin | 2013 |
Fidaxomicin versus conventional antimicrobial therapy in 59 recipients of solid organ and hematopoietic stem cell transplantation with Clostridium difficile-associated diarrhea.
Topics: Adult; Aged; Aminoglycosides; Analysis of Variance; Anti-Bacterial Agents; Clinical Trials as Topic; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fidaxomicin; Hematopoietic Stem Cell Transplantation; Humans; Male; Metronidazole; Middle Aged; Organ Transplantation; Survival Analysis; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2013 |
Comparison of treatment outcomes with vancomycin alone versus combination therapy in severe Clostridium difficile infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies; Treatment Outcome; Vancomycin; Young Adult | 2013 |
Risk factors of fecal toxigenic or non-toxigenic Clostridium difficile colonization: impact of Toll-like receptor polymorphisms and prior antibiotic exposure.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Cefepime; Cefuroxime; Cephalosporins; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Male; Metronidazole; Middle Aged; Odds Ratio; Polymorphism, Genetic; Risk Factors; Toll-Like Receptor 4; Vancomycin | 2013 |
The role of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
Topics: Administration, Ophthalmic; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Costs; Humans; Metronidazole; Severity of Illness Index; Vancomycin | 2013 |
Successful treatment of simulated Clostridium difficile infection in a human gut model by fidaxomicin first line and after vancomycin or metronidazole failure.
Topics: Clostridioides difficile; Clostridium Infections; Drug Therapy, Combination; Gastrointestinal Tract; Humans; Metronidazole; Microbial Sensitivity Tests; Models, Biological; Treatment Failure; Treatment Outcome; Vancomycin | 2014 |
Defining the vulnerable period for re-establishment of Clostridium difficile colonization after treatment of C. difficile infection with oral vancomycin or metronidazole.
Topics: Administration, Oral; Aged; Aged, 80 and over; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Resistance, Bacterial; Feces; Female; Humans; Male; Metronidazole; Microbiota; Middle Aged; Prospective Studies; Vancomycin | 2013 |
Clostridium difficile bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Clostridioides difficile; Clostridium Infections; Humans; Intestinal Perforation; Levofloxacin; Lymphoma, Mantle-Cell; Male; Metronidazole; Middle Aged; Treatment Outcome; Vancomycin | 2013 |
[Clostridium difficile infection (CDI) in the course of time - an issue only for the internist?].
Topics: Aminoglycosides; Clostridioides difficile; Colectomy; Colostomy; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Enterocolitis, Pseudomembranous; Feces; Fidaxomicin; Germany; Humans; Incidence; Metronidazole; Recurrence; Transplantation; Vancomycin | 2014 |
Comparative in vitro activities of SMT19969, a new antimicrobial agent, against 162 strains from 35 less frequently recovered intestinal Clostridium species: implications for Clostridium difficile recurrence.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium; Cluster Analysis; Fidaxomicin; Metronidazole; Microbial Sensitivity Tests; RNA, Ribosomal, 16S; Species Specificity; Vancomycin | 2014 |
In vitro and in vivo antibacterial evaluation of cadazolid, a new antibiotic for treatment of Clostridium difficile infections.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Cricetinae; Enterocolitis, Pseudomembranous; Enterotoxins; Female; Fluoroquinolones; Humans; Linezolid; Male; Metronidazole; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Oxazolidinones; Spores, Bacterial; Survival Analysis; Vancomycin | 2014 |
Predictors of first recurrence in Clostridium difficile-associated disease. A study of 306 patients hospitalized in a Romanian tertiary referral center.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Infective Agents; Clostridioides difficile; Community-Acquired Infections; Cross Infection; Enterocolitis, Pseudomembranous; Female; Hospitalization; Hospitals, Teaching; Humans; Kaplan-Meier Estimate; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Recurrence; Retrospective Studies; Risk Factors; Romania; Tertiary Care Centers; Time Factors; Treatment Outcome; Vancomycin; Young Adult | 2013 |
Prevention of Clostridium difficile spore formation by sub-inhibitory concentrations of tigecycline and piperacillin/tazobactam.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clostridioides difficile; Humans; Metronidazole; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Ribotyping; Spores, Bacterial; Tazobactam; Tigecycline; Vancomycin | 2014 |
Therapeutic approaches for Clostridium difficile infections.
Topics: Aminoglycosides; Anti-Infective Agents; Antibodies, Bacterial; Antibodies, Monoclonal; Antitoxins; Bacterial Vaccines; Biological Therapy; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Therapy; Fidaxomicin; Humans; Immunotherapy; Metronidazole; Vancomycin | 2013 |
Editorial Commentary: the trials and tribulations of treating Clostridium difficile infection-one step backward, one step forward, but still progress.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin | 2014 |
Intestinal microbiota transplantation: a case of Crohn's colitis with superimposed Clostridium difficile infection.
Topics: Addison Disease; Adult; Anti-Infective Agents; Clostridioides difficile; Crohn Disease; Enterocolitis, Pseudomembranous; Fatal Outcome; Feces; Female; Humans; Intestines; Metagenome; Metronidazole; Microbiota; Superinfection; Vancomycin | 2013 |
Fidaxomicin inhibits Clostridium difficile toxin A-mediated enteritis in the mouse ileum.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bacterial Toxins; Clostridioides difficile; Edema; Enterocolitis, Pseudomembranous; Enterotoxins; Epithelial Cells; Fibroblasts; Fidaxomicin; Gene Expression; Ileum; Injections, Intralesional; Interleukin-1beta; Intestinal Mucosa; Male; Metronidazole; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; RNA, Messenger; Vancomycin | 2014 |
Outcomes from rectal vancomycin therapy in patients with Clostridium difficile infection.
Topics: Administration, Rectal; Aged; Anti-Bacterial Agents; Clostridioides difficile; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Treatment Outcome; Vancomycin | 2014 |
Antibiotics for Treatment of Clostridium difficile Infection in Hospitalized Patients with Inflammatory Bowel Disease.
Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Hospitalization; Humans; Inflammatory Bowel Diseases; Male; Metronidazole; Retrospective Studies; Treatment Outcome; Vancomycin | 2014 |
[Epidemiology of Clostridium difficile-associated disease (CDAD) in Salamanca].
Topics: Aged; Aged, 80 and over; Antacids; Anti-Bacterial Agents; Antineoplastic Agents; Clostridioides difficile; Clostridium Infections; Comorbidity; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Hospitals, University; Humans; Incidence; Male; Metronidazole; Middle Aged; Neoplasms; Postoperative Complications; Recurrence; Spain; Surveys and Questionnaires; Vancomycin | 2014 |
Combination of oral antibiotics may be effective in severe pediatric ulcerative colitis: a preliminary report.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; C-Reactive Protein; Child; Colitis, Ulcerative; Doxycycline; Drug Resistance; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Metronidazole; Remission Induction; Retreatment; Retrospective Studies; Severity of Illness Index; Tumor Necrosis Factor-alpha; Vancomycin | 2014 |
In vivo assessment of SMT19969 in a hamster model of clostridium difficile infection.
Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cricetinae; Male; Mesocricetus; Metronidazole; Microbial Sensitivity Tests; Vancomycin | 2014 |
Healthcare resource utilization for recurrent Clostridium difficile infection in a large university hospital in Houston, Texas.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Female; Hospitals, University; Humans; Length of Stay; Male; Metronidazole; Middle Aged; Prospective Studies; Recurrence; Texas; Vancomycin | 2014 |
Parietal subdural empyema as complication of acute odontogenic sinusitis: a case report.
Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Craniotomy; Diagnosis, Differential; Empyema, Subdural; Follow-Up Studies; Humans; Male; Maxillary Sinus; Meropenem; Metronidazole; Parietal Lobe; Sinusitis; Subdural Space; Thienamycins; Tomography, X-Ray Computed; Tooth Extraction; Treatment Outcome; Vancomycin | 2014 |
High frequency of nonadherence to Clostridium difficile treatment guidelines.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Critical Pathways; Decision Support Systems, Clinical; Guideline Adherence; Humans; Metronidazole; Patient Selection; Practice Guidelines as Topic; Retrospective Studies; Severity of Illness Index; Vancomycin | 2014 |
Commentary on "High frequency of nonadherence to Clostridium difficile treatment guidelines".
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Guideline Adherence; Humans; Metronidazole; Vancomycin | 2014 |
Characterization of Clostridium difficile isolates from human fecal samples and retail meat from Pennsylvania.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Cattle; Chickens; Clindamycin; Clostridioides difficile; Drug Resistance, Multiple, Bacterial; Feces; Fluoroquinolones; Gene Deletion; Genes, Bacterial; Genotype; Humans; Meat; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Pennsylvania; Phenotype; Repressor Proteins; Ribotyping; Swine; Vancomycin | 2014 |
Clostridium difficile in retail baskets, trolleys, conveyor belts, and plastic bags in Saudi Arabia.
Topics: ADP Ribose Transferases; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Cross-Sectional Studies; DNA, Bacterial; Drug Resistance, Bacterial; Enterotoxins; Equipment Contamination; Fomites; Food Handling; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prevalence; Repressor Proteins; Ribotyping; RNA, Bacterial; Saudi Arabia; Vancomycin | 2014 |
Cost-effectiveness analysis of treatment strategies for initial Clostridium difficile infection.
Topics: Anti-Bacterial Agents; Biological Therapy; Clostridioides difficile; Clostridium Infections; Computer Simulation; Cost-Benefit Analysis; Humans; Metronidazole; Quality-Adjusted Life Years; Vancomycin | 2014 |
[Clostridium difficile in visceral surgery].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Cohort Studies; Cross Infection; Cross-Sectional Studies; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Fidaxomicin; Germany; Hospital Mortality; Humans; Incidence; Intensive Care Units; Male; Metronidazole; Middle Aged; Minocycline; Patient Readmission; Retrospective Studies; Survival Rate; Tigecycline; Vancomycin; Young Adult | 2015 |
Subinhibitory concentrations of LFF571 reduce toxin production by Clostridium difficile.
Topics: Aminoglycosides; Clostridioides difficile; Fidaxomicin; Metronidazole; Microbial Sensitivity Tests; Thiazoles; Vancomycin | 2015 |
Emphysematous cystitis due to recurrent Clostridium difficile infection.
Topics: Aged; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Cystitis; Emphysema; Enterocolitis, Pseudomembranous; Female; Humans; Intraabdominal Infections; Metronidazole; Recurrence; Urinary Bladder; Vancomycin | 2014 |
Antibiotics "just-in-case" in a patient with aspiration pneumonitis.
Topics: Anti-Bacterial Agents; Cerebral Palsy; Clostridioides difficile; Enterocolitis, Pseudomembranous; Epilepsy, Tonic-Clonic; Fatal Outcome; Humans; Male; Metronidazole; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Aspiration; Radiography; Vancomycin | 2015 |
Ambush of Clostridium difficile spores by ramoplanin: activity in an in vitro model.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Depsipeptides; Metronidazole; Microbial Sensitivity Tests; Spores, Bacterial; Vancomycin | 2015 |
The first Clostridium difficile ribotype 027 strain isolated in Taiwan.
Topics: Aged; Anti-Bacterial Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Clostridioides difficile; Enterocolitis, Pseudomembranous; Esophageal Neoplasms; Humans; Male; Metronidazole; Shock, Septic; Taiwan; Vancomycin | 2016 |
Frozen encapsulated stool in recurrent Clostridium difficile: exploring the role of pills in the treatment hierarchy of fecal microbiota transplant nonresponders.
Topics: Abdominal Pain; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Biological Therapy; Capsules; Clostridioides difficile; Colonoscopy; Diarrhea; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Feces; Female; Fidaxomicin; Freezing; Humans; Irritable Bowel Syndrome; Male; Metronidazole; Microbiota; Recurrence; Transplantation, Homologous; Treatment Outcome; Vancomycin | 2015 |
Treatment of Clostridium difficile infection in a French university hospital.
Topics: Adult; Aged; Clostridioides difficile; Cohort Studies; Cross Infection; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; France; Hospitals, University; Humans; Incidence; Male; Metronidazole; Middle Aged; Prospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome; Vancomycin | 2015 |
Loss of Microbiota-Mediated Colonization Resistance to Clostridium difficile Infection With Oral Vancomycin Compared With Metronidazole.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Clostridioides difficile; Disease Models, Animal; Disease Resistance; Escherichia coli; Female; Klebsiella pneumoniae; Metronidazole; Mice, Inbred C57BL; Vancomycin; Vancomycin-Resistant Enterococci | 2015 |
Effects of surotomycin on Clostridium difficile viability and toxin production in vitro.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Cell Wall; Clostridioides difficile; Enterotoxins; Gene Expression Regulation, Bacterial; Lipopeptides; Metronidazole; Microbial Sensitivity Tests; Mutation; Peptides, Cyclic; Spores, Bacterial; Vancomycin; Virulence Factors | 2015 |
Molecular characterization and antimicrobial susceptibilities of Clostridium difficile clinical isolates from Victoria, Australia.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Fluoroquinolones; Genetic Variation; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Vancomycin; Victoria | 2015 |
Bacteremic meningitis caused by Parvimonas micra in an immunocompetent host.
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria, Anaerobic; Ceftriaxone; Dyslipidemias; Firmicutes; Gram-Positive Bacterial Infections; Hepatitis B, Chronic; Humans; Male; Meningitis, Bacterial; Metronidazole; Middle Aged; Treatment Outcome; Vancomycin | 2015 |
Editorial Commentary: Critically Ill Patients With Clostridium difficile Infection: Are 2 Antibiotics Better Than One?
Topics: Anti-Infective Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Vancomycin | 2015 |
The Addition of Intravenous Metronidazole to Oral Vancomycin is Associated With Improved Mortality in Critically Ill Patients With Clostridium difficile Infection.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Anti-Infective Agents; Clostridioides difficile; Critical Illness; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome; Vancomycin | 2015 |
Adynamic ileus and diarrhoea: a rare adverse effect of antidepressants.
Topics: Aged; Anti-Bacterial Agents; Antidepressive Agents; Colonoscopy; Diarrhea; Female; Humans; Iatrogenic Disease; Ileus; Metronidazole; Parenteral Nutrition; Recurrence; Treatment Outcome; Vancomycin | 2015 |
Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colectomy; Colonoscopy; Fecal Microbiota Transplantation; Female; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies; Sepsis; Shock, Septic; Vancomycin | 2015 |
A national survey of the molecular epidemiology of Clostridium difficile in Israel: the dissemination of the ribotype 027 strain with reduced susceptibility to vancomycin and metronidazole.
Topics: Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Humans; Incidence; Israel; Metronidazole; Microbial Sensitivity Tests; Molecular Epidemiology; Ribotyping; Vancomycin | 2015 |
[Analysis of Clostridium difficile associated diarrhea in pediatric patients with antibiotic-associated diarrhea].
Topics: Adolescent; Anti-Bacterial Agents; Case-Control Studies; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Diarrhea; Humans; Incidence; Metronidazole; Probiotics; Vancomycin | 2015 |
U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Toxins; Clindamycin; Clostridioides difficile; Diarrhea; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fidaxomicin; Fluoroquinolones; Genes, Bacterial; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Multiplex Polymerase Chain Reaction; Prohibitins; Sentinel Surveillance; United States; Vancomycin | 2015 |
Routine disc diffusion antimicrobial susceptibility testing of Clostridium difficile and association with PCR ribotype 027.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Humans; Metronidazole; Ribotyping; Vancomycin | 2015 |
Diarrhea With Clostridium difficile-Positive Stool-Trick or Treat: A Teachable Moment.
Topics: Aged; Anti-Bacterial Agents; Axitinib; Carcinoma, Renal Cell; Clostridioides difficile; Costs and Cost Analysis; Diagnosis, Differential; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Imidazoles; Indazoles; Metronidazole; Protein Kinase Inhibitors; Recurrence; Treatment Outcome; Vancomycin; Withholding Treatment | 2015 |
The Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Colonization and Infection among Long-Term Acute Care Hospital Residents.
Topics: Aged; Anti-Bacterial Agents; Carbapenems; Carrier State; Case-Control Studies; Drug Resistance, Bacterial; Fecal Incontinence; Female; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Metronidazole; Middle Aged; Organ Transplantation; Respiration, Artificial; Risk Factors; Stem Cell Transplantation; Thienamycins; Time Factors; Vancomycin | 2016 |
Risk Factors and Outcomes for Bloodstream Infections Secondary to Clostridium difficile Infection.
Topics: Aged; Anti-Infective Agents; Bacteremia; Candida; Candidiasis; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Coinfection; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Metronidazole; Multivariate Analysis; Odds Ratio; Risk Factors; Survival Analysis; Treatment Outcome; Vancomycin | 2016 |
Evaluation of a bedside scoring system for predicting clinical cure and recurrence of Clostridium difficile infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Humans; Male; Metronidazole; Middle Aged; Point-of-Care Testing; Predictive Value of Tests; Prognosis; Recurrence; Retrospective Studies; Treatment Outcome; Vancomycin | 2015 |
Cadazolid Does Not Promote Intestinal Colonization of Vancomycin-Resistant Enterococci in Mice.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Clostridioides difficile; Colony Count, Microbial; Diarrhea; Enterocolitis, Pseudomembranous; Fidaxomicin; Intestines; Metronidazole; Mice; Microbial Sensitivity Tests; Oxazolidinones; Streptococcal Infections; Treatment Outcome; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2016 |
Susceptibility of Clostridium difficile Isolates of Varying Antimicrobial Resistance Phenotypes to SMT19969 and 11 Comparators.
Topics: Aminoglycosides; Anti-Bacterial Agents; Benzimidazoles; Ceftriaxone; Clostridioides difficile; Clostridium Infections; Drug Resistance, Multiple, Bacterial; Fidaxomicin; Fluoroquinolones; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Phenotype; Pyridines; Ribotyping; Vancomycin | 2016 |
Clinical and Healthcare Burden of Multiple Recurrences of Clostridium difficile Infection.
Topics: Anti-Bacterial Agents; Canada; Clostridioides difficile; Cohort Studies; Cost of Illness; Enterocolitis, Pseudomembranous; Hospitalization; Incidence; Metronidazole; Recurrence; Retrospective Studies; Risk Factors; Vancomycin | 2016 |
Epidemiology and factors associated with candidaemia following Clostridium difficile infection in adults within metropolitan Atlanta, 2009-2013.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Candida; Candidemia; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Female; Georgia; Humans; Longitudinal Studies; Male; Metronidazole; Middle Aged; Prevalence; Risk Factors; Vancomycin; Young Adult | 2016 |
Thermosensitive hydrogel for periodontal application: in vitro drug release, antibacterial activity and toxicity evaluation.
Topics: Anti-Bacterial Agents; Chitosan; Drug Carriers; Gelatin; Glycerophosphates; HEK293 Cells; Humans; Hydrogels; Hydrogen-Ion Concentration; Metronidazole; Microscopy, Electron, Scanning; Molecular Weight; Periodontics; Phosphates; Rheology; Solutions; Temperature; Vancomycin | 2016 |
The Uncertain Benefits of Combination Therapy for Clostridium difficile Infection.
Topics: Anti-Infective Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Vancomycin | 2016 |
Reply to Young, Ochi, and Marimuthu.
Topics: Anti-Infective Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Vancomycin | 2016 |
Effect of Surotomycin, a Novel Cyclic Lipopeptide Antibiotic, on Intestinal Colonization with Vancomycin-Resistant Enterococci and Klebsiella pneumoniae in Mice.
Topics: Animals; Anti-Bacterial Agents; Female; Gram-Negative Bacteria; Klebsiella pneumoniae; Lipopeptides; Metronidazole; Mice; Peptides, Cyclic; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2016 |
Evaluating the Effects of Surotomycin Treatment on Clostridium difficile Toxin A and B Production, Immune Response, and Morphological Changes.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Caco-2 Cells; Cell Line, Tumor; Clostridioides difficile; Enterotoxins; Humans; Interleukin-8; Lipopeptides; Metronidazole; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Peptides, Cyclic; Vancomycin | 2016 |
The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databases.
Topics: Adult; Aged; Aged, 80 and over; Clostridium Infections; Databases, Factual; Female; Health Care Costs; Hospitals; Humans; Incidence; Longitudinal Studies; Male; Medicare; Metronidazole; Middle Aged; Retrospective Studies; United States; Vancomycin | 2016 |
A novel method for imaging the pharmacological effects of antibiotic treatment on Clostridium difficile.
Topics: Agar; Aminoglycosides; Anti-Bacterial Agents; Cell Wall; Clostridioides difficile; Culture Media; Fidaxomicin; Metronidazole; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Optical Imaging; Vancomycin | 2016 |
Clostridium difficile Associated Diarrhea.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Humans; Metronidazole; Recurrence; Vancomycin | 2016 |
[Antibiotic treatment of clostridial colitis].
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Recurrence; Vancomycin | 2016 |
Correlation between fecal calprotectin levels, disease severity and the hypervirulent ribotype 027 strain in patients with Clostridium difficile infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Resistance, Bacterial; Feces; Female; Hospitalization; Hospitals; Humans; Immunoassay; Inflammation; Israel; Leukocyte L1 Antigen Complex; Leukocytosis; Male; Metronidazole; Middle Aged; Recurrence; Ribotyping; Severity of Illness Index; Vancomycin; Young Adult | 2016 |
The efficacy of intracolonic vancomycin for severe Clostridium difficile colitis: a case series.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Colon; Drug Administration Routes; Enterocolitis, Pseudomembranous; Female; Humans; Intensive Care Units; Male; Megacolon, Toxic; Metronidazole; Middle Aged; Retrospective Studies; Risk Factors; Vancomycin | 2016 |
Pseudomembranous colitis presenting as a mechanical large bowel obstruction.
Topics: Administration, Intravenous; Administration, Oral; Anastomosis, Surgical; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colectomy; Diatrizoate Meglumine; Enterocolitis, Pseudomembranous; Humans; Ileostomy; Intestinal Obstruction; Male; Metronidazole; Middle Aged; Tomography, X-Ray Computed; Treatment Outcome; Vancomycin | 2018 |
Alteration of Esophageal Microbiome by Antibiotic Treatment Does Not Affect Incidence of Rat Esophageal Adenocarcinoma.
Topics: Adenocarcinoma; Ampicillin; Anastomosis, Surgical; Animals; Anti-Bacterial Agents; Barrett Esophagus; Disease Models, Animal; DNA, Bacterial; DNA, Ribosomal; Esophageal Neoplasms; Esophagus; Gastroesophageal Reflux; Jejunum; Male; Metronidazole; Microbiota; Neomycin; Penicillin G; Polymorphism, Restriction Fragment Length; Random Allocation; Rats; Rats, Wistar; Streptomycin; Vancomycin | 2016 |
Effect of metronidazole use on tacrolimus concentrations in transplant patients treated for Clostridium difficile.
Topics: Adult; Aged; Anti-Bacterial Agents; Clinical Decision-Making; Clostridioides difficile; Clostridium Infections; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Immunosuppressive Agents; Male; Metronidazole; Middle Aged; Organ Transplantation; Retrospective Studies; Tacrolimus; Treatment Outcome; Vancomycin | 2016 |
Efficacy of Oral Vancomycin in Preventing Recurrent Clostridium difficile Infection in Patients Treated With Systemic Antimicrobial Agents.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Humans; Metronidazole; Vancomycin | 2016 |
Comparison of agar dilution and broth microdilution methods for Clostridium difficile antimicrobial susceptibility testing.
Topics: Agar; Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Fluoroquinolones; Japan; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Vancomycin | 2016 |
Use of intravenous tigecycline in patients with severe Clostridium difficile infection: a retrospective observational cohort study.
Topics: Administration, Intravenous; Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Colectomy; Enterocolitis, Pseudomembranous; Female; Humans; Intraabdominal Infections; Male; Metronidazole; Middle Aged; Minocycline; Recurrence; Retrospective Studies; Sepsis; Tigecycline; Treatment Outcome; Vancomycin | 2016 |
Molecular types and antimicrobial susceptibility patterns of Clostridium difficile isolates in different epidemiological settings in a tertiary care center in Israel.
Topics: Adult; Anti-Bacterial Agents; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Genotype; Humans; Israel; Metronidazole; Prospective Studies; Tertiary Care Centers; Vancomycin | 2016 |
High prevalence of nontoxigenic Clostridium difficile isolated from hospitalized and non-hospitalized individuals in rural Ghana.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Toxins; Carrier State; Ceftriaxone; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Cross-Sectional Studies; Diarrhea; Feces; Female; Ghana; Hospitalization; Humans; Infant; Infant, Newborn; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prevalence; Prospective Studies; Ribotyping; Risk Factors; Rural Population; Vancomycin; Young Adult | 2016 |
Bypass graft infection and bacteremia caused by Anaerostipes caccae: First report of human infection caused by a recently described gut anaerobe.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anastomosis, Surgical; Anti-Bacterial Agents; beta-Lactams; Blood Culture; Clostridiales; Ertapenem; Female; Gram-Positive Bacterial Infections; Humans; Metronidazole; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Surgical Wound Infection; Vancomycin | 2016 |
Clostridium difficile infection in children: epidemiology and risk of recurrence in a low-prevalence country.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Diarrhea; Female; Humans; Infant; Infant, Newborn; Italy; Male; Metronidazole; Prevalence; Recurrence; Retrospective Studies; Risk Assessment; Treatment Outcome; Vancomycin | 2017 |
[Clostridium difficile infection : What is currently available for treatment?]
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Evidence-Based Medicine; Fidaxomicin; Humans; Megacolon, Toxic; Metronidazole; Treatment Outcome; Vancomycin | 2016 |
Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis.
Topics: Aged; Amino Acid Substitution; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Clostridioides difficile; Clostridium Infections; Czech Republic; DNA Gyrase; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Capillary; Female; Fluoroquinolones; Gene Expression; Humans; Male; Methyltransferases; Metronidazole; Microbial Sensitivity Tests; Minisatellite Repeats; Moxifloxacin; Multilocus Sequence Typing; Retrospective Studies; Ribotyping; Tertiary Care Centers; Vancomycin | 2017 |
An institutional comparison of total abdominal colectomy and diverting loop ileostomy and colonic lavage in the treatment of severe, complicated Clostridium difficile infections.
Topics: Aged; Anti-Bacterial Agents; Clostridium Infections; Colectomy; Colon; Female; Humans; Ileostomy; Male; Metronidazole; Middle Aged; Organ Sparing Treatments; Recurrence; Retrospective Studies; Severity of Illness Index; Therapeutic Irrigation; Vancomycin; Virginia | 2017 |
Photo Quiz: A 44-Year-Old Kidney Transplant Patient with Pneumonia.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; beta-Lactamases; Clostridioides difficile; Enterobacter cloacae; Female; Humans; Imipenem; Kidney Failure, Chronic; Kidney Transplantation; Metronidazole; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Respiratory Insufficiency; Vancomycin | 2017 |
Lack of adherence to SHEA-IDSA treatment guidelines for Clostridium difficile infection is associated with increased mortality.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colitis; Drug Therapy, Combination; Female; Guideline Adherence; Humans; Male; Medical Records; Metronidazole; Middle Aged; Retrospective Studies; Treatment Outcome; Vancomycin | 2017 |
Lack of Benefit With Combination Therapy for Clostridium difficile Infection.
Topics: Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Clostridioides difficile; Combined Modality Therapy; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Infant; Length of Stay; Male; Metronidazole; Middle Aged; Proportional Hazards Models; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Vancomycin; Young Adult | 2017 |
Comparative Effectiveness of Vancomycin and Metronidazole for the Prevention of Recurrence and Death in Patients With Clostridium difficile Infection.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Feces; Female; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies; Risk Assessment; Secondary Prevention; Survival Analysis; Treatment Outcome; United States; Vancomycin | 2017 |
Real-Time Electronic Tracking of Diarrheal Episodes and Laxative Therapy Enables Verification of Clostridium difficile Clinical Testing Criteria and Reduction of Clostridium difficile Infection Rates.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Electronic Data Processing; Enterocolitis, Pseudomembranous; Evidence-Based Medicine; Female; Hospital Information Systems; Humans; Laxatives; Male; Metronidazole; Middle Aged; Vancomycin | 2017 |
Rare Presentation of Brain Abscess.
Topics: Anti-Infective Agents; Brain; Brain Abscess; Ceftriaxone; Child; Craniotomy; Female; Fever; Humans; Metronidazole; Tomography, X-Ray Computed; Treatment Outcome; Vancomycin | 2017 |
Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolates from two Korean hospitals.
Topics: Anti-Bacterial Agents; Asian People; Clostridioides difficile; Clostridium Infections; Cross Infection; Daptomycin; Diarrhea; Electrophoresis, Gel, Pulsed-Field; Feces; Genes, Bacterial; Hospitals; Humans; Metronidazole; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Reproducibility of Results; Republic of Korea; Ribotyping; Vancomycin | 2017 |
An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Disease Outbreaks; Female; Humans; Male; Metronidazole; Middle Aged; Polymerase Chain Reaction; Prospective Studies; Recurrence; Ribotyping; Risk Factors; Spain; Survival Analysis; Treatment Outcome; Vancomycin; Young Adult | 2017 |
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Metronidazole; Microscopy, Electron, Scanning; Reproducibility of Results; Vancomycin | 2017 |
Pituitary abscess.
Topics: Anti-Bacterial Agents; Antiprotozoal Agents; Brain Abscess; Ceftriaxone; Diagnosis, Differential; Humans; Hydrocortisone; Hypopituitarism; Magnetic Resonance Imaging; Male; Metronidazole; Pituitary Diseases; Pituitary Gland; Treatment Outcome; Vancomycin; Young Adult | 2017 |
Vancomycin vs Metronidazole for Clostridium difficile infection: focus on recurrence and mortality.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Feces; Female; Humans; Male; Metronidazole; Middle Aged; Recurrence; Risk Assessment; Secondary Prevention; Survival Analysis; Treatment Outcome; United States; Vancomycin | 2017 |
High in vitro activity of fidaxomicin against Clostridium difficile isolates from a university teaching hospital in China.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Toxins; China; Clostridioides difficile; Clostridium Infections; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Fidaxomicin; Fluoroquinolones; Genes, Bacterial; Hospitals, Teaching; Hospitals, University; Humans; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Multilocus Sequence Typing; Ribotyping; Tigecycline; Vancomycin | 2018 |
Antimicrobial susceptibility of Clostridium difficile isolates in Israel.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Drug Combinations; Feces; Hospitals; Humans; Israel; Metronidazole; Microbial Sensitivity Tests; Ribotyping; Tigecycline; Vancomycin | 2017 |
Post-hospitalization Treatment Regimen and Readmission for C. difficile Colitis in Medicare Beneficiaries.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colitis; Cross Infection; Drug Therapy, Combination; Female; Hospitalization; Humans; Male; Medicare; Metronidazole; Patient Readmission; Recurrence; Retrospective Studies; United States; Vancomycin | 2018 |
Treating Clostridium difficile infection in patients presenting with hematological malignancies: Are current guidelines applicable?
Topics: Adult; Clostridioides difficile; Clostridium Infections; Cross Infection; Disease Management; Female; Hematologic Neoplasms; Hospital Units; Hospitals, Teaching; Humans; Immunocompromised Host; Male; Medication Adherence; Metronidazole; Middle Aged; Practice Guidelines as Topic; Recurrence; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Vancomycin | 2017 |
Recurrent bacteremia and liver abscess caused by Clostridium difficile: A case report.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Translocation; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Clostridioides difficile; Clostridium Infections; Humans; Liver Abscess; Liver Cirrhosis, Biliary; Liver Neoplasms; Male; Metronidazole; Recurrence; Vancomycin | 2017 |
Analysis of Clostridium difficile biofilms: imaging and antimicrobial treatment.
Topics: Aminoglycosides; Anti-Bacterial Agents; Biofilms; Biological Transport; Clostridioides difficile; Colony Count, Microbial; Fidaxomicin; Humans; Lipopeptides; Metronidazole; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Peptides, Cyclic; Spores, Bacterial; Vancomycin | 2018 |
Sterile subdural empyema: an unusual presentation.
Topics: Aged; Anti-Bacterial Agents; Biopsy; Brain; Ceftriaxone; Diagnosis, Differential; Drainage; Empyema, Subdural; Humans; Magnetic Resonance Imaging; Male; Metronidazole; Vancomycin | 2017 |
Clostridium difficile treatment in neutropenic patients: Clinical outcomes of metronidazole, vancomycin, combinations, and switch therapy.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Diarrhea; Female; Humans; Inpatients; Leukocyte Count; Male; Metronidazole; Middle Aged; Neutrophils; Recurrence; Retrospective Studies; Treatment Outcome; Vancomycin | 2019 |
Successful treatment by fecal microbiota transplantation for Japanese patients with refractory Clostridium difficile infection: A prospective case series.
Topics: Aged; Aged, 80 and over; Clostridioides difficile; Clostridium Infections; Colonoscopy; Fecal Microbiota Transplantation; Feces; Female; Gastrointestinal Microbiome; Humans; Japan; Male; Metronidazole; Prospective Studies; Treatment Outcome; Vancomycin | 2019 |
Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from hospitals during a 4-year period in China.
Topics: Anti-Infective Agents; Bacterial Proteins; China; Clindamycin; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Humans; Metronidazole; Microbial Sensitivity Tests; Molecular Epidemiology; Moxifloxacin; Tertiary Care Centers; Vancomycin | 2018 |
Citrobacter rodentium Relies on Commensals for Colonization of the Colonic Mucosa.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Citrobacter rodentium; Colon; Gastrointestinal Microbiome; Intestinal Mucosa; Kanamycin; Metronidazole; Mice; Vancomycin; Virulence | 2017 |
The outcome of patients with severe and severe-complicated Clostridium difficile infection treated with tigecycline combination therapy: a retrospective observational study.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anti-Bacterial Agents; Australia; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Middle Aged; Minocycline; Retrospective Studies; Tigecycline; Treatment Outcome; Vancomycin | 2018 |
The Rise and Fall of Metronidazole for Clostridium difficile Infection.
Topics: Anti-Bacterial Agents; Clostridium Infections; Humans; Metronidazole; Vancomycin | 2018 |
Regulation of vitamin D metabolism following disruption of the microbiota using broad spectrum antibiotics.
Topics: 24,25-Dihydroxyvitamin D 3; 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; Ampicillin; Animals; Anti-Bacterial Agents; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Gene Expression Regulation; Ligands; Male; Metronidazole; Mice; Mice, Inbred C57BL; Mice, Knockout; Microbiota; Neomycin; Receptors, Calcitriol; Signal Transduction; Toll-Like Receptors; Vancomycin; Vitamin D | 2018 |
Molecular characterization, toxin detection and resistance testing of human clinical Clostridium difficile isolates from Lebanon.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Drug Resistance, Multiple, Bacterial; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Female; Fluoroquinolones; Humans; Lebanon; Male; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Multilocus Sequence Typing; Phenotype; Ribotyping; Vancomycin | 2018 |
Comparison of outcomes with vancomycin or metronidazole for mild-to-moderate Clostridium difficile associated diarrhea among solid organ transplant recipients: A retrospective cohort study.
Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Diarrhea; Female; Humans; Male; Metronidazole; Middle Aged; Organ Transplantation; Recurrence; Retrospective Studies; Transplant Recipients; Treatment Outcome; Vancomycin | 2018 |
Risk factors for recurrent Clostridium difficile infection in a tertiary hospital in Israel.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Cephalosporins; Clindamycin; Clostridioides difficile; Clostridium Infections; Female; Humans; Israel; Male; Metronidazole; Middle Aged; Prospective Studies; Retrospective Studies; Risk Factors; Secondary Prevention; Tertiary Care Centers; Vancomycin | 2018 |
Molecular epidemiologic study of Clostridium difficile infections in university hospitals: Results of a nationwide study in Japan.
Topics: Adolescent; ADP Ribose Transferases; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Clostridioides difficile; Clostridium Infections; Epidemiological Monitoring; Feces; Female; Hospitals, University; Humans; Inhibitory Concentration 50; Japan; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Polymerase Chain Reaction; Ribotyping; Severity of Illness Index; Vancomycin; Young Adult | 2018 |
Clostridium difficile cure with fecal microbiota transplantation in a child with Pompe disease: a case report.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Female; Glycogen Storage Disease Type II; Humans; Immunocompetence; Infant; Metronidazole; Polymerase Chain Reaction; Treatment Outcome; Vancomycin | 2018 |
Combination Antibiotics Improves Disease Activity and Alters Microbial Communities in Children With Ulcerative Colitis.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Child; Colitis, Ulcerative; Doxycycline; Female; Fluconazole; Gastrointestinal Microbiome; Humans; Male; Metronidazole; Retrospective Studies; Vancomycin; Young Adult | 2018 |
The 'ins and outs' of faecal microbiota transplant for recurrent Clostridium difficile diarrhoea at Wits Donald Gordon Medical Centre, Johannesburg, South Africa.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Drug Resistance, Bacterial; Fecal Microbiota Transplantation; Female; Humans; Intubation, Gastrointestinal; Male; Metronidazole; Middle Aged; Outcome and Process Assessment, Health Care; Recurrence; South Africa; Vancomycin | 2018 |
The emergence of Clostridium difficile PCR ribotype 078 in piglets in the Czech Republic clusters with Clostridium difficile PCR ribotype 078 isolates from Germany, Japan and Taiwan.
Topics: Amino Acid Substitution; Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Czech Republic; DNA Gyrase; Germany; Japan; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Multilocus Sequence Typing; Ribotyping; Swine; Taiwan; Tetracycline; Vancomycin | 2018 |
Gut microbiota modulate neurobehavior through changes in brain insulin sensitivity and metabolism.
Topics: Animals; Anti-Bacterial Agents; Anxiety; Brain; Diet, High-Fat; Gastrointestinal Microbiome; Inflammation; Insulin; Insulin Resistance; Male; Metronidazole; Mice; Mice, Inbred C57BL; Microbiota; Obesity; RNA, Ribosomal, 16S; Vancomycin | 2018 |
Molecular epidemiology and antimicrobial susceptibility of human Clostridium difficile isolates from a single institution in Northern China.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Beijing; China; Clostridioides difficile; Clostridium Infections; Disease Outbreaks; Drug Resistance, Microbial; Humans; Metronidazole; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Phylogeny; Vancomycin | 2018 |
The evolving epidemiology of
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Canada; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies; Treatment Outcome; Vancomycin; Young Adult | 2018 |
Highly antibiotic-resistant Clostridium difficile isolates from Iranian patients.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Iran; Metronidazole; Microbial Sensitivity Tests; Vancomycin | 2018 |
Antibiotic-induced microbiome depletion alters metabolic homeostasis by affecting gut signaling and colonic metabolism.
Topics: Amphotericin B; Ampicillin; Animals; Anti-Bacterial Agents; Bile Acids and Salts; Blood Glucose; Body Composition; Body Weight; Cecum; Colon; Fatty Acids, Volatile; Gastrointestinal Microbiome; Gene Expression Regulation; Glucose; Homeostasis; Insulin; Insulin Resistance; Male; Metronidazole; Mice; Mice, Inbred C57BL; Neomycin; Obesity; RNA, Ribosomal, 16S; Vancomycin | 2018 |
Comparison of the in vitro antibacterial activity of Ramizol, fidaxomicin, vancomycin, and metronidazole against 100 clinical isolates of Clostridium difficile by broth microdilution.
Topics: Anti-Bacterial Agents; Benzoates; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Inhibitory Concentration 50; Metronidazole; Microbial Sensitivity Tests; Stilbenes; Vancomycin | 2018 |
Clostridium difficile infection in young people - 2 case reports.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Ceftriaxone; Clostridioides difficile; Clostridium Infections; Female; Humans; Metronidazole; Risk Factors; Salmonella enteritidis; Salmonella Infections; Salmonella typhi; Treatment Outcome; Vancomycin | 2018 |
Commensal bacteria aggravate allergic asthma via NLRP3/IL-1β signaling in post-weaning mice.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Asthma; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Epithelial Cells; Gene Expression; Interleukin-1beta; Lung; Macrophages, Peritoneal; Metronidazole; Mice; Mice, Inbred C57BL; Mice, Knockout; Microbiota; NLR Family, Pyrin Domain-Containing 3 Protein; Ovalbumin; Signal Transduction; Symbiosis; Vancomycin; Weaning | 2018 |
Fidaxomicin in the treatment of Clostridium difficile infection in oncohematology patients.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colonic Neoplasms; Diarrhea; Female; Fidaxomicin; Hematologic Neoplasms; Humans; Male; Metronidazole; Middle Aged; Treatment Outcome; Vancomycin | 2019 |
Long-term impact of oral vancomycin, ciprofloxacin and metronidazole on the gut microbiota in healthy humans.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Biodiversity; Ciprofloxacin; Feces; Gastrointestinal Microbiome; Healthy Volunteers; Humans; Male; Metronidazole; Time Factors; Vancomycin; Young Adult | 2019 |
Multispacer sequence typing of Coxiella burnetii DNA from removed prosthetic heart valve material discloses first human case of infective endocarditis caused by MST_18.
Topics: Abscess; Aged; Aortic Valve; Coxiella burnetii; Denmark; DNA, Bacterial; Doxycycline; Echinocandins; Endocarditis, Bacterial; Fatal Outcome; Gentamicins; Heart Valve Prosthesis; Humans; Male; Meropenem; Metronidazole; Multilocus Sequence Typing; Rifampin; RNA, Ribosomal, 16S; Vancomycin | 2019 |
A multicenter-based study on epidemiology, antibiotic susceptibility and risk factors of toxigenic Clostridium difficile in hospitalized patients in southwestern Iran.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Clostridioides difficile; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Female; Hospitals, Teaching; Humans; Iran; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Vancomycin; Young Adult | 2018 |
What Is the Role for Metronidazole in the Treatment of Clostridium difficile Infection? Results From a National Cohort Study of Veterans With Initial Mild Disease.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Female; Humans; Logistic Models; Male; Metronidazole; Vancomycin; Veterans | 2019 |
The emergence of metronidazole and vancomycin reduced susceptibility in Clostridium difficile isolates in Iran.
Topics: Aged; Aged, 80 and over; Animals; Chlorocebus aethiops; Clostridioides difficile; Clostridium Infections; Drug Resistance, Multiple, Bacterial; Feces; Female; Humans; Iran; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Tertiary Care Centers; Vancomycin; Vero Cells | 2019 |
Changes in Clostridium (Clostridioides) difficile PCR-Ribotype Distribution and Antimicrobial Resistance in a German Tertiary Care Hospital Over the Last 10 Years.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Epidemiological Monitoring; Feces; Germany; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Ribotyping; Tertiary Care Centers; Vancomycin | 2019 |
The first isolation of Clostridium difficile RT078/ST11 from pigs in China.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Cefoxitin; Chickens; China; Ciprofloxacin; Clostridioides difficile; Ducks; Imipenem; Metronidazole; Molecular Epidemiology; Multilocus Sequence Typing; Polymerase Chain Reaction; Ribotyping; Swine; Tetracycline; Vancomycin | 2019 |
Association Between Antibiotic Use and Hospital-onset Clostridioides difficile Infection in US Acute Care Hospitals, 2006-2012: An Ecologic Analysis.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Clostridioides difficile; Clostridium Infections; Cross Infection; Cross-Sectional Studies; Drug Prescriptions; Ecological and Environmental Phenomena; Female; Fluoroquinolones; Hospitalization; Hospitals; Humans; Interrupted Time Series Analysis; Male; Metronidazole; Middle Aged; United States; Vancomycin | 2020 |
Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Cross Infection; Female; Hospitals; Humans; Inpatients; Japan; Logistic Models; Male; Metronidazole; Proton Pump Inhibitors; Recurrence; Retrospective Studies; Risk Factors; Vancomycin | 2019 |
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Clostridium Infections; Croatia; Female; Guideline Adherence; Humans; Infant; Infant, Newborn; Male; Metronidazole; Middle Aged; Retrospective Studies; Tertiary Care Centers; Treatment Outcome; Vancomycin; Young Adult | 2019 |
Risk factors and outcomes of Clostridium difficile infection in hospitalized patients.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Humans; Male; Metronidazole; Middle Aged; Multivariate Analysis; Risk Factors; Treatment Outcome; Vancomycin | 2019 |
Clostridium difficile: A Frequent Infection in Children After Intestinal Transplantation.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Cross-Sectional Studies; Diarrhea; Feces; Female; Follow-Up Studies; Humans; Intestinal Mucosa; Intestine, Small; Male; Metronidazole; Postoperative Complications; Prevalence; Recurrence; Retrospective Studies; Risk Factors; Vancomycin | 2020 |
Commensal Microbes Affect Host Humoral Immunity to
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Bacteroidetes; Bordetella pertussis; Dysbiosis; Female; Firmicutes; Gastrointestinal Microbiome; Immunity, Humoral; Immunity, Innate; Immunoglobulin G; Metronidazole; Mice; Mice, Inbred BALB C; Neomycin; Proteobacteria; Symbiosis; Vancomycin; Whooping Cough | 2019 |
Use of Oral Vancomycin for Clostridioides difficile Infection and the Risk of Vancomycin-Resistant Enterococci.
Topics: Anti-Bacterial Agents; Clostridioides; Clostridioides difficile; Clostridium Infections; Humans; Metronidazole; Retrospective Studies; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Risk factors and treatment outcomes of severe Clostridioides difficile infection in Singapore.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridium Infections; Diarrhea; Female; Humans; Intensive Care Units; Male; Metronidazole; Recurrence; Risk Factors; Singapore; Treatment Outcome; Vancomycin | 2019 |
Does Addition of Intravenous Metronidazole to Oral Vancomycin Improve Outcomes in Clostridioides difficile Infection?
Topics: Adult; Anti-Bacterial Agents; Clostridioides; Clostridioides difficile; Clostridium Infections; Humans; Metronidazole; Retrospective Studies; Vancomycin | 2020 |
Potential impact of removing metronidazole from treatment armamentarium of mild acute
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Administration Schedule; Female; Humans; Israel; Male; Metronidazole; Middle Aged; Practice Guidelines as Topic; Retrospective Studies; Time Factors; Treatment Outcome; Vancomycin; Vancomycin-Resistant Enterococci; Young Adult | 2019 |
Clostridioides (Clostridium) difficile infection in Japanese hospitals 2008-2017: A real-world nationwide analysis of treatment pattern, incidence and testing density.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross-Sectional Studies; Drug Administration Routes; Female; Hospitalization; Hospitals; Humans; Immunoenzyme Techniques; Incidence; Inpatients; Japan; Male; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Time Factors; Vancomycin | 2020 |
Cost-effectiveness analysis of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in Japan.
Topics: Aged; Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Clostridioides difficile; Clostridium Infections; Cost-Benefit Analysis; Drug Costs; Drug Utilization Review; Female; Fidaxomicin; Humans; Japan; Length of Stay; Male; Metronidazole; Middle Aged; Network Meta-Analysis; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Recurrence; Vancomycin | 2020 |
Management of difficult-to-treat
Topics: Administration, Intravenous; Anti-Bacterial Agents; Clostridium Infections; Colitis; Combined Modality Therapy; Drug Resistance, Multiple, Bacterial; Fecal Microbiota Transplantation; Fidaxomicin; Foot; Humans; Male; Metronidazole; Middle Aged; Osteomyelitis; Vancomycin | 2020 |
The Trend for Antibiotic Use for Clostridioides (Clostridium) difficile Infection in Japan.
Topics: Anti-Bacterial Agents; Clostridium Infections; Drug Costs; Drug Utilization; Humans; Japan; Metronidazole; Vancomycin | 2020 |
Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non-Fulminant Severe Clostridioides difficile Infection.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; APACHE; Clostridium Infections; Cohort Studies; Critical Illness; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Metronidazole; Middle Aged; Retrospective Studies; Vancomycin | 2020 |
Characteristics of Clostridium difficile isolates and the burden of hospital-acquired Clostridium difficile infection in a tertiary teaching hospital in Chongqing, Southwest China.
Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; China; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Female; Hospitals, Teaching; Humans; Incidence; Male; Metronidazole; Middle Aged; Multilocus Sequence Typing; Polymerase Chain Reaction; Ribotyping; Risk Factors; Tertiary Care Centers; Vancomycin | 2020 |
Repurposing a platelet aggregation inhibitor ticagrelor as an antimicrobial against Clostridioides difficile.
Topics: Anti-Bacterial Agents; Biofilms; Cell Membrane; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Evaluation, Preclinical; Drug Repositioning; Drug Resistance, Bacterial; Drug Synergism; Humans; Metronidazole; Microbial Sensitivity Tests; Microscopy, Electron; Spores, Bacterial; Ticagrelor; Vancomycin | 2020 |
The tcdA-negative and tcdB-positive Clostridium difficile ST81 clone exhibits a high level of resistance to fluoroquinolones: a multi-centre study in Beijing, China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; China; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; DNA Gyrase; Drug Resistance, Bacterial; Enterotoxins; Fluoroquinolones; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Moxifloxacin; Vancomycin | 2020 |
In Vitro Investigation of Auranofin as a Treatment for Clostridium difficile Infection.
Topics: Anti-Bacterial Agents; Auranofin; Clostridioides difficile; Clostridium Infections; Drug Repositioning; Metronidazole; Microbial Sensitivity Tests; Microbial Viability; Spores, Bacterial; Vancomycin | 2020 |
Successful Treatment of Pseudomembranous Colitis with Fecal Microbiota Transplantation - A Case Study on A Patient Rescued by Extracorporeal Cardiopulmonary Resuscitation After Cardiac Arrest.
Topics: Adolescent; Anti-Bacterial Agents; Cardiopulmonary Resuscitation; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Female; Heart Arrest; Humans; Metronidazole; Treatment Outcome; Vancomycin | 2020 |
Incidence and Risk Factors of Recurrent Clostridioides difficile Infection in Patients With Cirrhosis.
Topics: Aged; Anti-Bacterial Agents; Clostridioides; Clostridium Infections; Comorbidity; Diagnostic Errors; Female; Fidaxomicin; Humans; Incidence; Lactulose; Laxatives; Liver Cirrhosis; Male; Metronidazole; Middle Aged; Patient Readmission; Recurrence; Retrospective Studies; Risk Factors; Severity of Illness Index; Treatment Failure; Vancomycin | 2020 |
[Non-severe Clostridioides difficile Infection: Are the data adequate to give up metronidazole?]
Topics: Anti-Bacterial Agents; Clostridioides difficile; Humans; Metronidazole; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Outcome; Vancomycin | 2020 |
Susceptibility patterns of anaerobes isolated from clinical specimens in tertiary Hospital, Malaysia.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Clindamycin; Drug Resistance, Bacterial; Humans; Imipenem; Malaysia; Metronidazole; Microbial Sensitivity Tests; Tertiary Care Centers; Vancomycin | 2020 |
Repurposing the Veterinary Antiprotozoal Drug Ronidazole for the Treatment of Clostridioides difficile Infection.
Topics: Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Caco-2 Cells; Cell Line, Tumor; Clostridioides difficile; Disease Models, Animal; Drug Repositioning; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Mice; Microbial Sensitivity Tests; Ronidazole; Vancomycin; Veterinary Drugs | 2020 |
Critique of "Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non-Fulminant Severe Clostridioides difficile Infection".
Topics: Clostridioides; Clostridium Infections; Critical Illness; Humans; Metronidazole; Vancomycin | 2020 |
Reply to Letters to the Editor.
Topics: Anti-Infective Agents; Clostridioides; Clostridium Infections; Critical Illness; Humans; Metronidazole; Vancomycin | 2020 |
Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection - An observational cohort study.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Female; Fidaxomicin; Hospitalization; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Recurrence; Treatment Outcome; Vancomycin | 2021 |
A preliminary study of bowel rest strategy in the management of Clostridioides difficile infection.
Topics: Aged; Aged, 80 and over; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Disease-Free Survival; Female; Humans; Male; Metronidazole; Retrospective Studies; Survival Rate; Vancomycin | 2020 |
Outcomes associated with recent guideline recommendations removing metronidazole for treatment of non-severe Clostridioides difficile infection: a retrospective, observational, nationwide cohort study.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Utilization; Female; Fidaxomicin; Humans; Male; Metronidazole; Middle Aged; Practice Guidelines as Topic; Recurrence; Retrospective Studies; Risk Factors; Treatment Outcome; Vancomycin | 2021 |
Antibiotic-associated dysbiosis affects the ability of the gut microbiota to control intestinal inflammation upon fecal microbiota transplantation in experimental colitis models.
Topics: Animals; Anti-Bacterial Agents; Colitis; Disease Models, Animal; Dysbiosis; Fecal Microbiota Transplantation; Female; Gastrointestinal Microbiome; Humans; Male; Metronidazole; Mice; Natural Killer T-Cells; Streptomycin; Th1 Cells; Th17 Cells; Vancomycin | 2021 |
Maternal antibiotic administration during a critical developmental window has enduring neurobehavioural effects in offspring mice.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anxiety; Ciprofloxacin; Cognition; Female; Homing Behavior; Imipenem; Male; Metronidazole; Mice; Mice, Inbred C57BL; Penicillin V; Pregnancy; Prenatal Exposure Delayed Effects; Social Behavior; Vancomycin; Vocalization, Animal | 2021 |
Changes in Metronidazole and Vancomycin Utilization for Nonsevere Clostridioides difficile Infection Among Institutions Caring for Children.
Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Cross-Sectional Studies; Drug Utilization; Humans; Infant; Metronidazole; Vancomycin | 2021 |
Changes in treatment of community-onset Clostridioides difficile infection after release of updated guidelines, Atlanta, Georgia, 2018.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Community-Acquired Infections; Female; Georgia; Guidelines as Topic; Humans; Male; Metronidazole; Middle Aged; Vancomycin | 2021 |
Retrospective study of the efficacy and safety of metronidazole and vancomycin for Clostridioides difficile infection.
Topics: Aged; Anti-Bacterial Agents; Clostridioides; Clostridioides difficile; Clostridium Infections; Female; Humans; Metronidazole; Retrospective Studies; Vancomycin | 2021 |
Antimicrobial resistance progression in the United Kingdom: A temporal comparison of Clostridioides difficile antimicrobial susceptibilities.
Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Erythromycin; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; United Kingdom; Vancomycin | 2021 |
Early Life Antibiotics Influence In Vivo and In Vitro Mouse Intestinal Epithelium Maturation and Functioning.
Topics: Amoxicillin; Animals; Animals, Newborn; Anti-Bacterial Agents; Disease Models, Animal; Enterocytes; Gene Expression Profiling; Gene Expression Regulation; Gene Regulatory Networks; Intestines; Metronidazole; Mice; Oligonucleotide Array Sequence Analysis; Permeability; Postnatal Care; Vacuoles; Vancomycin | 2021 |
Toxigenic
Topics: Anti-Bacterial Agents; Bacterial Proteins; Clostridioides difficile; Clostridium Infections; Diarrhea; DNA, Bacterial; Drug Therapy, Combination; Enterotoxins; Hematopoietic Stem Cell Transplantation; Humans; Metronidazole; Polymerase Chain Reaction; Treatment Outcome; Vancomycin | 2021 |
Raja 42, a novel gamma lactam compound, is effective against Clostridioides difficile.
Topics: Clostridioides difficile; Humans; Indoles; Metronidazole; Microbial Sensitivity Tests; Vancomycin | 2021 |
Outcomes of clinical decision support for outpatient management of
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Decision Support Systems, Clinical; Female; Fidaxomicin; Humans; Male; Metronidazole; Middle Aged; Outpatients; Vancomycin | 2022 |
Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
Topics: Aged; Aged, 80 and over; Bacteriological Techniques; Clostridioides; Clostridioides difficile; Clostridium Infections; Diagnostic Tests, Routine; Diarrhea; Feces; Female; Humans; Immunoenzyme Techniques; Male; Metronidazole; Middle Aged; Multivariate Analysis; Treatment Outcome; Vancomycin | 2021 |
A case of vasculitis triggered by infective endocarditis in a patient undergoing maintenance hemodialysis: a case report.
Topics: Aged; Anti-Bacterial Agents; Clostridium Infections; Echocardiography, Transesophageal; Endocarditis; Glucocorticoids; Humans; IgA Vasculitis; Kidney Failure, Chronic; Male; Methicillin-Resistant Staphylococcus aureus; Metronidazole; Prednisolone; Renal Dialysis; Staphylococcal Infections; Vancomycin | 2022 |
Seeing C diff differently.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Consumer Health Information; Cost of Illness; Enterocolitis, Pseudomembranous; False Negative Reactions; Humans; Metronidazole; Vancomycin | 2022 |
Non-inferiority of metronidazole to vancomycin in the treatment of first episode non-severe Clostridioides difficile infection: a single center retrospective cohort study.
Topics: Adult; Aftercare; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Hospital Mortality; Humans; Infant, Newborn; Metronidazole; Patient Discharge; Recurrence; Retrospective Studies; Vancomycin | 2022 |
Therapeutic Effects of Bifidobacterium breve YH68 in Combination with Vancomycin and Metronidazole in a Primary Clostridioides difficile-Infected Mouse Model.
Topics: Animals; Anti-Bacterial Agents; Bifidobacterium breve; Clostridioides; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Feces; Metronidazole; Mice; RNA, Ribosomal, 16S; Vancomycin | 2022 |
Effects of Four Antibiotics on the Diversity of the Intestinal Microbiota.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteria; Dysbiosis; Gastrointestinal Microbiome; Humans; Metronidazole; Mice; Neomycin; RNA, Ribosomal, 16S; Vancomycin | 2022 |
Activity of omadacycline in vitro against Clostridioides difficile and preliminary efficacy assessment in a hamster model of C. difficile-associated diarrhoea.
Topics: Animals; Anti-Bacterial Agents; Clindamycin; Clostridioides; Clostridioides difficile; Cricetinae; Diarrhea; Metronidazole; Tetracyclines; Tigecycline; Vancomycin | 2022 |
Dogs as carriers of virulent and resistant genotypes of Clostridioides difficile.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Clindamycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Dog Diseases; Dogs; Drug Resistance, Bacterial; Erythromycin; Genotype; Humans; Metronidazole; Microbial Sensitivity Tests; Multilocus Sequence Typing; Tetracyclines; Vancomycin | 2022 |
Long-term modification of gut microbiota by broad-spectrum antibiotics improves stroke outcome in rats.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Cytokines; Endothelin-1; Fatty Acids, Volatile; Gastrointestinal Microbiome; Infarction; Meropenem; Metronidazole; Rats; Stroke; Vancomycin | 2022 |
Cefotaxime-induced drug reaction with eosinophilia and systemic symptom in a child with cross-reactivity to other cephalosporins and cosensitization to teicoplanin.
Topics: Adult; Cefotaxime; Cephalosporins; Child; Child, Preschool; Drug Hypersensitivity Syndrome; Eosinophilia; Humans; Male; Metronidazole; Teicoplanin; Vancomycin | 2023 |
Clostridioides difficile infection in paediatric patients with cancer and haematopoietic stem cell transplant recipients.
Topics: Anti-Bacterial Agents; Child; Clostridioides difficile; Clostridium Infections; Hematopoietic Stem Cell Transplantation; Humans; Metronidazole; Neoplasms; Recurrence; Retrospective Studies; Vancomycin | 2022 |
Antibiotic Changes Host Susceptibility to Eimeria falciformis Infection Associated with Alteration of Gut Microbiota.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Coccidiosis; Eimeria; Gastrointestinal Microbiome; Metronidazole; Mice; Neomycin; Parasites; Vancomycin | 2022 |
Reference Susceptibility Testing and Genomic Surveillance of Clostridioides difficile, United States, 2012-17.
Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Genomics; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Ribotyping; United States; Vancomycin | 2023 |
[Clostridioides difficile infection: various therapeutic approaches].
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Metronidazole; Vancomycin | 2022 |
Antibiotic susceptibility and biofilm-forming ability of Veillonella strains.
Topics: Ampicillin; Anti-Bacterial Agents; Biofilms; Cefoxitin; Clindamycin; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Piperacillin; Tazobactam; Tetracyclines; Vancomycin; Veillonella | 2022 |
Intravenous metronidazole for fulminant Clostridioides difficile infection.
Topics: Anti-Bacterial Agents; Clostridium Infections; Humans; Metronidazole; Vancomycin | 2023 |
Combination of Bifidobacterium breve and antibiotics against Clostridioides difficile: effect of the time interval of combination on antagonistic activity.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Bifidobacterium breve; Chromatography, Liquid; Clostridioides; Clostridioides difficile; Enterotoxins; Metronidazole; Tandem Mass Spectrometry; Vancomycin | 2023 |
Model-informed precision dosing of antimicrobial drugs in pediatrics: experiences from a pilot scale program.
Topics: Anti-Bacterial Agents; Bayes Theorem; Child; Clindamycin; Critical Illness; Fluconazole; Humans; Linezolid; Meropenem; Metronidazole; Neoplasms; Piperacillin; Vancomycin | 2023 |
Risk factors for Recurrent Clostridioides Difficile Infection in Children.
Topics: Anti-Bacterial Agents; Child; Chronic Disease; Clostridioides difficile; Clostridium Infections; Female; Humans; Metronidazole; Recurrence; Risk Factors; Vancomycin | 2023 |
In vitro activity of fidaxomicin and combinations of fidaxomicin with other antibiotics against Clostridium perfringens strains isolated from dogs and cats.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Clindamycin; Clostridioides difficile; Clostridium Infections; Clostridium perfringens; Diarrhea; Dog Diseases; Dogs; Erythromycin; Fidaxomicin; Humans; Imipenem; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Vancomycin | 2023 |